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Efforts toward the Total Synthesis of Cyclocitrinol 
Carolyn S. Wei 
	  
This thesis documents our synthetic efforts toward cyclocitrinol, a unique steroid with a fused 
ring system possessing a rare bicyclo[4.4.1]undec-7,10-diene AB ring with a bridgehead double 
bond. Beginning with a summary of the Leighton group’s early model studies and later rational 
optimization of a strain-accelerated tandem Ireland-Claisen/Cope rearrangement to construct the 
ABC tricyclic core of cyclocitrinol (Chapter 1), we progress to our recent efforts to prepare the 
fully elaborated ABCD tetracyclic core and install the C17 side-chain. We discuss two strategies 
that were explored for the completion of the molecule: 1) an Ireland-Claisen/Cope/Claisen 
rearrangement followed by RCM strategy (Chapter 2) and 2) a 1,3-allylic transposition/RCM 
strategy (Chapter 3). Of these strategies, the latter led to the completion of the ABCD tetracyclic 
core and installation of the fully elaborated C17 side-chain. 
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Introduction to the Cyclocitrinols 
 
1.1 Background 
In 2000, Gräfe and co-workers reported the first isolation of cyclocitrinol, a new fungal 
metabolite isolated from terrestrial P. citrinum, possessing an unusual C25 skeleton.1 Initially 
misidentified as the tethered ring system 1.1, the structure was later revised by Crews and co-
workers by extensive spectroscopic and X-ray crystallographic analysis of analogues 
isocyclocitrinol A (1.3) and 22-O-acetylisocyclocitrinol A (1.4), and shown to be a fused ring 
system possessing a rare bicyclo[4.4.1]undec-7,10-diene AB ring with a bridgehead double bond 
(1.2) (Figure 1.1).2 Since the discovery of this unique class of steroids, a total of 24 members of 
the cyclocitrinol family have been isolated and identified, with the majority of analogs differing 
in only the C17 side-chain (Figure 1.2).3  
 
Figure 1.1. Original and revised structure of cyclocitrinol. 
Due to their unique structure, the cyclocitrinols have elicited much scientific interest, 
and their biological activities have been studied for pharmaceutical potential. Although the 
cyclocitrinols, to date, have shown little or no activity against cancer cell lines2-3 and exhibit 
























Figure 1.2. Current identified members of the cyclocitrinol family. 
and Enterococcus durans),2 there are still many unexplored medicinal applications for these rare 
steroids. For example, recent studies by Gu and Zhu indicate the potential of certain 
cyclocitrinols to induce the production of cAMP, a secondary messenger that regulates multiple 
neuronal functions, in GPR12-transfected CHO cells.3c A method to selectively up-regulate 









































































































































































1.2 Proposed Origin and Biosynthesis 
The origin of these unique steroids is believed to be ergosterol (1.5), a sterol often co-
isolated with the cyclocitrinols and believed to be a precursor for many microbial steroids. The 
proposed biosynthetic pathway for the construction of the unusual bicyclo[4.4.1] skeleton relies 
on the enzymatic activation of the C19 position of 1.5 to generate an electrophilic center 1.6, 
which can react with the C5-C6 alkene with concomitant oxidation of the C6 carbon to produce 
cyclopropane intermediate 1.7 (Scheme 1.1, top).3c,3d Subsequent fragmentation of the 
cyclopropane, initiated by deprotonation at C1, generates the bicyclo[4.4.1] AB ring of the 
cyclocitrinols (1.8). The C17 side-chain of the cyclocitrinols could be accessed through oxidation 
of the ergosterol side-chain, followed by elimination of acetone to produce intermediate 1.10, 
which could undergo subsequent reduction/oxidation and rearrangements to produce various 
observed functional groups (Scheme 1.1, bottom). 
 
Scheme 1.1. Proposed biosynthetic pathway to the cyclocitrinols (1.8) starting from ergosterol 






















































































1.3 Previous Synthetic Approaches Toward the Bicyclo[4.4.1]undecene Core 
1.3.1 Biomimetic Route via Cyclopropane Fragmentation 
Inspired by the proposed biosynthetic pathway for nature’s route to the rare 
bicyclo[4.4.1]undec-7,10-diene AB ring, Schmalz and co-workers explored a reductive 
fragmentation of cyclopropanated intermediate 1.14 to access the bicyclo[4.4.1] AB ring.5 The 
key cyclopropanated intermediate 1.14 was readily obtained in 14 steps from commercially 
available dehydroepiandrosterone (1.13) (Scheme 1.2). Treatment of 1.14 with SmI2 resulted in 
immediate fragmentation of the cyclopropane to give bicyclo[4.4.1]undecan-2,7-dione 1.15 in 
43% yield. 
 
Scheme 1.2. Schmalz’s reductive fragmentation approach to the cyclocitrinol AB core. 
Schmalz’s biomimetic approach validated the feasibility of a cyclopropane 
fragmentation step in the proposed biosynthetic formation of the bicyclo[4.4.1] AB ring. 
However, further elaboration of triketone 1.15 to a natural cyclocitrinol would be challenging 
due to the difficulty of differentiating the three ketones at C3, C6, and C17 for the installation of 
the C17 side-chain and the reduction of the C3 ketone. Perhaps recognizing the shortcomings of 
triketone 1.15, Schmalz later attempted to employ a similar fragmentation strategy to 
cyclopropanated intermediate 1.17 which possesses a protected C3 hydroxyl group. 
Unfortunately, all attempts at a Lewis acid-assisted fragmentation of 1.17 to obtain the desired 
bicyclo[4.4.1]undecene product were unsuccessful and, in the presence of Ac2O and BF3•Et2O, 





























Scheme 1.3. Schmalz’s attempts at a Lewis acid-mediated cyclopropane fragmentation. 
1.3.2 Type II Intramolecular [5+2] Cycloaddition Approach 
Recently, Li and co-workers developed a novel type II intramolecular oxidopyrylium-
mediated [5+2] cycloaddition reaction that allows the rapid formation of a series of bridged 
seven-membered bicyclic frameworks.7 This method was applied to the construction of the ABC 
tricyclic core of cyclocitrinol (1.21), by treatment of acetoxypyranone 1.19 with 1,1,3,3-
tetramethylpiperidine (TMP) at 160 ºC (Scheme 1.4). Although a relatively rapid and efficient 
method to generate the ABC skeleton, multiple redox steps and functional group manipulations 
on the AB ring would still be required to obtain the fully elaborated cyclocitrinol.  
	  
Scheme 1.4. Li’s type II intramolecular [5+2] cycloaddition to form the bicyclo[4.4.1] AB ring. 
1.4 Leighton Group Retrosynthetic Analysis 
The rare occurrence of natural products with highly-strained bicyclo[4.4.1]undec-1-ene 
rings and the significant synthetic challenges that they pose drew us to consider a fully synthetic 
route toward cyclocitrinol. Focusing on the bicyclo[4.4.1] AB ring, we simplified the enone 1.23 
to ketone 1.24 and recognized that the corresponding enolate 1.25 could potentially be generated 
from an anionic oxy-Cope rearrangement of [3.2.1]-bicycle 1.26 (Scheme 1.5). However, the 











































calculations8 of 1.26, which indicate that the termini of the alkenes are approximately 4.5 Å apart 
when the vinyl groups are oriented to allow for π overlap, suggest that a Cope rearrangement of 
1.26 may be disfavored.  
 
Scheme 1.5. Proposed anionic oxy-Cope rearrangement to form the bicyclo[4.4.1] AB ring. 
On the other hand, when we considered the precursor to the Cope rearrangement in the 
context of the ABCD tetracyclic core of cyclocitrinol, we recognized that by tethering the two 
vinyl groups into a 10-membered ring, not only was there substantial strain introduced, but also 
the distance of the termini of the alkenes was decreased to 3.4 Å (Scheme 1.6). Leveraging the 
strain inherent in the 10-membered bicyclic ring system, the modified [3.2.1]-bicycle 1.28 could 
potentially undergo a strain-accelerated Cope rearrangement under relatively mild conditions to 
form the ABC tricyclic core of cyclocitrinol in one step. Therefore, for our synthetic plan, it was 
critical to be able to access 1.28 in an efficient and stereoselective manner. 
 
Scheme 1.6. Revised retrosynthesis involving a transannular Cope rearrangement of 1.28. 
1.5 Model System for the Tandem Ireland-Claisen/Cope Rearrangement 
Although various approaches were attempted for the formation of the highly-strained 


























ultimately successful ring-contraction Ireland-Claisen rearrangement strategy that allowed access 
to 1.28. Since direct methods to obtain 1.28 had not prevailed or were low yielding, we examined 
the possibility of transiently forming the unstable Cope precursor by way of the more stable 14-
membered macrolactone 1.29. Once prepared, we envisioned that 1.29 could be readily 
converted to silyl ketene acetal 1.30, which could undergo a ring-contraction Ireland-Claisen 
rearrangement to give 1.31 followed by a strain-accelerated Cope rearrangement to provide the 
desired rearrangement product 1.32 (Scheme 1.7).  
 
Scheme 1.7. Proposed tandem Ireland-Claisen/Cope rearrangement to form the ABC tricyclic 
core of cyclocitrinol. 
To examine the viability of a tandem Ireland-Claisen/Cope cascade reaction to construct 
the ABC tricyclic core rapidly, we began with a simplified model system 1.29 that lacked a C3 
hydroxyl group and was racemic. A cornerstone moment in our program was the discovery by Dr. 
Chris Plummer that treatment of 1.29 with excess TESCl and DBU at 125 ºC, followed by acidic 
(1 M HCl) quench, successfully provided carboxylic acid 1.33 in 33% yield as a single 
diastereomer (Scheme 1.8).10 This established a proof of concept for the one-pot, tandem Ireland-
Claisen/Cope rearrangement and indicated a viable plan forward for our synthesis of 
cyclocitrinol. The structure and relative configuration of 1.33 was determined by single crystal 
X-ray diffraction, revealing that the C13 methyl group was in the desired β-position but the C14 
























Scheme 1.8. Model system to explore the tandem Ireland-Claisen/Cope rearrangement. 
Also isolated from the reaction, along with the desired 1.33, was a nonpolar TES-
containing compound, which upon treatment with HCl in MeOH provided methyl ester 1.34 in 
15% yield and acid 1.35 in 21% yield (Scheme 1.8). The structure of 1.34 was established by 
single crystal X-ray diffraction to be a 12-membered macrocycle with an inverted C14 
stereocenter relative to the C14 of 1.33. Thus, although the intended tandem Ireland-
Claisen/Cope rearrangement had occurred, the yields of the desired product 1.33 were 
diminished by a secondary rearrangement reaction that was also occurring during the reaction 
(vide infra). 
1.6 Development of a Practical Route toward a Chiral 14-Membered Macrolactone 
Having demonstrated the feasibility of using two consecutive rearrangements, a ring-
contraction Ireland-Claisen and a strain-release Cope, to construct the complex ABC core of 
cyclocitrinol rapidly and efficiently, we next applied this strategy to form the natural AB ring 
with a (R)-hydroxyl group at the C3 position. To prepare chiral macrolactone 1.41, significant 
modifications were made to the previous route. Notably, our efforts to streamline the preparation 
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that could convert vinyl epoxide 1.36 and alkene 1.37 to the desired bicyclo[3.2.1] ketone 1.38 in 
good yields and with reasonable selectivity for the desired (E)-isomer (Scheme 1.9).11 The 
efficient five-step route (from 1.36 and 1.37) developed for the preparation of macrolactone 1.41 
enabled the rapid formation of a variety of 14-membered macrolactone intermediates, including 
those that were prepared in this thesis, which were critical toward our synthetic efforts.  
 
Scheme 1.9. Preparation of chiral 1.42 via two strain-driven tandem reactions. 
Following the preparation of macrolactone 1.41, we subjected it to the optimized 
tandem Ireland-Claisen/Cope rearrangement conditions (Me2PhSiCl and DBU in trifluorotoluene 
at 140 ºC). Disappointingly, the yield of the desired tricyclic keto ester 1.42 remained modest 
(38% yield) and was comparable to the 33% yield observed previously for the rearrangement of 
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1.7 Rational Optimization of the Tandem Ireland-Claisen/Cope Rearrangement 
In order to improve the yield of the tandem Ireland-Claisen/Cope reaction, we 
undertook an effort to understand the mechanistic processes that were involved in the formation 
of the desired tricycle 1.33 versus the formation of the 12-membered ring by-products 1.34 and 
1.35 (Scheme 1.8). Considering the stereochemistry at C13 and C14 of 1.33, it is likely that the 
Ireland-Claisen rearrangement proceeds through a more energetically-favorable boat-like 
transition state to give the strained 10-membered macrocycle 1.43 (Scheme 1.10). Upon 
formation of 1.43, two possible strain-relieving pathways can occur: (1) a [3,3]-sigmatropic 
rearrangement to produce tricycle 1.44, which upon acid hydrolysis is converted to desired 1.33, 
or (2) a [1,3]-sigmatropic rearrangement to produce 12-membered macrocycle 1.45, which upon 
treatment with acidic MeOH converts to undesired 1.34 and 1.35. Our proposal that the 12-
membered by-products are formed via a [1,3]-sigmatropic rearrangement is based on the 
observed inversion of the C14 stereocenter of 1.34, which can be accounted for if an antarafacial 
migration of the C14 alkyl group had occurred on the same face (suprafacial) of the π system.  
 





























































Based on our hypothesis that the 12-membered by-products are formed from a [1,3]-
sigmatropic rearrangement, we reasoned that by placing a substituent group at C16 in an α-
orientation (1.46), we could potentially slow the rate of [1,3]-rearrangement while minimally 
impacting the rate of the desired Cope rearrangement (Scheme 1.11). It is worth mentioning that 
if the C16 substituent is in a β-orientation, as opposed to an α-orientation, no rearrangement 
occurred under the optimized Ireland-Claisen/Cope conditions. This is consistent with our 
transition state models for the Ireland-Claisen rearrangement, which suggest that a substituent in 
a β-orientation would lead to unfavorable 1,3-diaxial interactions in both the chair and boat 
configurations.  
 
Scheme 1.11. Proposed installation of a C16 R-group to disfavor [1,3]-rearrangement.  
To examine the effect of an R-group at C16 on the tandem Ireland-Claisen/Cope 
rearrangement, macrolactones 1.50 and 1.5212 were prepared in the previously described manner 
(Section 1.6). Separately subjecting 1.50 and 1.52 to Me2PhSiCl and DBU at 140 ºC resulted in 
improved yields of the desired tricyclic products 1.51 and 1.53 in 68% and 64% yield, 
respectively (Scheme 1.12). The 12-membered ring by-products were also isolated from the 
















































H) gave only a 38% yield of the corresponding tricycle 1.42 with a combined 36% yield of the 
12-membered ring by-products. These results support the hypothesis that an R-group at C16 can 
suppress the undesired [1,3]-rearrangement and thereby increase the yield of the Ireland-
Claisen/Cope reaction.  
 
Scheme 1.12. Rearrangement of 1.50 and 1.52 under optimized Ireland-Claisen/Cope conditions. 
As illustrated in this introduction chapter, our previous model studies and experiments 
exploring the scope of the Ireland-Claisen/Cope reaction led to a fundamental understanding of 
this key transformation. Our understanding of the productive (Claisen/Cope) and unproductive 
(Claisen/1,3-sigmatropic) rearrangement pathways was later used to inform our design of the 14-
membered macrolactone substrate, which ultimately provided improved yields of this high 
complexity-generating reaction. The previous efforts of past Leighton group members13 laid the 
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Evaluation of a Tandem Ireland-Claisen/Cope/Claisen Strategy toward the ABCD Core 
 
2.1 Previous Synthetic Efforts toward the ABCD Core and C17 Side-Chain 
With the development of a concise method to construct the ABC core ring system of the 
cyclocitrinol steroids, we turned our attention to the formation of the final D ring and the 
installation of the C17 side-chain. Previous work by Dr. Chris Plummer was directed toward the 
exploration of numerous methods to convert the C13 olefin and C14 aldehyde of ketoaldehyde 
2.1 into the 5-membered D ring. Notably, efforts to utilize an aldol condensation to cyclize the D 
ring gave the desired C17 enone 2.3; however, under the basic conditions, the C14 stereocenter 
was epimerized to form the thermodynamically more favorable cis-5,6-fused ring system 
(Scheme 2.1). Additional attempts to close the D ring through an intramolecular enolate 
alkylation and a Β-alkyl Suzuki coupling were unsuccessful (Scheme 2.2). 
An alternative route using ring-closing metathesis (RCM) delivered the desired 5-
membered ring compound 2.9; however, the functional group handle was located at the C15 
carbon, opposite to the C17 position where the side-chain must be installed (Scheme 2.3). Efforts 
to convert the C15 allylic alcohol to the C17 side-chain through a 1,4-addition to enone 2.10 or  
 



































Scheme 2.2. Enolate alkylation and B-alkyl Suzuki approaches toward D ring closure. 
through a [3,3]-sigmatropic rearrangement after inversion of the C15 alcohol were unsuccessful, 
and it was postulated that the steric shielding by the adjacent C19 angular methyl group 
prevented addition to the β-face of the C17 carbon. 
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From these efforts, it became clear that the C17 functionality must be introduced prior 
to the closure of the D ring. However, previous efforts to bring in a C17 group using 
tetrasubstituted macrolactone 2.15 resulted in a complete inhibition of the key tandem Ireland-
Claisen/Cope reaction (Scheme 2.4). This was hypothesized to be due to the unfavorable 1,3-
interactions between the siloxy group and the newly introduced R group at C17 and between the 
siloxy group and the C19 methyl group, which prevent the 14-membered ring from adopting 
either a boat- or chair-like transition state, respectively.  
	  
Scheme 2.4. Attempts to bring in the C17 group from a tetrasubstituted macrolactone. 
2.2 Retrosynthetic Analysis 
It was at this stage of the project that I joined the Leighton group and we sought an 
alternative strategy that would combine the previous RCM approach to close the D ring with a 
method to introduce the C17 side-chain with the correct stereochemical configuration at C17.  
Inspired by the success of the tandem Ireland-Claisen/Cope strategy to construct the ABC core 
rapidly, we envisioned that the olefin at C13 produced from the Ireland-Claisen/Cope could be 
elaborated into a secondary allyl enol ether, which could undergo a second Claisen 








































addition to introducing two stereocenters efficiently through substrate-controlled 
diastereoselective induction by a single chiral center, the rearrangement would give a 
disubstituted alkene that could participate in the subsequent RCM reaction to form the D ring.  
	  
Scheme 2.5. Proposed installation of D ring and C17 side-chain via Claisen rearrangement. 
2.3 Preparation of the C9-C19 Fragment and Attempts to Form the Macrolactone 
In order to evaluate whether a Claisen reaction could be utilized to establish the C17 
side-chain and D ring of cyclocitrinol, we needed to prepare the 14-membered macrolactone 2.19. 
Diene 2.24 was prepared in 9 steps from 4-pentyn-1-ol 2.20 and (–)-Me-lactate (Scheme 2.6). 
Alkyne 2.20 underwent a Zr-mediated methylalumination followed by iodine quench to give 
exclusively the (E)-vinyl iodide. PCC oxidation and methylenation of the primary alcohol gave 
iododiene 2.21, which was lithiated and then added into TBDPS-protected (S)-lactaldehyde to 
give anti-diol 2.22 in 81% yield and 9.2:1 dr. As predicted from the Felkin-Ahn model, the use 
of less bulky protecting groups such as TBS and Tr on the aldehyde resulted in lower 
diastereoselectivity, giving 2.4:1 dr and 4.3:1 dr, respectively. Subsequent PMB protection of 
alcohol 2.22 and removal of the TBDPS group gave primary alcohol 2.23. Using a method 


















































Scheme 2.6. Preparation of PMB-protected (2S,3R,E)-2,3-nonenediol 2.24. 
Although diene 2.24 underwent a Ru-catalyzed cross metathesis/semipinacol 
rearrangement with vinyl epoxide 1.36 to give bicyclo[3.2.1] diketone 2.25 in 45% yield as a 
2.4:1 mixture of E/Z isomers (Scheme 2.6), the diketone was problematic for the next step, 
which required the addition of allylMgBr to the ketone on the bicyclo[3.2.1]octane ring. To 
avoid allylation of the acetonyl group during the synthesis of the 14-membered macrolactone, the 
acetonyl group of 2.24 had to be protected.  
	  
Scheme 2.7. Tandem cross metathesis/semipinacol rearrangement to form diketone 2.25. 
	  
We believed that masking the acetonyl as an enol ether could accomplish both the 
protection of the ketone and also provide the enol ether for the Claisen rearrangement. 
Unfortunately, attempts to form the enol ether under standard deprotonation conditions followed 
by quenching with Bz2O gave low yields (10-30%) of the thermodynamic Bz enol ether 2.26, 
and significant amounts of Bz-protection of 2.23 were observed, indicating deacetonylation of 
2.24 (Scheme 2.8). Fortunately, the only isomer detected was the desired (Z)-isomer, as 
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determined by NOE analysis. Based on the chair transition state for the [3,3]-sigmatropic 
rearrangement, the (Z)-enolate would deliver the desired (R)-configuration at C20 (Scheme 2.9).  
	  
Scheme 2.8. Formation of the trisubstituted Bz enol ether 2.26. 
	  
Scheme 2.9. Model of the Claisen rearrangement for (Z)- and (E)-enol ether.  
Encouraged by the high selectivity for the (Z)-enol ether, we proceeded to test the 
coupling of Bz enol ether 2.26 with vinyl epoxide 1.36. Gratifyingly, the corresponding 
bicyclo[3.2.1] ketone 2.28 was formed in 40% yield with 3.5:1 E/Z selectivity (Scheme 2.10). 
However, subsequent allylMgBr addition to the ketone on the bicyclo[3.2.1]octane ring resulted 
in cleavage of the Bz group and provided a mixture of bisallylated and deacetonylated products. 
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Scheme 2.10. Tandem CM/pinacol rearrangement using enol ethers 2.26 and 2.28. 
Because the MOM-protected enol ether 2.29, obtained during the acetonylation of 2.23, 
could serve as a convenient protected acetonyl, we examined the coupling of 2.29 with vinyl 
epoxide 1.36. Disappointingly, the cross metathesis/semipinacol rearrangement of 2.29 and 1.36 
resulted in a complex mixture with no detectable formation of the desired bicyclo[3.2.1] ketone 
2.30 (Scheme 2.10). This is presumably due to the ability of the terminal disubstituted olefin of 
the enol ether to react with the Ru catalyst, giving a mixture of homodimers, RCM products, and 
cross metathesis (CM) products.  
In order to advance the acetonyl forward, we decided to protect it as a more stable 1,3-
dioxolane. Refluxing diene 2.24 with ethylene glycol in the presence of catalytic p-TsOH gave 
2.31 in 63% yield (Scheme 2.11). Subsequent Ru-catalyzed cross metathesis/rearrangement of 
2.31 with 1.36 gave bicyclo[3.2.1] ketone 2.32 in 69% yield as a mixture of 4.5:1 E/Z isomers. 
Addition of allylMgBr into the resulting ketone followed by DDQ removal of the PMB group 
gave 2.33 in 62% yield as a single (E)-isomer. EDC-mediated acryloylation and Ru-catalyzed 
RCM gave 14-membered macrolactone 2.34 with the newly formed olefin bond in a (Z) 










































Although we were able to obtain a masked variant of the acetonylated 14-membered 
macrolactone, acidic conditions to remove the ketal resulted in decomposition of 2.34. 
	  
Scheme 2.11. Preparation of 14-membered macrolactone 2.34. 
2.4 Revised Strategy for the Ireland-Claisen/Cope/Claisen Route 
Faced with a potential late-stage installation of the trisubstituted enol ether, which we 
previously demonstrated to be low yielding, we sought to modify the C13 olefin fragment to a 
more stable and easier to form propenyl ether 2.36 (Scheme 2.12). The slight modification would 
result in α-methyl aldehyde 2.37 instead of tertiary α-hydroxy aldehyde 2.17 following the 
Claisen rearrangement. Since the C20 stereocenter would no longer be set through the Claisen 
rearrangement, the E/Z-selectivity of the enol ether formation would no longer be critical to the 
success of the route.  
However, a potential new challenge to the route arises in the form of generating the 
C20 tertiary α-hydroxy stereocenter. A recent example of an asymmetric α-hydroxylation of an 
aldehyde to form a chiral tertiary α-hydroxy aldehyde was reported by Kuwajima in the total 
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Scheme 2.12. Revised C13 olefin fragment. 
	  
asymmetric dihydroxylation using DHQ-PHN as the chiral ligand gave the desired tertiary α-
hydroxy aldehyde in high yield and enantioselectivity. Encouraged by these results, we pursued a 
route that involved a Claisen rearrangement to set the C17 stereocenter followed by asymmetric 
α-hydroxylation to set the C20 stereocenter.  
2.5 Preparation of the Propenyl Ether Fragment and Attempts at CM-Rearrangement 
The revised enol ether fragment was prepared by allylation of primary alcohol 2.23 
followed by isomerization to the propenyl ether (Scheme 2.13). Initial attempts at isomerization 
of allyl ether 2.38 using Ir4 and Ru5 catalysts gave the (E)-propenyl ether; however, 
isomerization of the terminal double bond into conjugation with the internal trisubstituted olefin 
also occurred. Fortunately, Williard and coworkers recently published on a transition-metal free 
method to form (Z)-propenyl ethers from allyl ethers using LDA.6 Using this method, we were 






































Scheme 2.13. Preparation of propenyl ether 2.39 and attempt at RCM/rearrangement. 
Unfortunately, coupling of propenyl ether 2.39 with vinyl epoxide 1.36 using the 
standard CM/rearrangement conditions failed to give the desired bicyclo[3.2.1] ketone 2.40 and 
instead led to the decomposition of 2.39 along with unreacted 1.36. The decomposition of 
propenyl ether 2.39 in the presence of the Hoveyda-Grubbs catalyst is perhaps unsurprising, 
since the reaction of Ru carbenes with vinyl ethers is well documented and leads to the formation 
of Fischer carbenes.7   
2.6 Preparation of Bicyclo[3.2.1] Ketone and Subsequent Claisen/Cope 
Undeterred by the failed coupling of propenyl ether 2.39 with vinyl epoxide 1.36, we 
determined that a reasonable solution would be to install the propenyl ether at a later stage in the 
synthetic sequence. Since large quantities of TBDPS-protected diene 2.22 were already available 
from our previous route toward the C9-C19 fragment, 2.22 was coupled with vinyl epoxide 1.36 
to give 85% yield of the bicyclo[3.2.1] ketone 2.42 as a 3.4:1 mixture of E/Z isomers (Scheme 
2.14). Following the established route to the 14-membered macrolactone, 2.48 was obtained and 
subjected to the Ireland-Claisen/Cope conditions. Surprisingly, no rearrangement was observed 








































unconjugated isomer 2.52. A similar disappointing result was obtained with Tr-protected 
macrolactone 2.49.  
	  
Scheme 2.14. Attempted Ireland-Claisen/Cope for TBDPS- and Tr-protected macrolactones. 
A possible explanation for the lack of reactivity of the TBDPS- and Tr-protected 
macrolactone is that the bulky protecting group prevents the macrocycle from adopting a boat-
like configuration due to an unfavorable 1,3-interaction between the large C16 group and the 
silyl group of the enol ether (Scheme 2.15). Because a chair-like configuration is also prohibited 
by the 1,3-diaxial interaction between the silyl group of the enol ether and the methyl group of 
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Scheme 2.15. Unfavorable steric interactions preventing Ireland-Claisen rearrangement. 
To minimize the 1,3-interaction that prevents the macrolactone from adopting a boat-
like configuration, we attempted to use a smaller silylating reagent such as TMSCl for the 
Ireland-Claisen/Cope reaction. Unfortunately, extensive heating of Tr-protected macrolactone 
2.49 with excess TMSCl and DBU at 140 ºC did not give the desired tricycle 2.51 and, once 
again, returned only unreacted 2.49 and its unconjugated isomer 2.53. Since previous studies 
showed that the 14-membered macrolactone 1.52 with i-Pr at the C16 position could undergo 
concerted Ireland-Claisen/Cope rearrangement to form the ABC tricyclic core (Chapter 1), we 
were confident that reducing the steric bulk at C16 would lead to a successful Ireland-
Claisen/Cope reaction. Trityl deprotection of macrolactone 2.49 using PPTS gave the secondary 
alcohol 2.54 in 89% yield (Scheme 2.16). Gratifyingly, the deprotected macrolactone 2.54 
underwent the Ireland-Claisen/Cope rearrangement under the standard conditions (Me2PhSiCl, 
DBU, 140 ºC) to provide keto ester 2.55 in 38% yield after aqueous acid work-up and treatment 
of the crude acid with TMS-diazomethane. Although the yield was modest, we were delighted 















































Scheme 2.16. Ireland-Claisen/Cope rearrangement of alcohol 2.54 and allyl ether 2.56. 
Since numerous unidentifiable decomposition products were observed for the Ireland-
Claisen/Cope rearrangement of 2.54, it was possible that the harsh conditions of the reaction 
resulted in gradual decomposition of the free secondary alcohol. In order to provide a more 
stable substrate for the rearrangement, the free alcohol needed to be protected. An ideal 
protecting group would allow the convenient installation of the propenyl ether and, to this end, 
an allyl group on the secondary alcohol was a logical choice. Ag2O-promoted allylation of 2.54 
gave allyl ether 2.56 in 84% yield based on recovered starting material (Scheme 2.16). 
Subjecting 2.56 to the previous Ireland-Claisen/Cope conditions gave the desired tricyclic 2.57 in 
a superior 61% yield. The major by-product from the reaction was a 12-membered ring 
macrocycle 2.58 that was observed as a 15% relative impurity in the 1H NMR spectrum and was 
isolated in 10% yield. This by-product originates from a competing [1,3]-sigmatropic shift that 
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2.7 Evaluation of the Claisen Rearrangement 
With the allyl ether side-chain installed at C13 of the cyclocitrinol ABC core, we were 
ready to evaluate the proposed Claisen reaction. Using a procedure developed by Nelson4 for the 
two-step, one-pot isomerization/Claisen rearrangement of allyl ethers, we were able to 
quantitatively isomerize allyl ether 2.57 into propenyl ether 2.58 using 1 mol% cationic Ir-PCy3 
catalyst and then directly subject 2.58 to thermal Claisen conditions to obtain aldehyde 2.59 in 
59% yield as a 1.6:1 mixture of diastereomers (Scheme 2.17). When 2.58 was separately isolated 
by silica gel chromatography to remove the iridium impurities and then heated at 140 ºC, the 
Claisen rearrangement gave mostly a single diastereomer in 50% yield (6.4:1 dr). This suggests 
that, for the two-step, one-pot procedure, the presence of residual iridium or Lewis basic PPh3 
used to deactivate the Ir catalyst might be accelerating the epimerization of aldehyde 2.59, 
leading to the poor diastereoselectivity observed after the reaction.    
	  












































i. 0.5 mol% [Ir(coe)2Cl]2/PCy3
    1 mol% NaBPh4
    DCM/acetone, rt
ii. then PPh3
    p-xylene, 140 ºC











2.8 Determination of the Stereochemical Configuration at C17 and C20 
The determination of the configuration at C17 of aldehyde 2.59 was serendipitously 
achieved when 2.59α underwent an unexpected tandem Dieckmann-type condensation/retro-
Claisen deformylation in the presence of K2CO3 and MeOH to form 5-membered ring ketone 
2.61 (Scheme 2.18). An identical product was obtained with diastereomer 2.59β  under the same 
conditions. Although we did not anticipate the formation of 2.61, a similar tandem 
cyclization/deformylation reaction was reported by Xue and Li during their formal synthesis of 
(±)-estrone, where treatment of ester aldehyde 2.62 with excess KOtBu in dichloromethane at  
0 ºC led to the formation of cyclopentanone 2.63 (Scheme 2.19).8 Perhaps interesting was the 
extraordinary mild conditions of the deformylation of intermediate β-ketoaldehyde 2.60. Similar 
deformylation of α-substituted β-ketoaldehydes such as 2.64 have been observed at ambient 
temperature but typically in the presence of NaOH.9 
	  





































































Scheme 2.19. Examples of Dieckmann-type condensation and retro-Claisen deformylation. 
Although ketone 2.61 was not a valuable intermediate toward the synthesis of 
isocyclocitrinol, it did allow the determination of the relative stereochemistry at C17. The cis 
relationship of the hydrindane ring was confirmed by the strong NOE correlation between the 
C14 proton and the angular C19 methyl group (Scheme 2.18). The NOE cross peaks between the 
C19 methyl and C17 proton as well as between the C14 proton and C17 proton indicate a syn 
relationship among the groups, suggesting that the C17 stereocenter is in the desired (R)-
configuration.  
Because the α-methyl group of ketone 2.61 is enolizable and readily isomerizes to 
place the methyl group trans to the propenyl group at C17, we were unable to define the 
stereochemistry at C20 for aldehydes 2.59α  and 2.59β . However, based on the determination of 
the C17 stereocenter and the 6-membered closed transition state models for the Claisen 
rearrangement, it is inferred that the major isomer 2.59α  has a C20 stereocenter in the (S)-




























Scheme 2.20. Transition state models for the Claisen rearrangement. 
2.9 Attempts at Reduction of the C14 Ester Following the Claisen Rearrangement 
With the C17 stereocenter set in the correct configuration, we next turned our attention 
to the inversion of the C14 stereocenter and conversion of the C14 ester to an olefin. To 
selectively reduce the C14 ester to an alcohol, the aldehyde and ketone moieties of 2.59α  were 
protected with ethylene glycol to give diketal 2.66 in 81% yield. Unfortunately, when 2.66 was 
treated with standard reducing agents (DIBAL-H, LiAlH4, LiEt3BH), no reduction of the ester 
was observed even at elevated temperatures, and only 2.66 and the carboxylic acid of 2.66 were 
recovered (Scheme 2.21). The difficulty of reducing the C14 ester in 2.66 was attributed to the 
steric shielding of the ester carbonyl by the adjacent B ring and the large tertiary alkyl group 
appended to the C13 carbon. 
	  













































































































2.10 Reduction of C14 Ester Before the Claisen Rearrangement 
In order to minimize the steric congestion around the C14 ester, the reduction of the 
C14 ester was attempted prior to the introduction of the C17 tertiary alkyl group derived from the 
Claisen rearrangement. Fortunately, the reduction of allyl ether 2.57 by LiAlH4 proceeded 
efficiently, and diol 2.68 was obtained as a 3.6:1 mixture of endo and exo products (Scheme 
2.22). Crude diol 2.68 was directly subjected to the Ley-Griffith oxidation, and the C14 aldehyde 
was subsequently epimerized using K2CO3 and MeOH to give ketoaldehyde 2.69 in 57% yield 
over 3 steps and as a 7.7:1 thermodynamic mixture of C14 aldehyde epimers favoring the desired 
isomer. Selective Wittig methylenation of ketoaldehyde 2.69 provided alkene 2.70 in 80% yield. 
Using the previous conditions for the Ir-catalyzed allyl isomerization, allyl ether 2.70 was 
converted to (E)-propenyl ether, and then subjected to the thermal Claisen rearrangement 
conditions to give 2.71 in 50% yield based on 1H NMR and as a 3.7:1 ratio of diastereomers. 
After silica gel chromatography, ketoaldehyde 2.71α  was isolated in 34% yield as a single 
isomer.  
	  





















1. cat. TPAP, NMO
    4 A MS, DCM, rt
2. K2CO3
    MeOH, rt
























1. 0.5 mol% [Ir(coe)2Cl]2/PCy3
    1 mol% NaBPh4
    DCM/acetone, rt (98%)
2. p-xylene, 160 ºC
















2.11 Attempts at D Ring Formation via Ring-Closing Metathesis 
With the ketoaldehyde 2.71α  prepared, we were ready to examine the RCM reaction 
that would close the D ring. Much to our dismay, both ketoaldehyde 2.71α  and diketal 2.73α  
failed to cyclize in the presence of various Ru or Mo metathesis catalysts (Grubbs II, Hoveyda-
Grubbs II, Stewart-Grubbs, Schrock) (Scheme 2.23). Even with near stoichiometric amounts of 
catalyst and in refluxing CH2Cl2 or benzene, only unreacted starting material was recovered. 
This lack of reactivity was hypothesized to be due to the same steric constraints around C14 that 
were problematic for the reduction of ester 2.66. The inability of the bulky Ru or Mo catalyst to 
approach the terminal C14 alkene prevents the initiation of the RCM reaction, and therefore no 
metathesis product was detected. 
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2.12 Relay Ring-Closing Metathesis Approach and an Unexpected [2,3]-Wittig 
Rearrangement 
Since relay ring-closing metathesis (RRCM) is often employed to activate hindered 
alkenes for RCM,10 we explored the possibility of using a relay chain off the C14 carbon to 
initiate the desired RCM reaction. In principle, the relay chain could facilitate the initiation of the 
catalytic cycle by introducing a readily accessible terminal olefin for the Ru catalyst to react with, 
thereby forming a Ru alkylidene at the terminus of the relay chain. Subsequent extrusion of a 5-
membered ring through RCM would deliver the Ru in an intramolecular fashion to the C14 
olefin.  
To evaluate the RRCM approach, we prepared pentaene 2.75 from the selective Wittig 
olefination of aldehyde 2.69 using 5-hexenyltriphenylphosphonium iodide (Scheme 2.24). 
Unfortunately, attempts to use the same Ir-PCy3 catalyst as before to isomerize allyl ether 2.75 to 
the corresponding (E)-propenyl ether resulted in migration of the terminal olefin of the relay 
chain into conjugation with the internal double bond. To prevent promiscuous olefin 
isomerization, we explored the LDA-mediated isomerization of allyl ethers to (Z)-propenyl 
ethers that was developed by Williard and coworkers.6 Treatment of allyl ether 2.75 with excess 
LDA at room temperature resulted in an unexpected [2,3]-Wittig rearrangement11 to form 
secondary allylic alcohol 2.76 as a single diastereomer. Based on our evaluation of plausible 5-
membered, enveloped transition states for the [2,3]-Wittig rearrangement, it was determined that 
the newly introduced C17 stereocenter was likely in the desired (R)-configuration. Thus, the 
serendipitous rearrangement of 2.75 provided the desired C17 stereocenter along with the 




Scheme 2.24. Unexpected LDA-mediated [2,3]-Wittig rearrangement. 
Delighted with the facile formation of the C17 stereocenter through a [2,3]-sigmatropic 
rearrangement, we proceeded to protect allylic alcohol 2.76 with TBSOTf and 2,6-lutidine to 
discourage initiation at the terminal allylic alcohol (Scheme 2.25). With TBS-protected allylic 
alcohol 2.77 in hand, we were prepared to explore the RRCM for the formation of the D ring. 
Unfortunately, prolonged heating of a dilute solution of 2.77 (0.005 M) with 50 mol% Hoveyda-
Grubbs II did not give the desired ring closure product 2.78, but instead gave dimer 2.79 (44%) 
and unreacted starting material (48%). The failure of the C14 olefin to participate in RCM or 
RRCM suggests that the Ru alkylidene is unable to approach the C14 olefin in a side-long 
manner to undergo the necessary [2+2] cycloaddition for RCM. This highlights the steric 
congestion around the C14 position that is created by the proximal B ring and the adjacent 
tertiary alkyl group at C13. Indeed, a molecular model of 2.76, obtained from MM2 force-field 
calculations, indicates that the si face of the C15 sp2 carbon of the olefin attached at C14 is 
blocked by the C7 hydrogen of the B ring, and the re face is blocked by the trans olefin attached 
to C17 (Figure 2.1). The inaccessibility of both the front and back face of the C15 sp2 carbon 
explains the previous observed lack of reactivity of ester 2.66 toward LiAlH4 and of alkenes 2.71, 












































Scheme 2.25. Unsuccessful attempt at RRCM to form D ring. 
	  
 Figure 2.1. Molecular model of 2.77 based on B3LYP/6-31G(d) in the gas phase (only select 
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2.15 Experimental Section 
General Procedures. All reactions were conducted under an inert atmosphere of 
nitrogen or argon in flame-dried or oven-dried glassware unless otherwise indicated. High 
pressure reactions were carried out in a Pyrex sealed tube with a Teflon screw cap. Benzene, 
toluene, methylene chloride, tetrahydrofuran, and diethyl ether were purchased from Fisher and 
purified by degassing with argon followed by passage through both an activated neutral alumina 
column and Q5 reactant column. Acetonitrile, dimethyl sulfoxide, methanol, and trifluorotoluene 
were purchased as anhydrous from Sigma-Aldrich. Triethylamine, diisopropylamine, pyridine, 
2,6-lutidine, and 1,8-diazabicycloundec-7-ene were distilled over CaH2 and stored over activated 
4Å molecular sieves. Chlorodimethylphenylsilane and tert-butyldimethylsilyl 
trifluoromethanesulfonate were distilled over CaH2 and stored under argon. All other 
commercially available reagents were used without further purification, unless otherwise stated.  
Reactions were monitored by thin-layer chromatography (TLC) carried out on 0.25 mm 
EMD/Merck KGaA silica gel plates (60F-254) using UV light as a visualizing agent and either a 
phosphomolybdic acid (PMA) or p-anisaldehyde stain with heat as a developing agent. SiliCycle 
silica gel 60 (230-240 mesh) was used for flash column chromatography. 1H NMR spectra were 
recorded on Bruker Avance III HD 400, Bruker Avance III HD 500, or Bruker Ascend 500 
spectrometers. 1H NMR chemical shifts are reported in parts per million from CDCl3 (7.26 ppm) 
or C6D6 (7.16 ppm) and spectral data is reported as follows: (s = singlet, d = doublet, t = triplet, 
br = broad, q = quartet, dd = doublet of doublets, dt = doublet of triplets, m = multiplet; coupling 
constant(s) in Hz; integration). Proton decoupled 13C NMR spectra were recorded on Bruker 
Avance III HD 400 or Bruker Avance III HD 500 and are reported in ppm from CDCl3 (77.16 
ppm) or C6D6 (128.39 ppm). Infrared (IR) spectra were recorded on a Nicolet Avatar 370 DTGS 
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FT-IR. Optical rotations were recorded on a JASCO DIP-1000 digital polarimeter; the 
concentration c is reported in g/100 mL. Mass spectra were obtained on a JOEL HX110 mass 
spectrometer (FAB) or JEOL AccuTOF LP 4G mass spectrometer (APCI/ESI). 
 
Methyl (S)-2-(trityloxy)propionate: To a cooled (0 ºC) solution of methyl (S)-lactate (20.0 mL, 
209 mmol, 1.2 equiv) in dichloromethane (400 mL) was added trityl chloride (48.8 g, 175 mmol) 
and DBU (50.0 mL, 334 mmol, 1.9 equiv). The reaction was allowed to warm to room 
temperature and stirred for 18 h, and then was poured into water (300 mL). The aqueous and 
organic layers were separated and the aqueous layer was further extracted with dichloromethane 
(2 x 150 mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated. 
The crude reaction mixture was purified by flash chromatography through silica gel (1:1 
dichloromethane and hexanes) to afford 48 g (77%) methyl (S)-2-(trityloxy)propionate as a white 
solid. [α]23D = -38.6º (c 1.0, CH2Cl2, l = 50 mm); IR (thin film, neat) 3057, 3029, 1757, 1736, 
1491, 1448, 1200, 1131, 1091, 1058, 1012, 763, 748, 702, 633 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.50 – 7.45 (m, 6H), 7.32 – 7.27 (m, 6H), 7.26 – 7.21 (m, 3H), 4.21 (q, J = 6.7 Hz, 
1H), 3.24 (s, 3H), 1.40 (d, J = 6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 174.1, 144.0, 129.1, 
127.9, 127.3, 88.2, 69.9, 51.5, 20.2; HRMS for C23H22O3Na (ESI+): calcd 369.1467 ([M+Na]+); 
found: 369.1461 ([M+Na]+). 
 
(S)-2-(Trityloxy)propanal: To a cooled (-78 ºC) solution of methyl ester methyl (S)-2-























solution of DIBAL-H (1 M in CH2Cl2, 160 mL, 160 mmol, 1.4 equiv). After stirring for 1 h at -
78 ºC, the reaction was quenched with ethyl acetate (50 mL) and warmed to 0 ºC before addition 
of saturated aqueous Rochelle’s salt (200 mL). The mixture was stirred vigorously at room 
temperature until both phases cleared, and then the aqueous and organic layers were separated. 
The aqueous layer was further extracted with dichloromethane (2 x 100 mL) and the combined 
organic layers were dried over MgSO4, filtered, and concentrated. The crude reaction mixture 
was purified by crystallization from dichloromethane and hexanes at -78 ºC to afford 34 g (91%) 
(S)-2-(trityloxy)propanal as a white crystalline solid. [α]24D = -8.4º (c 1.0, CH2Cl2, l = 50 mm); 
IR (thin film, neat) 2915, 2847, 1728, 1490, 1448, 1077, 1022, 763, 746, 706 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 8.72 (d, J = 3.1 Hz, 1H), 7.58 – 7.41 (m, 6H), 7.35 – 7.28 (m, 6H), 7.28 – 
7.23 (m, 3H), 4.01 (qd, J = 7.0, 3.1 Hz, 1H), 1.31 (d, J = 7.0 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 202.8, 144.0, 128.8, 128.2, 127.7, 87.9, 75.4, 17.5; HRMS for C22H20O2Na (FAB+): 
calcd 339.1361 ([M+Na]+); found: 339.1366 ([M+Na]+). These data are consistent with 
literature values.12  
 
(E)-5-Iodo-4-methylpent-4-en-1-ol (2.20-1): To a cooled (0 ºC) solution of zirconocene 
dichloride (36.9 g, 126 mmol, 0.9 equiv) in dichloromethane (40 mL) was added dropwise a 
solution of trimethylaluminum (2 M in heptane, 220 mL, 440 mmol, 3.0 equiv). The slurry was 
warmed to room temperature and stirred for 2 h, and then a solution of 2.20 (13.6 mL, 146 
mmol) in dichloromethane (40 mL) was added dropwise at -15 ºC. The reaction was allowed to 
warm to room temperature and stirred for an additional 15 h, and then cooled to -40 ºC and a 





ii)  I22.20 2.20-1
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The reaction was warmed to room temperature and stirred for 3 h. Then the reaction was 
carefully quenched by a dropwise addition of water (100 mL) at 0 ºC, and then diluted with 
diethyl ether (100 mL). The resulting suspension was filtered through Celite and the white solid 
was washed with additional diethyl ether (100 mL). The filtrate was treated with 1 M HCl (300 
mL) and the aqueous and organic layers were separated. The organic layer was sequentially 
washed with saturated aqueous solutions of NaHCO3 (300 mL), Rochelle’s salt (300 mL), and 
then brine (300 mL). The organic layer was dried over MgSO4, filtered, and concentrated. The 
crude reaction mixture was purified by flash chromatography through silica gel (20% ethyl 
acetate in hexanes) to afford 25.4 g (77%) 2.20-1 as a yellow oil. IR (thin film, neat) 3308 (br), 
2938, 2873, 1376, 1266, 1142, 1059, 769, 666 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.93 (q, J = 
1.2 Hz, 1H), 3.64 (t, J = 6.4 Hz, 2H), 2.31 (td, J = 7.5, 1.2 Hz, 2H), 1.85 (d, J = 1.1 Hz, 3H), 1.75 
– 1.67 (m, 2H), 1.30 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 147.6, 75.1, 62.1, 35.9, 30.7, 24.0; 
HRMS for C6H11OI (EI+): calcd 225.9855 ([M]+); found: 225.9854 ([M]+). These data are 
consistent with literature values.13 
 
(E)-1-Iodo-2-methylhexa-1,5-diene (2.21): To a solution of alcohol 2.20-1 (7.67 g, 33.9 mmol) 
in dichloromethane (200 mL) was added pyridinium chlorochromate  (14.7 g, 68.3 mmol, 2.0 
equiv) and stirred at room temperature. After 2 h, the reaction was diluted with hexanes (200 
mL) followed by the addition of Celite (43 g) and stirred for 30 min. The slurry was purified 
through a plug of silica gel (1:1 diethyl ether and hexanes) and then concentrated to 100 mL 
under vacuum at 0 ºC. In a separate flask, add a solution of NaHMDS (1 M in THF, 61 mL, 61 










(120 mL) at 0 ºC. After stirring for 30 min, the solution of aldehyde was added dropwise to the 
cooled (0 ºC) solution of ylide and then the reaction was allowed to warm to room temperature. 
After 1 h, the reaction was poured into water (100 mL) and the aqueous and organic layers were 
separated. The aqueous phase was extracted with diethyl ether (2 x 100 mL) and the combined 
organic layers were dried over Na2SO4, filtered, and concentrated. The crude reaction mixture 
was purified by flash chromatography through silica gel (100% hexanes) to afford 4.47 g (59%) 
of 2.21 as a colorless oil. IR (thin film, neat) 2913, 2846, 1639, 1618, 1376, 1267, 1142, 991, 
911, 766, 669 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.90 (q, J = 1.1 Hz, 1H), 5.76 (ddt, J = 16.8, 
10.1, 6.5 Hz, 1H), 5.03 (dq, J = 17.1, 1.7 Hz, 1H), 4.98 (dq, J = 10.2, 1.4 Hz, 1H), 2.32 –2.27 (m, 
2H), 2.23 – 2.16 (m, 2H), 1.84 (d, J = 1.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 147.4, 137.5, 
115.3, 75.1, 39.0, 32.1, 24.0. These data are consistent with literature values.14 
 
Diene 2.41: To a cooled (-78 ºC) solution of 2.21 (11.1 g, 50.0 mmol, 1.2 equiv) in diethyl ether 
(200 mL) was added dropwise a solution of n-BuLi (2.46 M in hexanes, 20.0 mL, 49.2 mmol, 1.2 
equiv). After stirring for 1 h, a solution of (S)-2-(trityloxy)propanal (13.5 g, 42.7 mmol) in 
diethyl ether (50 mL) was added dropwise to the prepared solution of alkenyllithium. After 
stirring for 1 h at -78 ºC, the reaction was poured into saturated aqueous NH4Cl (150 mL) and the 
aqueous and organic layers were separated. The aqueous phase was extracted with diethyl ether 
(2 x 100 mL) and the combined organic layers were dried over MgSO4, filtered, and 
concentrated to give a crude mixture of 4:1 anti and syn diols. The crude reaction mixture was 
purified by flash chromatography through silica gel (3-5% ethyl acetate in hexanes) to afford 
















CH2Cl2, l = 50 mm); IR (thin film, neat) 3454 (br), 2930, 1490, 1448, 1060, 1018, 762, 746, 703, 
632 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.58 – 7.52 (m, 6H), 7.36 – 7.29 (m, 6H), 7.28 – 7.24 
(m, 3H), 5.77 (ddt, J = 16.9, 10.2, 6.5 Hz, 1H), 5.12 (dq, J = 8.2, 1.3 Hz, 1H), 4.99 (dq, J = 17.1, 
1.7 Hz, 1H), 4.94 (ddt, J = 10.2, 2.3, 1.2 Hz, 1H), 3.82 (dt, J = 8.2, 3.0 Hz, 1H), 3.65 (qd, J = 6.3, 
3.1 Hz, 1H), 2.29 (d, J = 2.8 Hz, 1H), 2.21 – 1.98 (m, 4H), 1.34 (d, J = 1.3 Hz, 3H), 1.01 (d, J = 
6.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 145.1, 138.5, 138.4, 129.0, 128.0, 127.3, 124.1, 
114.7, 87.2, 72.9, 70.9, 39.1, 32.1, 16.9, 15.5; HRMS for C29H32O2Na (ESI+): calcd 435.2300 
([M+Na]+); found: 435.2300 ([M+Na]+).  
 
(E)-Diol 2.45: To a solution of vinyl epoxide 1.3615  (496 mg, 1.61 mmol) and diene 2.41 (802 
mg, 1.94 mmol, 1.2 equiv) in chloroform (10 mL) was added Hoveyda-Grubbs II (67.7 mg, 
0.108 mmol, 0.067 equiv) catalyst. The resulting green solution was purged with nitrogen and 
refluxed for 15 h, then cooled to room temperature and concentrated. The black residue was 
purified by flash chromatography through pH 7.0 buffered silica gel (1-8% acetone in hexanes) 
to give 635 mg (57%) 2.43 as an inseparable mixture of E/Z isomers (3.8:1 ratio). The mixture of 
ketones was diluted with tetrahydrofuran (9.0 mL) and cooled to -78 ºC, and then a solution of 
allylmagnesium bromide (1.0 M in Et2O, 4.6 mL, 4.6 mmol) was added dropwise. After stirring 
at -78 ºC for 30 min, the mixture was quenched with saturated aqueous NH4Cl (10 mL) and 
stirred to room temperature. The layers were partitioned and the aqueous phase extracted with 
diethyl ether (2 x 5 mL). The combined organic layers were dried over MgSO4, filtered, and 



























chromatography through pH 7.0 buffered silica gel (1-4% acetone in hexanes) to obtain 530 mg 
(45% over 2 steps) 2.45 as a single (E)-isomer. [α]19D  = +25.4º (c 1.03, CH2Cl2, l = 50 mm); IR 
(thin film, neat) 3446 (br), 2931, 2865, 1448, 1381, 1059, 1008, 883, 759, 705, 680 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.56 – 7.50 (m, 6H), 7.35 – 7.28 (m, 6H), 7.27 – 7.22 (m, 3H), 5.85 
(ddt, J = 17.5, 10.1, 7.5 Hz, 1H), 5.26 – 5.20 (m, 1H), 5.18 (dd, J = 10.2, 2.2 Hz, 1H), 5.13 (dd, J 
= 17.1, 2.3 Hz, 1H), 5.07 (d, J = 8.3 Hz, 1H), 4.07 (t, J = 5.2 Hz, 1H), 3.77 (dt, J = 8.3, 2.7 Hz, 
1H), 3.65 (qd, J = 6.3, 3.1 Hz, 1H), 2.70 (d, J = 16.6 Hz, 1H), 2.35 – 2.26 (m, 3H), 2.22 – 2.11 
(m, 4H), 2.05 – 1.87 (m, 5H), 1.70 (ddt, J = 20.2, 14.2, 2.7 Hz, 2H), 1.60 (s, 1H), 1.30 (d, J = 1.3 
Hz, 3H), 1.02 (s, 24H); 13C NMR (101 MHz, CDCl3) δ 145.1, 142.9, 139.2, 133.9, 129.0, 128.0, 
127.3, 123.7, 120.7, 119.5, 87.3, 77.2, 72.8, 70.8, 65.7, 48.8, 42.9, 39.9, 39.4, 37.9, 36.0, 31.3, 
27.1, 18.3, 18.3, 16.9, 15.4, 12.3; HRMS for C48H66O4SiNa (EI+): calcd 757.4628 ([M+Na]+); 
found: 757.4623 ([M+Na]+). 
 
Acrylate 2.47: To a cooled (0 ºC) solution of (E)-diol 2.45 (2.20 g, 2.99 mmol) in 
dichloromethane (10 mL) was added triethylamine (4.2 mL, 30 mmol, 10 equiv), acrylic acid 
(620 µL, 9.03 mmol, 3.0 equiv) then 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (2.3 g, 12 
mmol, 4.0 equiv). The resulting slurry was allowed to warm to room temperature and stirred for 
16 h, then diluted with dichloromethane (40 mL) and poured into saturated aqueous NaHCO3 (40 
mL). The layers were separated and the aqueous phase was extracted with diethyl ether (3 x 20 
















reaction mixture was purified by flash chromatography through pH 7.0 buffered silica gel (3-
20% ethyl acetate in hexanes) to give 820 mg (35%) 2.47 as a pale yellow oil and 1.39 g (63%) 
recovered 2.45. [α]21D  = -1.9º (c 1.55, CH2Cl2, l = 50 mm); IR (thin film, neat) 3495 (br), 2940, 
2865, 1722, 1196, 1057, 1033, 1012, 704 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.54 – 7.48 (m, 
6H), 7.30 – 7.25 (m, 6H), 7.24 – 7.19 (m, 3H), 6.40 (dd, J = 17.3, 1.7 Hz, 1H), 6.16 (dd, J = 
17.3, 10.4 Hz, 1H), 5.91 – 5.78 (m, 2H), 5.57 (dd, J = 9.1, 2.9 Hz, 1H), 5.29 – 5.21 (m, 2H), 5.18 
(dd, J = 10.2, 2.2 Hz, 1H), 5.13 (dd, J = 17.0, 2.1 Hz, 1H), 4.07 (t, J = 5.2 Hz, 1H), 3.64 (qd, J = 
6.3, 2.9 Hz, 1H), 2.72 (d, J = 16.7 Hz, 1H), 2.31 (ddd, J = 13.7, 5.2, 2.9 Hz, 2H), 2.23 – 2.10 (m, 
4H), 2.08 – 1.90 (m, 5H), 1.71 (ddt, J = 20.4, 14.3, 2.7 Hz, 2H), 1.58 (s, 1H), 1.53 (d, J = 1.3 Hz, 
3H), 1.02 (s, 21H), 0.76 (d, J = 6.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 145.2, 143.0, 142.0, 
133.9, 130.2, 129.4, 129.3, 127.8, 127.1, 120.5, 120.1, 119.6, 86.9, 77.3, 74.7, 71.7, 65.7, 48.8, 
42.9, 39.9, 39.5, 37.9, 36.0, 31.4, 27.0, 18.3, 18.3, 17.0, 16.6, 12.3; LRMS for C51H68O5SiNa 
(FAB+): calcd 811.47 ([M+Na]+); found: 811.3 ([M+Na]+). 
 
Macrolactone 2.49: To a solution of acrylate 2.47 (1.95 g, 2.47 mmol) in dichloromethane (500 
mL) was added Hoveyda-Grubbs II catalyst (157 mg, 0.250 mmol, 0.10 equiv) and the mixture 
was heated at reflux. After 12 h, the mixture was cooled and ethyl vinyl ether (2 mL) was added. 
The resulting mixture was stirred open to the air for 1 h and then concentrated. The crude 
reaction mixture was purified by flash chromatography through silica gel (slurry packed with 1% 
triethylamine in hexane and eluted with 6-10% ethyl acetate in hexanes) to give 1.59 g (85%) 














2.49 as a yellow solid. [α]19D  = +78.3º (c 1.13, CH2Cl2, l = 50 mm); IR (thin film, neat) 3484 (br), 
2941, 2923, 2865, 1690, 1448, 1381, 1187, 1080, 1059, 1026, 1011, 883, 817, 759, 705, 679 cm-
1; 1H NMR (500 MHz, CDCl3) δ 7.53 – 7.47 (m, 6H), 7.29 – 7.24 (m, 6H), 7.24 – 7.19 (m, 3H), 
6.34 (ddd, J = 11.6, 9.3, 5.6 Hz, 1H), 5.85 (dt, J = 11.7, 1.8 Hz, 1H), 5.41 (d, J = 1.7 Hz, 2H), 
5.18 (ddd, J = 10.3, 4.2, 2.2 Hz, 1H), 4.05 (t, J = 5.2 Hz, 1H), 3.70 (qd, J = 6.1, 3.4 Hz, 1H), 3.14 
(ddd, J = 16.2, 9.3, 1.5 Hz, 1H), 2.64 (dt, J = 16.2, 2.1 Hz, 1H), 2.45 (ddd, J = 16.1, 5.7, 2.3 Hz, 
1H), 2.27 (ddd, J = 13.9, 5.2, 3.0 Hz, 1H), 2.21 (dt, J = 15.6, 4.2 Hz, 2H), 2.17 – 2.10 (m, 3H), 
2.03 (dd, J = 12.7, 2.3 Hz, 1H), 2.00 – 1.88 (m, 2H), 1.87 – 1.82 (m, 1H), 1.77 (dt, J = 14.0, 2.9 
Hz, 1H), 1.68 (dt, J = 13.5, 2.7 Hz, 1H), 1.65 (s, 3H), 1.30 (s, 1H), 1.03 (d, J = 2.3 Hz, 21H), 
0.73 (d, J = 6.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 166.2, 145.2, 143.8, 142.6, 141.7, 129.4, 
127.7, 127.1, 122.9, 121.0, 120.9, 86.8, 77.9, 73.7, 71.1, 65.2, 49.6, 39.9, 39.1, 37.9, 35.8, 31.2, 
26.7, 18.3, 18.3, 17.3, 16.5, 12.2; HRMS for C49H63O5Si (FAB+): calcd 759.4445 ([M-H]+); 
found: 759.4433 ([M-H]+). 
 
Diol 2.54: To a solution of Tr-protected macrolactone 2.49 (1.59 g, 2.09 mmol) in anhydrous 
methanol (42 mL) was added pyridinium p-toluenesulfonate (1.06 g, 4.22 mmol, 2.0 equiv). 
After stirring at 50 ºC for 2 h, the reaction was diluted with dichloromethane (50 mL) and cooled 
to 0 ºC, then quenched with saturated aqueous NaHCO3 (50 mL). The layers were separated and 
the aqueous phase was extracted with dichloromethane (2 x 30 mL). The combined organic 
layers were dried over MgSO4, filtered, and concentrated. The crude reaction mixture was 

















hexanes) to give 965 mg (89%) 2.54 as a white solid. [α]21D  = +115.5º (c 1.29, CH2Cl2, l = 50 
mm); IR (thin film, neat) 3429 (br), 2923, 2865, 1689, 1188, 1058, 1024, 1010, 882, 817, 758, 
677 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.38 (ddd, J = 11.7, 8.5, 6.4 Hz, 1H), 5.89 (dt, J = 11.6, 
1.8 Hz, 1H), 5.46 (dd, J = 10.0, 4.2 Hz, 1H), 5.28 (dd, J = 10.1, 1.6 Hz, 1H), 5.13 (dq, J = 10.0, 
2.7 Hz, 1H), 4.04 (t, J = 5.2 Hz, 1H), 3.96 (ddq, J = 6.4, 3.4, 3.4 Hz, 1H), 2.92 (ddd, J = 16.0, 
8.5, 1.6 Hz, 1H), 2.65 (d, J = 16.6 Hz, 1H), 2.59 (ddd, J = 16.0, 6.6, 2.1 Hz, 1H), 2.28 – 2.09 (m, 
5H), 2.05 (dd, J = 13.1, 2.5 Hz, 1H), 2.02 – 1.91 (m, 3H), 1.88 – 1.82 (m, 1H), 1.79 (d, J = 1.3 
Hz, 3H), 1.74 (dt, J = 14.1, 2.9 Hz, 1H), 1.67 (dt, J = 14.3, 2.9 Hz, 1H), 1.36 (s, 1H), 1.16 (d, J = 
6.4 Hz, 3H), 1.01 (s, 21H); 13C NMR (101 MHz, CDCl3) δ 166.4, 144.5, 143.6, 142.7, 122.3, 
121.0, 119.5, 77.9, 74.5, 69.1, 65.2, 49.2, 39.8, 39.5, 38.9, 37.9, 35.8, 31.3, 26.6, 18.3, 18.3, 16.6, 
12.2; HRMS for C30H49O5Si (FAB+): calcd 517.3349 ([M-H]+); found: 517.3334 ([M-H]+). 
 
Ketoester 2.55: To a solution of macrolactone 2.54 (462 g, 890 µmol) in trifluorotoluene (19 
mL) was added 1,8-diazabicyclo[5.4.0]undec-7-ene (1.4 mL,  9.4 mmol, 11 equiv) and 
Me2PhSiCl (1.5 mL, 8.9 mmol, 10 equiv). The vessel was sealed under argon using a Teflon 
screw cap and heated to 140 ºC. After 14 h, the solution was cooled and then poured into 
aqueous 1 M HCl (10 mL). The layers were separated and the aqueous phase was extracted with 
diethyl ether (4 x 5 mL). The combined organics were dried over Na2SO4, filtered, and 
concentrated. The residue was dissolved in diethyl ether (3.5 mL) and methanol (14.3 mL), and 
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4.0 equiv). After stirring for 2 h at room temperature, the solution was concentrated and the 
residue was purified by flash chromatography through silica gel (10-30% ethyl acetate in 
hexanes) to give 179 mg (38%) 2.55 as a pale yellow oil. [α]22D  = +11.1º (c 1.0, CH2Cl2, l = 50 
mm); IR (thin film, neat) 3456 (br), 2942, 2865, 1732, 1686, 1462, 1368, 1156, 1091, 1063, 883, 
798, 681 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.64 – 5.55 (m, 2H), 5.50 (dd, J = 15.9, 5.9 Hz, 
1H), 4.23 (qd, J = 6.3, 6.3 Hz, 1H), 3.57 (s, 3H), 3.47 (tt, J = 10.2, 3.4 Hz, 1H), 2.83 – 2.70 (m, 
2H), 2.65 (dd, J = 13.0, 4.3 Hz, 1H), 2.59 – 2.39 (m, 5H), 2.33 (d, J = 23.5 Hz, 1H), 2.33 – 2.21 
(m, 1H), 2.24 – 2.11 (m, 2H), 1.71 (ddd, J = 13.1, 10.2, 4.7 Hz, 1H), 1.58 – 1.47 (m, 2H), 1.41 – 
1.31 (m, 1H), 1.25 (d, J = 10.1 Hz, 1H), 1.22 (d, J = 6.3 Hz, 3H), 1.18 (s, 3H), 1.04 (s, 21H); 13C 
NMR (101 MHz, CDCl3) δ 212.6, 173.4, 146.6, 138.6, 132.0, 124.1, 69.0, 66.0, 54.9, 51.1, 49.6, 
48.6, 45.8, 45.2, 37.8, 37.3, 32.8, 31.2, 26.5, 26.1, 25.3, 23.7, 18.2, 18.2, 12.4; HRMS for 
C31H52O5Si (FAB+): calcd 531.3506 ([M-H]+); found: 531.3492 ([M-H]+). 
 
Allyl ether 2.56: To a solution of diol 2.54 (348 mg, 671 µmol) in diethyl ether (10 mL) was 
added activated 4Å molecular sieves (700 mg). After stirring for 15 min at room temperature, 
allyl bromide (1.1 mL, 13.4 mmol, 20 equiv) and Ag2O (780 mg, 3.37 mmol, 5.0 equiv) were 
added to the reaction. After heating at reflux for 12 h under argon, additional allyl bromide (1.1 
mL, 13.4 mmol, 20 equiv) and Ag2O (780 mg, 3.37 mmol, 5.0 equiv) were added to the reaction. 
After refluxing for an additional 20 h, the reaction was filtered through Celite and rinsed with 

















chromatography through pH 7.0 buffered silica gel (10-40% ethyl acetate in hexanes) to afford 
289 mg (77%) 2.56 as a colorless oil and 28 mg (8%) recovered diol 2.54. [α]21D  = +103.3º (c 
1.0, CH2Cl2, l = 50 mm); IR (thin film, neat) 3474 (br), 2928, 2865, 1689, 1462, 1383, 1202, 
1059, 1007, 920, 883, 818, 677 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.35 (ddd, J = 11.6, 8.9, 6.1 
Hz, 1H), 5.95 – 5.83 (m, 2H), 5.55 (dd, J = 9.9, 3.4 Hz, 1H), 5.31 (dd, J = 10.0, 1.5 Hz, 1H), 
5.26 (dq, J = 17.2, 1.7 Hz, 1H), 5.14 (dq, J = 10.4, 1.5 Hz, 2H), 4.14 – 4.00 (m, 3H), 3.67 (qd, J 
= 6.4, 3.4 Hz, 1H), 3.02 (ddd, J = 16.1, 8.9, 1.6 Hz, 1H), 2.64 (dt, J = 16.6, 2.4 Hz, 1H), 2.53 
(ddd, J = 16.1, 6.1, 2.2 Hz, 1H), 2.30 – 2.09 (m, 5H), 2.05 (dd, J = 12.7, 2.3 Hz, 1H), 2.00 – 1.90 
(m, 2H), 1.87 – 1.82 (m, 1H), 1.76 (d, J = 1.3 Hz, 3H), 1.73 (dt, J = 11.8, 2.9 Hz, 1H), 1.68 (dt, J 
= 14.3, 2.5 Hz, 1H), 1.31 (d, J = 1.7 Hz, 1H), 1.13 (d, J = 6.4 Hz, 3H), 1.01 (s, 21H); 13C NMR 
(101 MHz, CDCl3) δ 166.4, 143.6, 143.1, 142.1, 135.5, 122.6, 121.1, 120.4, 116.7, 77.9, 75.8, 
73.1, 70.9, 65.2, 49.4, 39.8, 39.3, 39.0, 37.9, 35.8, 31.3, 26.6, 18.3, 18.2, 16.6, 16.5, 12.3; HRMS 
for C33H53O5Si (FAB+): calcd 557.3662 ([M-H]+); found: 557.3677 ([M-H]+). 
 
Ketoester 2.57: To a solution of macrolactone 2.56 (264 mg, 472 µmol) in trifluorotoluene (10 
mL) was added 1,8-diazabicyclo[5.4.0]undec-7-ene (706 µL, 4.72 mmol, 10 equiv) and 
Me2PhSiCl (790 µL, 4.71 mmol, 10 equiv). The vessel was sealed under argon using a Teflon 
screw cap and heated to 140 ºC. After 24 h, the solution was cooled and then poured into 
aqueous 1 M HCl (5 mL). The layers were separated and the aqueous phase was extracted with 
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concentrated. The residue was dissolved in diethyl ether (1.9 mL) and methanol (7.6 mL), and 
the resulting solution was treated with TMS-diazomethane (2.0 M in hexanes, 1.0 mL, 2.0 mmol, 
4.2 equiv). After stirring for 2 h at room temperature, the solution was concentrated and the 
residue was purified by flash chromatography through silica gel (5-20% diethyl ether in hexanes) 
to give 164 mg (61%) 2.57 as a pale yellow oil. [α]24D  = +3.4º (c 1.0, CH2Cl2, l = 50 mm); IR 
(thin film, neat) 2942, 2865, 1734, 1687, 1463, 1367, 1156, 1088, 1066, 882, 799, 679 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 5.89 (ddt, J = 16.3, 10.8, 5.6 Hz, 1H), 5.61 (t, J = 7.3 Hz, 1H), 5.55 
(d, J = 15.9 Hz, 1H), 5.34 (dd, J = 15.9, 7.6 Hz, 1H), 5.24 (dd, J = 17.2, 1.8 Hz, 1H), 5.15 (dd, J 
= 10.4, 1.6 Hz, 1H), 3.93 (ddt, J = 12.6, 5.4, 1.6 Hz, 1H), 3.80 (p, J = 6.5 Hz, 1H), 3.75 (ddt, J = 
12.7, 5.9, 1.4 Hz, 1H), 3.56 (s, 3H), 3.47 (tt, J = 10.3, 3.5 Hz, 1H), 2.79 – 2.70 (m, 2H), 2.65 (dt, 
J = 13.5, 4.3 Hz, 1H), 2.59 – 2.42 (m, 5H), 2.39 – 2.32 (m, 1H), 2.31 – 2.11 (m, 3H), 1.72 (ddd, 
J = 13.1, 10.2, 4.7 Hz, 1H), 1.59 – 1.51 (m, 2H), 1.40 (dt, J = 13.4, 3.4 Hz, 1H), 1.20 (d, J = 6.4 
Hz, 3H), 1.18 (s, 3H), 1.04 (s, 21H); 13C NMR (101 MHz, CDCl3) δ 212.6, 173.4, 146.6, 140.6, 
135.3, 130.0, 124.1, 116.8, 76.1, 69.0, 66.0, 54.9, 51.1, 49.7, 48.6, 45.8, 45.3, 38.0, 37.3, 32.8, 
31.2, 26.6, 26.2, 25.5, 22.0, 18.2, 18.2, 12.5; HRMS for C34H56O5SiNa (APCI+): calcd 595.3795 
([M+Na]+); found: 595.3798 ([M+Na]+). 
 
Aldehyde 2.59α/β: A solution of [Ir] catalyst (1.4 mM in Ir) was prepared by dissolving 
[(coe)2IrCl]2 (1.9 mg, 2.1 µmol) and tricyclohexylphosphine (3.5 mg, 12.5 µmol) in 
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mg, 4.1 µmol) and acetone (120 µL). To ketoester 2.57 (80 mg, 139 µmol) was added the 
solution of [Ir] catalyst (1 mL, 1.4 µmol in Ir, 0.01 equiv in Ir) and the reaction was stirred at 
room temperature under argon. After 5 h, the reaction was concentrated and the resulting (E)-
enol ether was redissolved in p-xylene (2.0 mL). To the solution of enol ether was added 
triphenylphosphine (2.6 mg, 9.9 µmol, 0.07 equiv) and the reaction was stirred at 140 ºC for 3 
days. The reaction was directly purified by flash chromatography through pH 7.0 buffered silica 
gel (3-10% ethyl acetate in hexanes) to give 47 mg (59%) 2.59α  : 2.59β  in a 1.6 : 1 ratio as a 
pale yellow oil. [α]24D  for 2.59α  = +33.4º (c 0.7, CH2Cl2, l = 50 mm); IR (thin film, neat) 2926, 
2864, 1726, 1686, 1463, 1192, 1156, 1095, 882, 799, 680 cm-1; 1H NMR for 2.59α  (500 MHz, 
CDCl3) δ 9.60 (d, J = 4.3 Hz, 1H), 5.57 (dd, J = 8.3, 6.2 Hz, 1H), 5.47 – 5.36 (m, 2H), 3.57 (s, 
3H), 3.46 (tt, J = 10.2, 3.6 Hz, 1H), 2.73 (q, J = 5.2 Hz, 1H), 2.67 – 2.58 (m, 2H), 2.56 – 2.33 
(m, 7H), 2.27 (dddd, J = 13.7, 8.5, 4.0, 2.0 Hz, 1H), 2.17 (dt, J = 7.4, 2.3 Hz, 1H), 2.05 (ddd, J = 
17.8, 12.3, 5.3 Hz, 2H), 1.76 – 1.61 (m, 5H), 1.56 – 1.49 (m, 2H), 1.07 (s, 3H), 1.04 (s, 24H); 13C 
NMR for 2.59α  (101 MHz, CDCl3) δ 212.8, 206.2, 173.6, 146.4, 131.0, 125.8, 123.9, 77.4, 66.0, 
56.7, 53.4, 50.9, 49.5, 48.8, 46.3, 45.9, 45.1, 39.6, 37.3, 32.7, 31.6, 26.4, 26.2, 19.9, 18.2, 18.2, 
15.9, 12.4; HRMS for C34H56O5SiNa (ESI+): calcd 595.3795 ([M+Na]+); found: 595.3808 
([M+Na]+). 
 
Diketone 2.61: To a solution of aldehyde 2.59α  (2.5 mg, 4.4 µmol) in methanol (0.5 mL) was 
























reaction was diluted with dichloromethane (0.5 mL) and poured into saturated aqueous NH4Cl (1 
mL). The layers were separated and the aqueous phase was extracted with dichloromethane (2 x 
1 mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated. The 
crude reaction mixture was purified by flash chromatography through silica gel (3% acetone in 
hexanes) to give 2.2 mg (97%) 2.61 as a colorless oil. 1H NMR (500 MHz, C6D6) δ 5.52 (dd, J = 
8.2, 6.3 Hz, 1H), 5.37 (dq, J = 15.2, 6.3 Hz, 1H), 5.10 (ddd, J = 15.1, 8.7, 1.8 Hz, 1H), 3.73 (tt, J 
= 9.9, 3.6 Hz, 1H), 3.58 (dd, J = 17.8, 12.4 Hz, 1H), 2.90 – 2.83 (m, 1H), 2.67 – 2.56 (m, 2H), 
2.53 (q, J = 5.4 Hz, 1H), 2.40 (dddd, J = 13.7, 8.3, 3.4, 1.7 Hz, 1H), 2.25 (d, J = 13.8 Hz, 1H), 
2.11 (dd, J = 13.8, 6.3 Hz, 1H), 1.99 (td, J = 11.4, 3.3 Hz, 1H), 1.94 – 1.86 (m, 1H), 1.83 (dq, J = 
10.9, 7.1 Hz, 1H), 1.75 (ddd, J = 13.1, 9.9, 5.0 Hz, 1H), 1.61 (dd, J = 6.4, 1.6 Hz, 3H), 1.57 (dd, 
J = 10.5, 8.5 Hz, 1H), 1.45 (dd, J = 4.4, 1.6 Hz, 1H), 1.26 – 1.17 (m, 2H), 1.17 – 1.05 (m, 21H), 
1.00 (d, J = 7.1 Hz, 3H), 0.94 (td, J = 13.3, 5.6 Hz, 2H), 0.86 (s, 3H); 13C NMR (101 MHz, 
C6D6) δ 218.1, 211.2, 146.6, 128.8, 128.6, 123.8, 66.5, 59.8, 58.1, 49.4, 49.3, 48.6, 46.0, 45.5, 
41.5, 37.8, 33.0, 30.2, 29.8, 27.0, 26.3, 23.4, 18.4, 18.2, 14.7, 12.7; LRMS for C32H52O3Si 
(FAB+): calcd 512.9 ([M]+); found: 513.5 ([M]+). 
 
Dioxolane 2.66: To a solution of aldehyde 2.59α  (14.8 mg, 25.8 µmol) in benzene (1.0 mL) was 
added ethylene glycol (29 µL, 520 µmol, 20 equiv), triethyl orthoformate (43 µL, 259 µmol, 10 
equiv), and catalytic para-toluenesulfonic acid. The solution was then heated to 60 ºC. After 14 h, 
the reaction was quenched with saturated aqueous NaHCO3 (1.0 mL). The layers were 
(CH2OH)2, HC(OEt)3

























partitioned and the aqueous phase extracted with diethyl ether (3 x 1.0 mL). The combined 
organic layers were dried over MgSO4, filtered, and concentrated. The crude reaction mixture 
was purified by flash chromatography through silica gel (1% acetone in hexanes) to give 13.8 mg 
(81%) 2.66 as a white solid. [α]24D  = +64.2º (c 0.5, CH2Cl2, l = 50 mm); IR (thin film, neat) 2927, 
2865, 1728, 1463, 1195, 1150, 1085, 1004, 882, 806, 678 cm-1; 1H NMR (500 MHz, CDCl3) 
δ 5.46 (ddd, J = 15.1, 10.8, 1.8 Hz, 1H), 5.39 (dd, J = 8.1, 4.8 Hz, 1H), 5.28 – 5.18 (m, 1H), 4.72 
(d, J = 4.8 Hz, 1H), 4.20 – 4.13 (m, 1H), 3.99 – 3.83 (m, 6H), 3.81 – 3.74 (m, 2H), 3.53 (s, 3H), 
2.55 – 2.45 (m, 2H), 2.40 – 2.21 (m, 4H), 2.16 (d, J = 13.5 Hz, 1H), 2.09 – 1.91 (m, 4H), 1.79 
(dt, J = 12.1, 5.8 Hz, 1H), 1.65 (dd, J = 6.4, 1.6 Hz, 3H), 1.54 (d, J = 19.0 Hz, 1H), 1.51 – 1.37 
(m, 4H), 1.10 (s, 3H), 1.05 (d, J = 2.0 Hz, 21H), 0.93 (d, J = 6.9 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 174.3, 143.4, 128.7, 128.0, 122.5, 113.1, 106.5, 65.7, 65.1, 64.6, 64.6, 64.2, 56.1, 55.9, 
50.5, 45.2, 40.0, 38.6, 36.9, 36.3, 35.6, 34.0, 33.0, 32.0, 29.2, 24.8, 19.4, 18.3, 18.2, 18.2, 17.3, 
12.4; HRMS for C38H65O7Si (ASAP+): calcd 661.4500 ([M+H]+); found: 661.4507 ([M+H]+). 
 
Aldehyde 2.69β: To a solution of ester 2.57 (174 mg, 304 µmol) in tetrahydrofuran (3.0 mL) 
was added LiAlH4 (240 mg, 6.32 mmol, 21 equiv). The reaction was heated at 50 ºC for 5 h, then 
diluted with diethyl ether (3.0 mL) and cooled to 0 ºC. The resulting mixture was then slowly 
quenched by dropwise addition of water (250 µL), followed by 3.0 M NaOH (160 µL) and 
additional water (750 µL). The slurry was warmed to room temperature and stirred for 1 h until a 
fine white precipitate formed. The mixture was dried over MgSO4, filtered and concentrated to 
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(3.0 mL) and acetonitrile (300 µL), then 4 Å molecular sieves (500 mg) and 4-
methylmorpholine-N-oxide (84.8 mg, 726 µmol, 2.4 equiv) was added. After stirring at room 
temperature for 15 min, tetrapropylammonium perruthenate (10.6 mg, 30.2 µmol, 0.10 equiv) 
was added as a solid. After 8 h, the reaction was concentrated and the dark residue was filtered 
through a silica gel plug (8% ethyl acetate in hexanes) to give 2.69α .  The crude aldehyde was 
dissolved in methanol (9 mL) and then treated with potassium carbonate (240 mg, 1.74 mmol, 10 
equiv). The resulting slurry was stirred vigorously for 24 h, then diluted with dichloromethane 
(10 mL) and poured into water (20 mL). The layers were separated and the aqueous phase was 
extracted with diethyl ether (2 x 10 mL). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated. The residue was purified by flash chromatography through pH 7.0 
buffered silica gel (5-10 % ethyl acetate in hexanes) to give 94 mg (57% over 3 steps) 2.69β  : 
2.69α  in a 7.7 : 1 ratio as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 9.79 (d, J = 3.9 Hz, 
0.11H for (R)-isomer), 9.59 (d, J = 2.8 Hz, 0.85H for (S)-isomer), 5.95 – 5.85 (m, 1H), 5.68 (d, J 
= 15.7 Hz, 1H), 5.55 (t, J = 7.3 Hz, 1H), 5.36 (dd, J = 15.8, 7.6 Hz, 1H), 5.25 (dq, J = 17.2, 1.7 
Hz, 1H), 5.16 (dq, J = 10.4, 1.4 Hz, 1H), 3.97 (ddt, J = 12.8, 5.2, 1.6 Hz, 1H), 3.92 – 3.80 (m, 
2H), 3.57 (tt, J = 10.5, 3.6 Hz, 1H), 2.80 (q, J = 4.8 Hz, 1H), 2.74 – 2.46 (m, 6H), 2.29 – 2.22 
(m, 1H), 2.16 (dd, J = 11.0, 2.9 Hz, 1H), 2.05 (dd, J = 17.8, 12.2 Hz, 1H), 1.94 (td, J = 11.3, 3.5 






Tetraene 2.70: To a cooled (0 ºC) slurry of MePPh3Br (58 mg, 163 µmol, 1.5 equiv) in 
tetrahydrofuran (3.0 mL) was added KHMDS (1.0 M in THF, 160 µL, 160 µmol, 1.5 equiv) and 
the suspension was stirred for 30 min. The ylide was then added dropwise to a cooled (-78 ºC) 
solution of aldehyde 2.69β  (58 mg, 106 µmol) in tetrahydrofuran (2.0 mL). After 15 min, the 
reaction was warmed to room temperature and stirred for 1 h. The reaction was quenched with 
saturated aqueous NH4Cl (3 mL), then the layers were partitioned and the aqueous phase 
extracted with dichloromethane (2 x 2 mL). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated. The crude reaction mixture was purified by flash 
chromatography through silica gel (2-5% ethyl acetate in hexanes) to afford 46 mg (80%) 2.70 as 
a single diastereomer. 1H NMR (500 MHz, CDCl3) δ 5.89 (dddd, J = 17.3, 10.4, 6.1, 5.2 Hz, 
1H), 5.53 (t, J = 7.7 Hz, 1H), 5.49 (d, J = 15.9 Hz, 1H), 5.41 (dt, J = 17.0, 10.1 Hz, 1H), 5.23 
(dd, J = 17.3, 1.7 Hz, 1H), 5.19 (dd, J = 15.9, 7.9 Hz, 1H), 5.14 (dq, J = 10.3, 1.4 Hz, 1H), 5.06 
(dd, J = 10.3, 2.0 Hz, 1H), 4.83 (dd, J = 17.0, 2.1 Hz, 1H), 3.97 (ddt, J = 12.8, 5.2, 1.5 Hz, 1H), 
3.85 – 3.77 (m, 2H), 3.55 (tt, J = 10.4, 3.5 Hz, 1H), 2.78 – 2.71 (m, 1H), 2.67 (d, J = 13.3 Hz, 
1H), 2.64 – 2.52 (m, 3H), 2.49 (d, J = 13.6 Hz, 1H), 2.30 – 2.21 (m, 1H), 2.15 – 1.99 (m, 2H), 




















Aldehyde 2.71α: A solution of [Ir] catalyst (1.4 mM in Ir) was prepared by dissolving 
[(coe)2IrCl]2 (1.9 mg, 2.1 µmol) and tricyclohexylphosphine (3.5 mg, 12.5 µmol) in 
dichloromethane (2.9 mL) and stirring for 10 min at room temperature, then adding NaBPh4 (1.4 
mg, 4.1 µmol) and acetone (120 µL). To tetraene 2.70 (46 mg, 85 µmol) was added the solution 
of [Ir] catalyst (600 µL, 0.84 µmol in Ir, 0.01 equiv in Ir) and the reaction was stirred at room 
temperature under argon. After 14 h, the reaction was concentrated and the residue was purified 
by flash chromatography through pH 7.0 buffered silica gel (3% ethyl acetate in hexanes) to give 
45 mg (98%) of the corresponding (E)-enol ether. The enol ether was dissolved in p-xylene (2.0 
mL) and stirred at 160 ºC for 18 h to give a 3.7:1 ratio of C20 epimers 2.71α/2.71β  (based on 
integration of corresponding 1H NMR peaks). The crude reaction mixture was directly purified 
by flash chromatography through pH 7.0 buffered silica gel (2% ethyl acetate in hexanes) to give 
15 mg (34%) 2.71α . [α]24D  = +26.6º (c 0.7, CH2Cl2, l = 50 mm); IR (thin film, neat) 2928, 2865, 
1719, 1686, 1463, 1093, 1065, 918, 882, 802, 679 cm-1; 1H NMR (500 MHz, CDCl3) δ 9.67 (d, J 
= 4.3 Hz, 1H), 5.56 – 5.37 (m, 4H), 5.19 (dd, J = 10.3, 2.0 Hz, 1H), 4.96 (dd, J = 17.2, 2.0 Hz, 
1H), 3.54 (tt, J = 10.3, 3.4 Hz, 1H), 2.76 – 2.69 (m, 2H), 2.70 – 2.63 (m, 1H), 2.63 – 2.50 (m, 
3H), 2.47 (d, J = 13.7 Hz, 1H), 2.25 (ddt, J = 15.6, 8.2, 2.5 Hz, 1H), 2.18 – 1.98 (m, 4H), 1.89 
(td, J = 10.6, 3.9 Hz, 1H), 1.71 (dd, J = 6.2, 1.4 Hz, 3H), 1.68 (ddd, J = 13.2, 10.1, 4.6 Hz, 1H), 
1.58 – 1.53 (m, 1H), 1.51 – 1.42 (m, 3H), 1.08 – 1.03 (m, 21H), 1.01 (d, J = 6.9 Hz, 3H), 0.88 (s, 
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65.8, 56.6, 53.7, 52.7, 49.7, 49.3, 45.1, 40.1, 37.3, 34.6, 33.3, 26.9, 20.6, 18.2, 18.2, 18.2, 15.3, 
12.5; HRMS for C34H56O3SiNa (ESI+): calcd 563.3896 ([M+Na]+); found: 563.3899 ([M+Na]+). 
 
Pentaene 2.75: To cooled (-78 ºC) suspension of 5-hexenyltriphenylphosphonium iodide16 (203 
mg, 430 µmol, 3.1 equiv) in tetrahydrofuran (2.0 mL) was added dropwise a solution of KHMDS 
(1.0 M in THF, 410 µL, 410 µmol, 3.0 equiv). The resulting orange suspension was stirred for 1 
h at –78 °C, then a solution of aldehyde 2.69β  (74 mg, 137 µmol) in THF (1.0 mL) was added 
dropwise. The mixture was stirred at –78 °C for 2 h, and then at 0 °C for 1 h. The reaction was 
quenched with saturated aqueous NH4Cl (2 mL) and the layers were partitioned. The aqueous 
phase was extracted with dichloromethane (3 x 1 mL). The combined organic layers were dried 
over Na2SO4, filtered, and concentrated. The crude reaction mixture was purified by flash 
chromatography through silica gel (5% diethyl ether in hexanes) to give 56 mg (67%) 2.75 as a 
yellow oil. 1H NMR (500 MHz, CDCl3) δ 5.95 – 5.84 (m, 1H), 5.77 (ddt, J = 17.0, 10.2, 6.6 Hz, 
1H), 5.51 (t, J = 7.4 Hz, 1H), 5.49 (d, J = 15.9 Hz, 1H), 5.27 – 5.12 (m, 4H), 5.03 (ddt, J = 15.1, 
9.5, 1.2 Hz, 1H), 4.98 (dq, J = 17.2, 2.0 Hz, 1H), 4.93 (dt, J = 10.2, 1.0 Hz, 1H), 3.96 (ddt, J = 
12.9, 5.2, 1.6 Hz, 1H), 3.84 – 3.75 (m, 2H), 3.54 (tt, J = 10.6, 3.4 Hz, 1H), 2.74 (dt, J = 7.3, 4.5 
Hz, 1H), 2.72 – 2.65 (m, 1H), 2.65 – 2.51 (m, 3H), 2.48 (d, J = 13.7 Hz, 1H), 2.28 – 2.20 (m, 
1H), 2.13 – 1.94 (m, 6H), 1.90 (td, J = 10.5, 3.7 Hz, 1H), 1.68 (ddd, J = 13.0, 10.3, 4.3 Hz, 1H), 
























Allylic alcohol 2.76: A 0.2 M solution of LDA was prepared by the addition of n-BuLi (2.5 M in 
hexanes, 400 µL, 1.0 mmol) to diisopropylamine (170 µL, 1.2 mmol) in tetrahydrofuran (4.4 
mL) at -78 ºC and stirring for 30 min. A portion of the LDA solution (0.2 M in THF, 200 µL, 40 
µmol, 3.6 equiv) was transferred to a cooled (-78 ºC) flask and then a solution of pentaene 2.75 
(6.3 mg, 11 µmol) in tetrahydrofuran (0.5 mL) was added dropwise. The reaction was stirred at -
78 ºC for 10 min, and then stirred at 0 ºC for 1 h. The reaction was quenched with saturated 
aqueous NH4Cl (1 mL), and the aqueous and organic layers were separated. The aqueous layer 
was further extracted with diethyl ether (2 x 1 mL) and the combined organic layers were dried 
over Na2SO4, filtered, and concentrated. The crude reaction mixture was purified by flash 
chromatography through silica gel (3% diethyl ether in hexanes) to obtain 2.6 mg (39%) 2.76 as 
a single diastereomer. 1H NMR (500 MHz, CDCl3) δ 5.86 – 5.69 (m, 2H), 5.57 – 5.47 (m, 2H), 
5.46 – 5.32 (m, 2H), 5.14 – 5.01 (m, 4H), 4.96 (dd, J = 10.3, 1.8 Hz, 2H), 4.41 (t, J = 6.1 Hz, 
1H), 3.57 (td, J = 10.3, 8.6, 5.1 Hz, 1H), 2.77 – 2.64 (m, 2H), 2.64 – 2.50 (m, 3H), 2.47 (d, J = 
13.6 Hz, 1H), 2.33 (t, J = 10.3 Hz, 1H), 2.25 (d, J = 21.0 Hz, 1H), 2.15 – 1.91 (m, 9H), 1.69 (d, J 
= 4.8 Hz, 3H), 1.68 – 1.57 (m, 2H), 1.51 – 1.41 (m, 3H), 1.26 (d, J = 4.1 Hz, 2H), 1.05 (s, 21H), 
0.90 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 213.2, 148.2, 142.2, 138.6, 133.3, 130.5, 128.7, 
125.3, 122.6, 114.9, 113.9, 70.9, 65.7, 55.7, 53.6, 49.7, 49.0, 45.5, 45.0, 39.8, 37.2, 35.6, 34.1, 























Dimer 2.79: To a cooled (0 ºC) solution of allylic alcohol 2.76 (2.6 mg, 4.3 µmol) in 
dichloromethane (200 µL) was added 2,6-lutidine (12 µL, 103 µmol, 24 equiv) and TBSOTf (16 
µL, 70 µmol, 16 equiv). After 5 h at 0 ºC, the reaction was quenched with saturated aqueous 
NaHCO3 (1 mL) and then diluted with diethyl ether (1 mL). The aqueous and organic layers 
were separated and the aqueous layer was further extracted with diethyl ether (2 x 1 mL). The 
combined organic layers were dried over Na2SO4, filtered, and concentrated. The crude reaction 
mixture was purified by flash chromatography through pH 7.0 buffered silica gel (3% diethyl 
ether in hexanes) to afford 2.3 mg (3.2 µmol, 73%) of the TBS-protected allylic ether. The TBS-
protected allylic ether was dissolved in dichloromethane (620 µL) and to the solution was added 
catalytic Hoveyda-Grubbs II (1 mg, 1.6 µmol, 0.5 equiv). The reaction was sealed under argon 
and stirred at 50 ºC. After 14 h, the reaction was quenched with ethyl vinyl ether (100 µL) and 
stirred under air for 1 h. The reaction was concentrated and the dark residue was purified by flash 
chromatography through pH 7.0 buffered silica gel (3% diethyl ether in hexanes) to obtain 2.0 
mg (44%) 2.79 and 1.1 mg (48%) recovered 2.76. 1H NMR (500 MHz, CDCl3) δ 5.72 (ddd, J = 
17.7, 10.3, 7.6 Hz, 1H), 5.62 – 5.39 (m, 4H), 5.27 (dq, J = 13.2, 6.3 Hz, 1H), 5.19 – 5.10 (m, 
1H), 4.97 – 4.87 (m, 2H), 4.42 (d, J = 7.7 Hz, 1H), 3.66 – 3.56 (m, 1H), 2.79 – 2.68 (m, 2H), 
2.64 (d, J = 15.8 Hz, 2H), 2.57 (dt, J = 10.8, 6.8 Hz, 1H), 2.49 (d, J = 13.5 Hz, 1H), 2.35 (t, J = 
10.3 Hz, 1H), 2.31 – 2.23 (m, 1H), 2.19 – 1.99 (m, 7H), 1.94 (t, J = 10.8 Hz, 1H), 1.75 – 1.65 
(m, 6H), 1.54 – 1.43 (m, 4H), 1.33 – 1.23 (m, 3H), 1.08 (d, J = 1.9 Hz, 21H), 0.93 (s, 9H), 0.15 
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128.3, 127.5, 122.3, 113.5, 73.2, 65.5, 57.7, 53.6, 49.7, 49.0, 45.5, 44.8, 40.0, 37.1, 35.7, 33.8, 
32.9, 29.9, 29.7, 27.1, 27.0, 26.2, 20.5, 20.4, 18.3, 18.2, 12.5, -2.7, -3.6; LRMS for C88H152O6Si4 




Completion of the ABCD Tetracyclic Core and Installation of the C17 Side-Chain 
 
3.1 Second Generation Approach toward the ABCD Tetracyclic Core 
Based on the knowledge gained from our first generation route concerning the steric 
environment of the C14 group, it is clear that an RCM strategy to form the D ring cannot proceed 
through an initial attachment at the C14 terminal olefin. We reasoned that reversing the point of 
initiation for the RCM and placing the Ru alkylidene at the C17 position, instead of at the C14 
position, would eliminate the steric burden of the initiation step and also facilitate the ring 
closure. As previously illustrated in Figure 2.1 (Chapter 2), the olefin attached to C17 is 
conveniently situated behind the C14 olefin and its proximal location could place the resulting 
Ru alkylidene in direct alignment with the C14 olefin to undergo a [2+2] cycloaddition, hence 
facilitating the RCM reaction.  
To provide a terminal olefin at C17 for the initiation of the RCM, it was necessary to 
modify the original synthetic plan. We envisioned that the terminal olefin could be introduced 
after the Ireland-Claisen/Cope rearrangement, through a 1,3-isomerization of a primary allylic 
alcohol 3.3 to a secondary allylic alcohol 3.2 (Scheme 3.1). The alcohol moiety would serve as a 
convenient functional group handle for the eventual installation of the C17-β side-chain. To 
provide allylic alcohol 3.3 for the 2nd generation approach to close the D ring, we had to alter the 
initial coupling partners for the synthesis. For the C9-C19 fragment, instead of diene 2.15, we 




Scheme 3.1. Second generation approach to D ring formation and C17 side-chain installation.  
 
3.2 Preparation of the C9-C19 Fragment and Subsequent Formation of Macrolactone  
An enantioselective synthesis of diene 3.6 was accomplished in 11 steps from geraniol 
3.7 (Scheme 3.2). Ley-Griffith oxidation followed by Wittig methylenation of 3.7 produced 
triene 3.81 in 93% yield over 2 steps. Subsequent formation of chiral 1,2-diol 3.9 from 3.8 was 
achieved by a method described by Morken involving the regio- and enantioselective addition of 
B2pin2 to a terminal alkene in the presence of a chiral Pt catalyst followed by subsequent 
oxidative work-up.2,3 Selective TBDPS protection of the primary alcohol and then benzoylation 
of the secondary hydroxyl group gave fully protected 1,2-diol 3.10. Using an established method 
to convert terminal trisubstituted olefins to terminal olefins,4 3.10 was converted to terminal 
olefin 3.12 by a three-step sequence involving site-selective epoxidation, oxidative cleavage, and 
then Wittig methylenation. Final removal of the TBDPS group by a buffered solution of TBAF 






























































Scheme 3.2. Synthesis of C9-C19 diene fragment 3.6. 
With diene 3.6 in hand, we were ready to perform the Ru-catalyzed tandem cross-
metathesis/semipinacol rearrangement. Treatment of 3.6 and vinyl epoxide 1.36 with 5 mol% 
Hoveyda-Grubbs II catalyst gave bicyclo[3.2.1] ketone 3.13 in 69% yield as a 3.7:1 mixture of 
E/Z isomers (Scheme 3.3). Subsequent addition of excess allylMgBr to ketone 3.13 produced a 
separable mixture of diols, which after silica gel chromatography gave the (E)-diol 3.14 in 66% 
yield. Site-selective acryloylation using EDC followed by ring-closure with Hoveyda-Grubbs II 
produced 14-membered macrolactone 3.16.  
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3.3 Evaluating the Key Ireland-Claisen/Cope Rearrangement 
	  
Following the rapid construction of 14-membered macrolactone 3.16, we proceeded to 
examine the tandem Ireland-Claisen/Cope rearrangement that would generate the ABC tricyclic 
core of cyclocitrinol. Treatment of macrolactone 3.16 with Me2PhSiCl and DBU at 140 ºC, 
followed by an acidic (1 M HCl) quench and then esterification with TMS-diazomethane gave 
keto ester 3.17 in 49% yield (Scheme 3.4). 1H NMR analysis of the crude reaction mixture, prior 
to the acid treatment, indicated numerous decomposition products along with approximately 58% 
of 3.17 and 20% of 12-membered macrocycle 3.18 (integration relative to PMB). The large 
amount of impurities generated during the reaction and the disparity in yield after the HCl work-
up were attributed to the potential incompatibility of the acid-sensitive PMB-protecting group 
with the harsh reaction conditions and the acidic work-up.  
 
Scheme 3.4. Tandem Ireland-Claisen/Cope rearrangement of 3.16 and 3.19. 
In order to increase the yield of the Ireland-Claisen/Cope reaction, we evaluated the 
rearrangement of the more robust TBDPS-protected macrolactone 3.19. Preparation of 3.19 was 
accomplished from diene 3.12 in a similar manner to the PMB-protected macrolactone 3.16. 
Using identical conditions as previously described, macrolactone 3.19 gave keto ester 3.20 in a 
significantly greater yield of 71% (Scheme 3.4). An analysis of the 1H NMR spectrum of the 
crude reaction mixture indicated a notably cleaner reaction, with approximately 72% of 3.20 and 
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R1 = PMB (3.16) 













3.4 Inversion of the C14 Stereocenter and Formation of the Allylic Alcohol 
Satisfied with the results obtained using the TBDPS-protected macrolactone 3.19 in the 
Ireland-Claisen/Cope reaction, we proceeded to protect keto ester 3.20 with ethylene glycol and 
then reduce the Me ester with LiAlH4 (Scheme 3.5). Unfortunately, unwanted cleavage of the 
TBDPS ether was observed along with the desired ester reduction. The cleavage of TBDPS 
ethers by LiAlH4, although uncommon, has been documented in previous natural product 
syntheses.5   
 
Scheme 3.5. Attempts at ester reduction of the TBDPS-protected tricycle 3.21.   
To circumvent potential problems with the TBDPS group, we returned to the PMB-
protected keto ester 3.17 for the remainder of our synthesis. Protection of the ketone of 3.17 with 
ethylene glycol followed by reduction of the C14 ester with LiAlH4 and then Swern oxidation of 
the resulting alcohol provided aldehyde 3.24α  (Scheme 3.6). Subsequent epimerization of the 
C14 stereocenter with K2CO3 and MeOH gave a 3.8:1 thermodynamic mixture of C14 aldehyde 
epimers, favoring the desired configuration. Fortunately, the undesired epimer 3.24α  could be 
repeatedly resubjected to the epimerization conditions to provide the desired 3.24β  in 10:1 dr. 
Lastly, Wittig methylenation of aldehyde 3.24β  followed by DDQ-mediated deprotection of 



































Scheme 3.6. Preparation of allylic alcohol 3.26 from PMB-protected keto ester 3.17. 
3.5 Development of a Dual Catalytic 1,3-Isomerization/RCM Reaction  
Since a direct 1,3-isomerization of primary allylic alcohol 3.26 to secondary allylic 
alcohol 3.27 would be an efficient and step-economical way to install the desired vinyl group at 
the C17 position, we initially explored methods to convert 3.26 to 3.27 in one step. We began by 
examining oxorhenium complexes, such as MeReO3 and Ph3SiOReO3, which are typical 
catalysts for the reversible isomerization of allylic alcohols and have been previously employed 
in other total syntheses.6 Unfortunately, treatment of 3.26 with MeReO3 or Ph3SiOReO3 in 
dichloromethane, benzene, or acetonitrile did not lead to any observable formation of the desired 
secondary allylic alcohol 3.27. Recognizing that the Re-catalyzed 1,3-isomerization of allylic 
alcohols is a reversible, thermodynamically-controlled process, we interpreted the lack of 
product formation as an indication that the equilibrium of the allylic alcohols greatly favored 
primary alcohol 3.26. 
In order to push the equilibrium towards secondary alcohol 3.27, we devised a strategy 
to trap 3.27 from the equilibrium mixture by combining the 1,3-isomerization with a secondary 
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catalytic system employing a Re-catalyst for the allylic alcohol isomerization and a Ru-catalyst 
for the RCM. Although conceptually feasible, development of the cooperative dual catalytic 
reaction to transform primary allylic alcohol 3.26 directly to cyclized allylic alcohol 3.28 would 
require the compatibility of the Re and Ru catalysts.  
 
Scheme 3.7. Proposed dual catalytic reaction for allylic alcohol isomerization/RCM. 
Preliminary investigation of conditions for the proposed tandem isomerization/RCM 
reaction using an oxorhenium catalyst (MeReO3 or O3ReOSiPh3) in the presence of Hoveyda-
Grubbs 2nd generation catalyst resulted in the formation of diene 3.29 (Scheme 3.8, entries 1-2). 
Although no formation of desired cyclized allylic alcohol 3.28 was detected, we were delighted 
with these results, which confirmed the occurrence of the tandem isomerization/RCM. The 
formation of diene 3.29 indicated that the primary allylic alcohol 3.26 underwent a Re-mediated 
isomerization to give secondary allylic alcohol 3.27, which was immediately cyclized in the 
presence of the Ru-catalyst to form 3.28; subsequent dehydration of the resulting cyclic allylic 






























Scheme 3.8. Screening of conditions for the isomerization/RCM reaction. 
To prevent the formation of diene 3.29, we examined the pathway leading to 
elimination. Detailed studies on the mechanism of the Re-catalyzed isomerization suggest two 
concomitant pathways for isomerization: a [3,3]-sigmatropic pathway with a highly ordered 
polarized transition state and an ionization-recombination pathway.6a The latter pathway is 
believed to lead to the diene side-products commonly observed for the Re-catalyzed 
isomerization of allylic alcohols. Since formation of solvent-separated ion pairs is typically less 
favored in nonpolar solvents, we evaluated the tandem isomerization/RCM in benzene and 
discovered significant improvements in the reaction (Scheme 3.8, entry 3). Not only was the 
cyclized allylic alcohol 3.28β  detected in 21% yield as a single diastereomer but the rate of the 
reaction was also significantly improved, allowing the tandem reaction to occur at room 
temperature. When coordinating polar solvents such as acetonitrile were employed, no reaction 
occurred which is consistent with the well-documented7 deactivation of Ru-catalysts by 
acetonitrile (entry 4).  
Although these preliminary results were encouraging for the development of a dual 




















































































render the reaction synthetically useful. Thus, we turned to a step-wise method for the 
conversion of allylic alcohol 3.26 to cyclized allylic alcohol 3.28. 
3.6 Preparation of the C17 Keto D-Ring  
Using a standard method for the 1,3-transposition of allylic alcohols,8 primary alcohol 
3.26 was treated with PhSeCN and (n-Bu)3P9 to form a phenylselenide. Subsequent oxidation of 
the crude selenide with H2O2 in the presence of pyridine induces a selenium variant of the 
Mislow-Evans rearrangement to provide secondary allylic alcohol 3.27 as a 1.9:1 mixture of C17 
epimers in 88% yield over the two-step sequence (Scheme 3.9).  
 
Scheme 3.9. Selenium-mediated 1,3-transposition of allylic alcohol 3.26.  
With alcohol 3.27 in hand, we were finally ready to evaluate the crucial D ring closure 
by RCM. Gratifyingly, the ring-closure proceeded efficiently with 10 mol% Hoveyda-Grubbs II 
catalyst, resulting in the formation of desired cyclic allylic alcohol 3.28 in 85% yield (Scheme 
3.10). Since the ratio of C17 hydroxy epimers from 3.27 was retained after the closure of the D 
ring, the C17 stereocenter of each epimer was readily assigned by NOE analysis. As expected, 
the C17 stereocenter of the major epimer 3.27β  is in the (S)-configuration; this is readily 
explained by the approach of the selenoxide to the more accessible β-face of the olefin during the 
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Scheme 3.10. Preparation of C17 keto D-ring. 
The construction of the D ring with a C17 hydroxyl group was encouraging, since it 
meant that we could access the D ring bearing a C17 ketone. To obtain the desired C17 ketone 
3.29, cyclic allylic alcohol 3.28 was subjected to a selective hydrogenation of the disubstituted 
olefin in the presence of Wilkinson’s catalyst, followed by Ley-Griffith oxidation to give 3.29 in 
70% yield over two steps. The preparation of ketone 3.29 provides a wide variety of options for 
the installation of the C17 side-chain, since the C17 keto D ring is a privileged scaffold in the 
steroid literature for the installation of various C17 side-chains.   
3.7 Installation of the C17 Side-Chain 
The C17 side-chain of the cyclocitrinol family of steroids poses two main challenges: 1) 
the installation of the C17 stereocenter and 2) the formation of a C20 tertiary α-hydroxyl 
stereocenter. For the ease of the synthesis, we decided to target cyclocitrinol 1.2, the first 
compound isolated and identified in the cyclocitrinol family. The unique side-chain of 
cyclocitrinol contains a trans-1,4-butenediol that we envisioned could be introduced by the 
addition of a α-hydroxy vinyl group into a C20 methyl ketone.  
To prepare the C20 methyl ketone, we began by treating C17 ketone 3.29 with 
hydrazine, and then reacting the resulting hydrazone with I2 and 1,1,3,3-tetramethylguanidine 
(TMG) to form vinyl iodide 3.30 under standard Barton conditions (Scheme 3.11). The vinyl 






















1. 10 mol% [(Ph3P)3RhCl]
    1 atm H2, PhMe, rt (81%)
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yield. During the reaction, we observed significant formation of alkene 3.32, accounting for 
nearly 40% of the mass balance in the crude 1H NMR spectra. Due to the steric shielding of the 
vinyl lithiate of 3.30, which has a quaternary center at the adjacent C14 position, it is possible 
that α-deprotonation of N-methoxy-N-methylacetamide occurs at a competitive rate, thereby 
generating 3.32. The challenge of introducing an acyl substituent at the C17 position is well-
documented and various cross-coupling methods typically provide only modest yields (40-60%) 
of the corresponding enone.10 
 
Scheme 3.11. Formation of enone 3.31 via Barton vinyl iodide synthesis then acylation. 
Following the formation of enone 3.31, we next explored the use of a conjugate 
reduction to set the C17 stereocenter. Since the reduction of a C17 double bond by 
heterogeneous hydrogenation typically occurs selectively at the α-face of the double bond,11 
opposite from the C19 angular methyl group, we were hopeful that the protonation event 
following a hydride addition to the C16 carbon of enone 3.31 would similarly occur at the α-face 
of the C17 enolate. Treatment of 3.31 with Stryker’s reagent delivered methyl ketone 3.33 in 




















    EtOH, 50 ºC
2. I2, TMG
    Et2O, 0 ºC
75% over 2 steps
i) n-BuLi
  THF, -78 ºC;
ii) MeC(O)NMe(OMe)




















hydrogen was syn to the C14 hydrogen, thereby confirming that the C17 stereocenter was in the 
desired configuration.  
 
Scheme 3.12. Setting the C17 and C20 stereocenters of the side-chain. 
Delighted that the C17 stereocenter was now set in the correct configuration, we were 
ready to form the fully elaborated side-chain by addition of the alkenyllithium of 3.34 to methyl 
ketone 3.33. Treatment of 3.33 with excess alkenyllithium of 3.34 gave allylic alcohol 3.35 in 
77% yield as a single diastereomer. The configuration of the C20 stereocenter was inferred from 
previous literature indicating that the addition of a nucleophile to a C20 methyl ketone occurs 
selectively at the si face of the ketone, providing the desired C20 (S)-hydroxy configuration 
(Scheme 3.13).12 
 










































































































































3.8 Attempts at C6 Ketal Removal 
With the construction of the ABCD tetracyclic core and the installation of the C17 side-
chain, all that remained was the installation of the C6 enone and the global deprotection of the 
silyl protected hydroxyl groups. Unfortunately, all our efforts at deprotecting the C6 ketal of 3.35 
resulted in decomposition of the C17 side-chain (Scheme 3.14). This was attributed to the acute 
acid sensitivity of the C20 tertiary allylic alcohol. In the presence of various Bronsted acids  
(PPTS, p-TsOH, HCl) and Lewis acids (I213, CuCl214, PdCl2(MeCN)215, CAN16, CeCl317), the 
C17 side-chain was observed to decompose prior to any deprotection of the C6 ketal. In addition, 
attempts to protect the C20 tertiary allylic alcohol with TESOTf and 2,6-lutidine resulted in the 
elimination of the alcohol to form diene 3.45. Later examination of conditions required for the 
C6 ketal removal using an intermediate without the C17 side-chain indicated that extensive 
heating in the presence of p-TsOH (50 ºC for 9 days) was required to remove the ketal, further 
emphasizing the incompatibility of the acid sensitive C17 side-chain with the conditions 
necessary to remove the C6 ketal (Scheme 3.16). 
 



















































Scheme 3.15. Evaluating conditions necessary for C6 ketal removal. 
3.9  Attempts at Installing the C6 Enone Prior to the C17 Side-Chain  
Based on these disappointing results, we concluded that the C6 enone must be installed 
before the introduction of the C17 side-chain. To determine a logical entry point for the C6 
enone, we evaluated three potential scenarios: (1) conversion of keto ester 3.17 to enone 3.47 
immediately after the tandem Ireland Claisen/Cope reaction, (2) introduction of the enone after 
epimerization and methylenation of the C14 aldehyde to form 3.49, and (3) formation of the 
enone following RCM and protection of the allylic alcohol to give 3.51 (Scheme 3.16).  
 

























































Installation of enone after Wittig methylenation:




Previous exploratory work by Dr. Chris Plummer identified conditions to install the C6 
enone on keto ester 3.52 following the Ireland-Claisen/Cope. Formation of enone 3.51 was made 
feasible through a stereoselective α-selenylation of 3.50 followed by oxidative elimination 
(Scheme 3.17). Although this would provide an early entry to the C6 enone, we were concerned 
that planarization of the B ring by the C6 enone would impact the later epimerization of the C14 
stereocenter.  
 
Scheme 3.17. Model of C6 enone installation after Ireland-Claisen/Cope. 
In order to avoid potential incompatibilities with downstream chemistry, we focused our 
attention on the introduction of the C6 enone following the formation of the C14 olefin. To 
prepare ketone 3.56, we subjected keto ester 3.17 to LiAlH4 then Swern oxidation to give keto 
aldehyde 3.55α  with the C14 stereocenter in the wrong configuration (Scheme 3.18). Subjecting 
the crude aldehyde to standard epimerization conditions (K2CO3 and MeOH) provided aldehyde 
3.55β  as an 8.5:1 mixture of C14 epimers, favoring the desired isomer.  
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2. i) OxCl, DMSO, -78 ºC;  ii) Et3N
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The increased selectivity for the β-aldehyde in C6 ketone 3.55 compared to the 
analogous C6 ketal 3.24 (3.8:1 dr) is worth noting and these results are consistent with the 
previous observations by Dr. Chris Plummer for the epimerization of ketone 3.57 (8:1 dr) and 
ketal 3.58 (4:1 dr) (Scheme 3.19). Based on ground state energy calculations for 3.55α/β  and 
3.24α/β , the profound effect of the remote C6 group on the thermodynamic equilibrium of the 
C14 aldehyde could be due to the greater eclipsing interaction between the C7 hydrogen and C14 
aldehyde when the C6 group is planar, resulting in an additional destabilizing 1,3-diaxial 
interaction for ketone 3.55α  in comparison to ketal 3.24α  (Figure 3.1).  
 
Scheme 3.19. Previous results for the epimerization of C6 ketone 3.57 and C6 ketal 3.58. 
	  
	  
Figure 3.1. Molecular models of 3.55α  (top) and 3.24α  (bottom) based on MM2 force field 



































Following the Wittig methylenation of aldehyde 3.55β  to provide vinyl ketone 3.56, we 
were ready to explore the feasibility of C6 enone formation at this stage of the synthesis. 
Unfortunately, treatment of vinyl ketone 3.56 with excess LDA at -78 ºC followed by quenching 
with PhSeBr resulted in exclusive selenylation at the C5 bridgehead position to give selenide 
3.59, which was determined by the disappearance of the C5 proton in the 1H NMR spectra along 
with two strong NOE correlations: (1) between the ortho protons of the phenylselenide and the 
TIPS group at the C3 position and (2) between the ortho protons of the phenylselenide and the 
C4 methylene protons. A possible implication of the formation of 3.59 is that deprotonation at 
the bridgehead position is kinetically favored over deprotonation at the C7 position. Although 
suspicious, this possibility could be due to the eclipsing interactions of the C7 hydrogen with the 
C14 olefin, preventing easy access of the bulky amine base to the C7 protons.     
 
Scheme 3.20. Selenylation of vinyl ketone 3.56. 
3.10 Proposal of a Modified Route towards Cyclocitrinol 
The failed attempt at installing the C6 enone emphasizes the importance of steric 
considerations when introducing functionality on the B ring of the ABC fused ring system. To 
install the C6 enone through a selenoxide elimination, the C7 position must be accessible for 
deprotonation and for selenium addition. Based on our results indicating that selenide formation 




























group by tying it into the D ring may make the C7 position more accessible. With these 
considerations in mind, we proposed that the most logical point during the synthetic route to 
install the enone would be after the RCM reaction.  
Preliminary results indicate that formation of the D ring in the presence of an 
unprotected C6 ketone is achievable using a route similar to that employed for the formation of 
tetracyclic ketal 3.28. PMB-deprotection of allylic alcohol 3.56 using DDQ followed by 
selenium-mediated 1,3-isomerization gave secondary allylic alcohol 3.61 in 50% yield over 3 
steps as a 1.9:1 mixture of C17 epimers. During the selenylation of ketone 3.60 using PhSeCN 
and (n-Bu)3P, substantial formation of a C6 cyanohydrin was observed, accounting for the 
modest yield of the isomerization reaction. Subsequent formation of the D ring by RCM gave the 
ABCD tetracycle 3.62 in 79% yield (Scheme 3.21).  
 Scheme 3.21. Preparation of tetracyclic C6 ketone 3.62.  
With access to 3.62, future steps toward completion of the molecule would be to 
evaluate the enone formation and to ensure the compatibility of the C6 enone with the C17 side-
chain installation. Although this thesis will not cover the total synthesis, we are confident that it 
is achievable through slight modifications of our 2nd generation route. As shown in Scheme 3.22, 
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enone 3.63. With the enone masked as a protected allylic alcohol, the C17 side-chain could be 
readily installed in a similar fashion as before. Final deprotection and oxidation of the C6 allylic 
alcohol to reintroduce the C6 enone, followed by global silyl deprotection would deliver the 
synthetic target, cyclocitrinol.  
 
Scheme 3.22. Proposed modified route towards cyclocitrinol.  
	  
Our eventual completion of cyclocitrinol would serve as an elegant example of the use 
of strain-accelerated rearrangements to access synthetically challenging bridged ring systems 
rapidly. To date, no semisynthesis or total synthesis of any member of the cyclocitrinol family 
has been published, illustrating the synthetic challenge that this unique family of steroids poses 
to the synthetic community. 
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3.12 Experimental Section 
General Procedures. All reactions were conducted under an inert atmosphere of 
nitrogen or argon in flame-dried or oven-dried glassware unless otherwise indicated. High 
pressure reactions were carried out in a Pyrex sealed tube with a Teflon screw cap. Benzene, 
toluene, methylene chloride, tetrahydrofuran, and diethyl ether were purchased from Fisher and 
purified by degassing with argon followed by passage through both an activated neutral alumina 
column and Q5 reactant column. Acetonitrile, dimethyl sulfoxide, methanol, and trifluorotoluene 
were purchased as anhydrous from Sigma-Aldrich. Absolute (200 proof) ethanol was distilled 
over Mg turnings in the presence of catalytic I2 and stored over activated 3Å molecular sieves. 
Triethylamine, diisopropylamine, N,N-diisopropylethylamine, pyridine, 2,6-lutidine, 1,8-
diazabicycloundec-7-ene, and 1,1,3,3-tetramethylguanidine were distilled over CaH2 and stored 
over activated 4Å molecular sieves. Chlorodimethylphenylsilane and tert-butyldimethylsilyl 
trifluoromethanesulfonate were distilled over CaH2 and stored under argon. All other 
commercially available reagents were used without further purification, unless otherwise stated.  
Reactions were monitored by thin-layer chromatography (TLC) carried out on 0.25 mm 
EMD/Merck KGaA silica gel plates (60F-254) using UV light as a visualizing agent and either a 
phosphomolybdic acid (PMA) or p-anisaldehyde stain with heat as a developing agent. SiliCycle 
silica gel 60 (230-240 mesh) was used for flash column chromatography. 1H NMR spectra were 
recorded on Bruker Avance III HD 400, Bruker Avance III HD 500, or Bruker Ascend 500 
spectrometers. 1H NMR chemical shifts are reported in parts per million from CDCl3 (7.26 ppm) 
or C6D6 (7.16 ppm) and spectral data is reported as follows: (s = singlet, d = doublet, t = triplet, 
br = broad, q = quartet, dd = doublet of doublets, dt = doublet of triplets, m = multiplet; coupling 
constant(s) in Hz; integration). Proton decoupled 13C NMR spectra were recorded on Bruker 
	  
 83 
Avance III HD 400 or Bruker Avance III HD 500 and are reported in ppm from CDCl3 (77.16 
ppm) or C6D6 (128.39 ppm). Infrared (IR) spectra were recorded on a Nicolet Avatar 370 DTGS 
FT-IR. Optical rotations were recorded on a JASCO DIP-1000 digital polarimeter; the 
concentration c is reported in g/100 mL. Mass spectra were obtained on a JOEL HX110 mass 
spectrometer (FAB) or JEOL AccuTOF LP 4G mass spectrometer (APCI/ESI). 
 
(R)-Diol 3.91: To an oven-dried flask equipped with a magnetic stir bar was added Pt(dba)3 (733 
mg, 0.816 mmol, 0.010 equiv), (S,S)-3,5-di-iso-propylphenyl-TADDOL2 (890 mg, 1.10 mmol, 
0.013 equiv), B2(pin)2 (21.7 g, 85.5 mmol, 1.05 equiv), and tetrahydrofuran (60 mL). The 
catalyst mixture was purged with argon and then heated to 80 ºC in an oil bath for 1 h. The flask 
was then cooled to room temperature and charged with a solution of (E)-4,8-dimethylnona-1,3,7-
triene3 3.8 (12.3 g, 81.5 mmol, 1.0 equiv) in tetrahydrofuran (40 mL, 2.0 M). After additional 
purging with argon, the reaction was stirred at 60 ºC for 13 hours. The reaction mixture was 
cooled to 0 ºC and charged with 3 M NaOH (200 mL), followed by a dropwise addition of 30% 
(w/w) H2O2 in water (100 mL). The reaction was gradually warmed to room temperature and 
stirred for 5 h, then cooled to 0 ºC and carefully quenched with saturated aqueous Na2S2O3 (400 
mL) over 1 h. The reaction mixture was diluted with ethyl acetate (150 mL) and the aqueous and 
organic layers were separated. The aqueous layer was further extracted with ethyl acetate (2 x 
150 mL), and the combined organic layers were dried over Na2SO4, filtered, and concentrated. 
The crude reaction mixture was purified by flash chromatography through silica gel (10-30% 
acetone in hexanes) to afford 11.5 g (77%, 84% brsm, 91.6 ee%) 3.9 as a yellow oil. The 







i) 1 mol% Pt(dba)3/(S,S)-iPrPhTADDOL
   B2pin2, THF, 60 oC;
ii) H2O2, NaOH, 0 oC to RT3.8 3.9
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and catalytic p-toluenesulfonic acid to afford the corresponding acetonide for chiral GLC 
analysis (β-Dex 325, Supelco, 90 °C for 5 min, ramp 2 °C/min to 160 °C, 20 psi). The racemic 
mixture was prepared by mixing approximate equimolar amounts of the product made using 
(R,R)-3,5-di-iso-propylphenyl-TADDOL and (S,S)-3,5-di-iso-propylphenyl-TADDOL as the 
ligand in the diborylation reaction. [α]20D = -22.5º (c 1.0, CH2Cl2, l = 50 mm); IR (thin film, 
neat) 3333 (br), 2968, 2919, 2856, 1668, 1442, 1378, 1075, 1021 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 5.15 (d, J = 8.4 Hz, 1H), 5.07 (t, J = 6.8 Hz, 1H), 4.48 (td, J = 8.2, 3.8 Hz, 1H), 3.56 
(dd, J = 11.1, 3.8 Hz, 1H), 3.48 (dd, J = 11.1, 8.0 Hz, 1H), 2.16–1.93 (m, 6H), 1.71 (s, 3H), 1.68 
(s, 3H), 1.60 (s, 3H); 13C NMR (101 MHz, CHCl3) δ 141.5, 132.0, 123.9, 123.2, 
69.6, 66.6, 39.7, 26.5, 25.8, 17.8, 17.0; HRMS for C11H20O2 (EI+): calcd 184.1463 ([M]+); found: 
184.1457 ([M]+). 
 
Protected (R)-Diol 3.10: To a solution of diol 3.9 (11.5 g, 62.6 mmol) in dichloromethane (200 
mL, 0.3 M) was added TBDPSCl (19.5 mL, 75.2 mmol, 1.2 equiv), pyridine (25.2 mL, 312 
mmol, 5.0 equiv), and 4-dimethylaminopyridine (1.84 g, 15.1 mmol, 0.24 equiv). After 16 h at 
room temperature. benzoic anhydride (28.3 g, 125 mmol, 2.0 equiv) was added as a solid and the 
reaction was stirred for 5 days at 40 ºC. The reaction was quenched with saturated aqueous 
NaHCO3 (200 mL) and the aqueous and organic layers were separated. The aqueous phase was 
extracted with dichloromethane (2 x 100 mL), and the combined organic layers were dried over 
Na2SO4, filtered, and concentrated. The crude reaction mixture was purified by flash 
chromatography through silica gel (10-40% dichloromethane in hexanes) to give 29.9 g (91%) of 














2961, 2929, 2858, 1719, 1428, 1269, 1110, 708, 505 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.06 (d, 
J = 7.0 Hz, 2H), 7.68 (t, J = 6.6 Hz, 4H), 7.55 (t, J = 7.4 Hz, 1H), 7.44 (t, J = 7.7 Hz, 2H), 7.40 
(dd, J = 7.4, 2.0 Hz, 2H), 7.38 – 7.30 (m, 4H), 5.93 (ddd, J = 9.0, 7.0, 4.1 Hz, 1H), 5.24 (dd, J = 
9.0, 1.3 Hz, 1H), 5.05 (tq, J = 5.2, 1.4 Hz, 1H), 3.87 (dd, J = 10.9, 7.1 Hz, 1H), 3.75 (dd, J = 10.9, 
4.1 Hz, 1H), 2.12 – 1.98 (m, 4H), 1.76 (d, J = 1.3 Hz, 3H), 1.63 (d, J = 1.4 Hz, 3H), 1.56 (d, J = 
1.3 Hz, 3H), 1.02 (s, 9H); 13C NMR (126 MHz, CHCl3) δ 166.1, 142.4, 135.8, 135.8, 133.6, 
133.6, 132.8, 131.9, 131.0, 129.8, 129.8, 129.8, 128.4, 127.8, 127.8, 123.9, 120.0, 72.8, 65.8, 
39.7, 26.8, 26.4, 25.8, 19.3, 17.8, 17.2; HRMS for C34H42O3SiNa (ESI+): calcd 549.2801 
([M+Na]+); found: 549.2792 ([M+Na]+). 
 
Aldehyde 3.11: To a cooled (-15 ºC) solution of benzoate 3.10 (29.9 g, 56.8 mmol) in 
dichloromethane (300 mL) was added a solution of mCPBA (70-75% wt, 14.3 g, 62.2 mmol, 1.1 
equiv) in dichloromethane (150 mL) dropwise over 2 h. The resulting slurry was warmed to 0 ºC 
and stirred for 1 h and then quenched with saturated aqueous NaHCO3 (300 mL) and the aqueous 
and organic layers were separated. The aqueous phase was extracted with dichloromethane (3 x 
150 mL), and the combined organics were dried over Na2SO4, filtered, and concentrated. The 
resulting white solid was dissolved in tetrahydrofuran (60 mL). The solution of crude epoxide 
was then added dropwise to a cold (0 ºC) solution of HIO4•H2O (14.2 g, 62.3 mmol, 1.1 equiv) in 
water (57 mL). After 6 h at 0 ºC, the reaction was slowly quenched with saturated aqueous 
NaHCO3 (100 mL) and further diluted with diethyl ether (100 mL). The aqueous and organic 
layers were separated and the aqueous phase was extracted with diethyl ether (2 x 100 mL). The 









1. mCPBA, DCM, -15 to 0 oC
2. HIO4•2H2O, THF/H2O, 0 oC 3.113.10
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mixture was purified by flash chromatography through silica gel (5-10% ethyl acetate in 
hexanes) to afford 22.4 g (79%) of 3.11 as a pale yellow oil. [α]25D  = +17.9º (c 1.0, CH2Cl2, l = 
50 mm); IR (thin film, neat) 3074, 2930, 2858, 1719, 1428, 1270, 1111, 1073, 708, 505 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 9.75 (t, J = 1.6 Hz, 1H), 8.04 (dd, J = 8.3, 1.4 Hz, 2H), 7.69 – 7.63 
(m, 4H), 7.56 (t, J = 7.4 Hz, 1H), 7.47 – 7.39 (m, 4H), 7.35 (td, J = 7.8, 6.6 Hz, 4H), 5.89 (ddd, J 
= 9.0, 6.8, 4.3 Hz, 1H), 5.26 (dq, J = 9.0, 1.4 Hz, 1H), 3.87 (dd, J = 10.9, 6.9 Hz, 1H), 3.75 (dd, J 
= 10.9, 4.3 Hz, 1H), 2.53 (ddd, J = 8.0, 6.4, 1.4 Hz, 2H), 2.34 (t, J = 7.9 Hz, 2H), 1.77 (d, J = 1.3 
Hz, 3H), 1.01 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 201.8, 166.1, 140.4, 135.8, 135.7, 133.5, 
133.4, 132.9, 130.7, 129.9, 129.8, 129.8, 128.4, 127.8, 121.0, 72.4, 65.6, 41.9, 31.6, 26.8, 19.3, 
17.3; HRMS for C31H36O4SiNa (ESI+): calcd 523.2281 ([M+Na]+); found: 523.2266 ([M+Na]+). 
 
Diene 3.12: To a cooled (-78 ºC) slurry of MePPh3Br (19.2 g, 53.8 mmol, 1.2 equiv) in 
tetrahydrofuran (250 mL) was added n-butyllithium (2.5 M in THF, 19.7 mL, 49.3 mmol, 1.1 
equiv). The solution was warmed to 0 ºC and stirred for 30 min, then a solution of aldehyde 3.11 
(22.4 g, 44.7 mmol) in tetrahydrofuran (250 mL) was added to the ylide solution. After 1 h at 0 
ºC, the reaction was quenched with saturated aqueous NH4Cl (300 mL). The layers were 
partitioned and the aqueous phase extracted with dichloromethane (3 x 200 mL). The combined 
organic layers were dried over Na2SO4, filtered, and concentrated. The crude reaction mixture 
was purified by flash chromatography through silica gel (5-7% ethyl acetate in hexanes) to afford 
19.4 g (87%) of 3.12 as a pale yellow oil. [α]25D  = +14.8º (c 1.0, CH2Cl2, l = 50 mm); IR (thin 
film, neat) 3070, 2929, 2857, 1717, 1450, 1427, 1268, 1108, 1070, 1025, 705, 505 cm-1; 1H 
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7.55 (t, J = 7.4 Hz, 1H), 7.46 – 7.38 (m, 4H), 7.38 – 7.31 (m, 4H), 5.92 (ddd, J = 9.0, 6.9, 4.2 Hz, 
1H), 5.77 (ddt, J = 16.9, 10.2, 6.3 Hz, 1H), 5.26 (dd, J = 9.0, 1.3 Hz, 1H), 4.99 (dd, J = 17.1, 1.8 
Hz, 1H), 4.92 (dd, J = 10.1, 2.0 Hz, 1H), 3.88 (dd, J = 10.9, 6.9 Hz, 1H), 3.77 (dd, J = 10.9, 4.2 
Hz, 1H), 2.23 – 1.99 (m, 4H), 1.76 (d, J = 1.2 Hz, 3H), 1.02 (s, 9H). 13C NMR (126 MHz, 
CDCl3) δ 166.1, 141.9, 138.2, 135.8, 135.8, 133.6, 133.5, 132.8, 130.9, 129.8, 129.8, 128.4, 
127.8, 120.3, 114.8, 72.7, 65.8, 39.0, 32.0, 26.8, 19.3, 17.2; HRMS for C32H38O3SiNa (ESI+): 
calcd 521.2488 ([M+Na]+); found: 521.2492 ([M+Na]+). 
 
Primary Alcohol 3.12-1: To a cooled (0 ºC) solution of diene 3.12 (10.3 g, 20.7 mmol) in 
tetrahydrofuran (400 mL) was added acetic acid (1.80 mL, 31.5 mmol, 1.5 equiv) followed by a 
solution of TBAF (1.0 M in THF, 31.0 mL, 31.0 mmol, 1.5 equiv). The cloudy mixture was 
warmed to room temperature and stirred for 6 h, then diluted with dichloromethane (100 mL) 
and cooled to 0 ºC prior to the addition of water (200 mL). The layers were partitioned and the 
aqueous phase extracted with dichloromethane (2 x 100 mL). The combined organic layers were 
dried over Na2SO4, filtered, and concentrated. The crude reaction mixture was purified by flash 
chromatography through silica gel (10-30% ethyl acetate in hexanes) to afford 5.3 g (98%) of 
3.12-1 as a pale yellow oil. [α]25D  = +38.6º (c 1.0, CH2Cl2, l = 50 mm); IR (thin film, neat) 3421 
(br), 2982, 2919, 1713, 1450, 1269, 1113, 1070, 1025, 911, 712 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 8.05 (dd, J = 8.3, 1.4 Hz, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.43 (t, J = 7.8 Hz, 2H), 5.93 – 
5.64 (m, 2H), 5.24 (dt, J = 9.0, 1.3 Hz, 1H), 5.00 (dq, J = 17.0, 1.5 Hz, 1H), 4.95 (dq, J = 10.1, 
1.5, 0.9 Hz, 1H), 3.82 (dd, J = 11.8, 7.3 Hz, 1H), 3.73 (dd, J = 11.9, 4.3 Hz, 1H), 2.26 – 2.11 (m, 
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133.1, 130.4, 129.8, 128.5, 119.8, 115.0, 73.4, 65.0, 39.0, 32.0, 17.2; HRMS for C16H20O3Na 
(ESI+): calcd 283.1310 ([M+Na]+); found: 283.1308 ([M+Na]+). 
 
PMB Ether 3.6: To a solution of alcohol 3.12-1 (5.29 g, 20.3 mmol) in toluene (200 mL) was 
added PMB trichloroacetimidate (6.5 mL, 31.3 mmol, 1.5 equiv) and lanthanum triflate (605 mg, 
1.03 mmol, 0.5 equiv). After stirring for 17 h at room temperature, the reaction mixture was 
directly purified by flash chromatography through silica gel (5% ethyl acetate in hexanes) to 
afford 7.0 g (91%) of 3.6 as a pale yellow oil. [α]24D  = +9.4º (c 1.0, CH2Cl2, l = 50 mm); IR (thin 
film, neat) 2932, 2859, 1714, 1611, 1512, 1268, 1248, 1174, 1107, 1028, 821, 712 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 8.09 (dd, J = 8.3, 1.5 Hz, 2H), 7.55 (tt, J = 7.3, 1.5 Hz, 1H), 7.44 (dd, 
J = 8.4, 7.1 Hz, 2H), 7.27 (d, J = 8.7 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 6.02 (ddd, J = 9.0, 7.3, 
3.9 Hz, 1H), 5.80 (ddt, J = 16.9, 10.1, 6.3 Hz, 1H), 5.31 (dq, J = 9.0, 1.4 Hz, 1H), 5.02 (dt, J = 
17.0, 1.7 Hz, 1H), 4.96 (ddt, J = 10.3, 2.2, 1.2 Hz, 1H), 4.59 (d, J = 11.8 Hz, 1H), 4.52 (d, J = 
11.8 Hz, 1H), 3.79 (s, 3H), 3.72 (dd, J = 10.8, 7.3 Hz, 1H), 3.61 (dd, J = 10.8, 3.9 Hz, 1H), 2.27 
– 2.09 (m, 4H), 1.84 (d, J = 1.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 165.9, 159.2, 141.9, 
138.0, 132.8, 130.7, 130.3, 129.7, 129.7, 129.2, 128.3, 120.2, 114.8, 113.8, 113.8, 72.8, 71.4, 














Ketone 3.13: To a solution of vinyl epoxide 1.364  (1.03 g, 3.34 mmol) and PMB ether 3.6 (1.41 
g, 3.71 mmol, 1.1 equiv) in chloroform (65 mL) was added Hoveyda-Grubbs II (126 mg, 0.201 
mmol, 0.05 equiv) catalyst. The resulting green solution was purged with nitrogen and refluxed 
for 14 h, then cooled to room temperature and concentrated. The black residue was purified by 
flash chromatography through silica gel (slurry packed with 2% triethylamine in hexane and 
eluted with 5-10% diethyl ether in hexanes) to give 1.53 g (69%) 3.13 as a 3.7:1 mixture of E/Z 
isomers. [α]21D  = -29.6º (c 1.0, CH2Cl2, l = 50 mm); IR (thin film, neat) 2941, 2864, 1756, 1717, 
1513, 1268, 1248, 1082, 1068, 1008, 882, 712 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.05 (dd, J = 
8.3, 1.4 Hz, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.43 (t, J = 7.8 Hz, 2H), 7.24 (d, J = 8.6 Hz, 2H), 6.84 
(d, J = 8.6 Hz, 2H), 5.97 (ddd, J = 8.8, 7.1, 3.8 Hz, 1H), 5.34 (dt, J = 7.8, 2.9 Hz, 0.79H for (E) 
isomer), 5.24 (d, J = 8.8 Hz, 1H), 5.19 (t, J = 6.6 Hz, 0.21H for (Z) isomer), 4.56 (d, J = 11.8 Hz, 
1H), 4.50 (d, J = 11.8 Hz, 1H), 4.09 (t, J = 3.0 Hz, 1H), 3.79 (s, 3H), 3.67 (ddd, J = 10.7, 7.3, 5.1 
Hz, 1H), 3.56 (dt, J = 10.8, 4.6 Hz, 1H), 3.08 (dd, J = 16.1, 2.5 Hz, 1H), 2.88 (t, J = 2.4 Hz, 
0.21H for (Z) isomer), 2.64 (t, J = 3.2 Hz, 0.79H for (E) isomer), 2.57 – 2.30 (m, 6H), 2.18 – 
1.99 (m, 4H), 1.80 (dd, J = 3.5, 1.3 Hz, 3H), 1.04 (s, 21H); 13C NMR for (E) isomer (101 MHz, 
CDCl3) δ 220.2, 166.1, 159.3, 142.5, 136.2, 132.9, 130.8, 130.4, 129.8, 129.3, 128.4, 122.0, 
120.2, 113.9, 72.9, 71.5, 71.0, 65.5, 55.4, 52.9, 48.6, 45.6, 45.5, 39.0, 30.6, 26.3, 18.3, 18.2, 17.1, 


















(E)-Diol 3.14: To a cooled (-78 ºC) solution of ketone 3.13 (2.10 g, 3.17 mmol) in 
tetrahydrofuran (16 mL) was added allylmagnesium bromide (1.0 M in Et2O, 12.7 mL, 12.7 
mmol, 4.0 equiv). After 1 h, the mixture was quenched with saturated aqueous NH4Cl (30 mL) 
then stirred to room temperature. The layers were partitioned and the aqueous phase extracted 
with diethyl ether (2 x 15 mL). The combined organic layers were dried over Na2SO4, filtered, 
and concentrated. The crude reaction mixture was repeatedly purified (3 times) by flash 
chromatography through silica gel (slurry packed with 1% triethylamine in hexane and eluted 
with 10-20% ethyl acetate in hexanes) to obtain 1.24 g (66%, 83% of theoretical) 3.14 as a single 
(E)-isomer. [α]23D  = +1.4º (c 1.0, CH2Cl2, l = 50 mm); IR (thin film, neat) 3432 (br), 2922, 2864, 
1612, 1513, 1247, 1057, 1033, 1004, 882, 819, 675 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.27 (d, 
J = 9.8 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 5.86 (ddt, J = 17.5, 10.2, 7.5 Hz, 1H), 5.25 (d, J = 6.2 
Hz, 1H), 5.22 – 5.08 (m, 3H), 4.57 (td, J = 8.6, 3.2 Hz, 1H), 4.51 (s, 2H), 4.06 (t, J = 5.2 Hz, 
1H), 3.81 (s, 3H), 3.42 (dd, J = 9.6, 3.2 Hz, 1H), 3.31 (t, J = 9.2 Hz, 1H), 2.72 (d, J = 15.6 Hz, 
1H), 2.36 – 2.27 (m, 3H), 2.23 – 2.12 (m, 4H), 2.09 – 1.89 (m, 5H), 1.76 – 1.64 (m, 5H), 1.57 (br 
s, 1H), 1.02 (s, 21H). 13C NMR (101 MHz, CDCl3) δ 159.5, 143.1, 141.1, 133.9, 130.3, 129.6, 
122.8, 120.7, 119.6, 114.0, 77.3, 74.0, 73.2, 67.8, 65.7, 55.4, 48.8, 42.9, 40.0, 39.3, 37.9, 36.0, 

















Acrylate 3.15: To a cooled (0 ºC) solution of (E)-diol 3.14 (2.32 g, 3.88 mmol) in 
dichloromethane (13 mL) was added triethylamine (5.4 mL, 38.7 mmol, 10 equiv), acrylic acid 
(800 µL, 11.7 mmol, 3.0 equiv) then 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (3.07 g, 
16.0 mmol, 4.1 equiv). The resulting slurry was allowed to warm to room temperature and stirred 
for 16 h, then diluted with dichloromethane (50 mL) and poured into saturated aqueous NaHCO3 
(50 mL). The layers were separated and the aqueous phase was extracted with diethyl ether (3 x 
30 mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated. The 
crude reaction mixture was purified by flash chromatography through silica gel (slurry packed 
with 1% triethylamine in hexane and eluted with 8-30% ethyl acetate in hexanes) to give 1.37 g 
(54%) 3.15 as a yellow oil and 930 mg (40%) recovered 3.14. [α]23D  = -3.9º (c 1.0, CH2Cl2, l = 
50 mm); IR (thin film, neat) 3501 (br), 2923, 2864, 1723, 1513, 1247, 1192, 1057, 1035, 1004, 
882, 809, 675 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.24 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.7 Hz, 
2H), 6.40 (dd, J = 17.3, 1.5 Hz, 1H), 6.14 (dd, J = 17.3, 10.4 Hz, 1H), 5.93 – 5.76 (m, 3H), 5.24 
(br s, 1H), 5.22 – 5.08 (m, 3H), 4.53 (d, J = 11.8 Hz, 1H), 4.47 (d, J = 11.8 Hz, 1H), 4.06 (t, J = 
5.2 Hz, 1H), 3.57 (dd, J = 10.8, 7.3 Hz, 1H), 3.48 (dd, J = 10.8, 3.9 Hz, 1H), 2.72 (d, J = 16.6 
Hz, 1H), 2.30 (ddt, J = 13.6, 5.4, 2.9 Hz, 2H), 2.24 – 2.11 (m, 4H), 2.09 – 1.89 (m, 5H), 1.78 – 
1.64 (m, 5H), 1.59 (br s, 1H), 1.03 (d, J = 1.7 Hz, 21H); 13C NMR (101 MHz, CDCl3) δ 165.7, 
159.3, 143.1, 142.9, 133.9, 130.5, 130.4, 129.3, 129.0, 120.5, 119.7, 119.6, 113.9, 77.2, 72.9, 
71.5, 70.5, 65.7, 55.4, 48.8, 42.9, 40.0, 39.3, 37.9, 36.0, 31.4, 26.9, 18.3, 18.3, 17.1, 12.3; HRMS 

















Macrolactone 3.16: To a solution of acrylate 3.15 (2.07 g, 3.17 mmol) in dichloromethane (650 
mL) was added Hoveyda-Grubbs II catalyst (203 mg, 0.324 mmol, 0.10 equiv) and the mixture 
was heated at reflux. After 12 h, the mixture was cooled and ethyl vinyl ether (3 mL) was added. 
The resulting mixture was stirred open to the air for 1 h and then concentrated. The crude 
reaction mixture was purified by flash chromatography through silica gel (slurry packed with 1% 
triethylamine in hexane and eluted with 20-40% ethyl acetate in hexanes) to give 1.69 g (85%) 
3.16 as a white solid. [α]24D  = +85.3º (c 1.0, CH2Cl2, l = 50 mm); IR (thin film, neat) 3481 (br), 
2922, 2864, 1694, 1513, 1248, 1081, 1057, 1026, 1012, 882, 816, 676 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.25 (d, J = 9.0 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 6.33 (ddd, J = 11.6, 8.4, 6.5 Hz, 1H), 
5.79 (ddd, J = 9.9, 6.9, 4.3 Hz, 1H), 5.15 (d, J = 9.9 Hz, 1H), 5.11 (dd, J = 10.8, 3.2 Hz, 1H), 
4.53 (d, J = 11.8 Hz, 1H), 4.49 (d, J = 11.8 Hz, 1H), 4.04 (t, J = 5.2 Hz, 1H), 3.80 (s, 3H), 3.59 
(dd, J = 10.7, 6.9 Hz, 1H), 3.51 (dd, J = 10.7, 4.3 Hz, 1H), 2.90 (ddd, J = 16.0, 8.5, 1.7 Hz, 1H), 
2.64 (d, J = 16.7 Hz, 1H), 2.59 (ddd, J = 16.0, 6.5, 2.1 Hz, 1H), 2.28 – 2.07 (m, 5H), 2.01 – 1.91 
(m, 3H), 1.89 – 1.82 (m, 1H), 1.79 (d, J = 1.3 Hz, 3H), 1.73 (d, J = 13.8 Hz, 1H), 1.66 (d, J = 
14.4 Hz, 1H), 1.37 (br s, 1H), 1.02 (d, J = 2.2 Hz, 21H); 13C NMR (101 MHz, CDCl3) δ 166.4, 
159.4, 143.7, 143.3, 141.8, 130.3, 129.5, 122.7, 121.3, 120.9, 113.9, 77.9, 73.0, 71.3, 69.3, 65.2, 
55.4, 49.2, 39.8, 39.5, 38.9, 37.9, 35.8, 31.3, 26.5, 18.2, 16.6, 12.2; HRMS for C37H56O6SiNa 
(ESI+): calcd 647.3744 ([M+Na]+); found: 647.3741 ([M+Na]+). 
















Ketoester 3.17: To a solution of macrolactone 3.16 (1.69 g, 2.71 mmol) in trifluorotoluene (54 
mL) in a high pressure Pyrex tube was added 1,8-diazabicyclo[5.4.0]undec-7-ene (4.1 mL, 27.4 
mmol, 10 equiv) and Me2PhSiCl (4.50 mL, 26.8 mmol, 10 equiv). The vessel was sealed under 
argon using a Teflon screw cap and heated to 140 ºC. After 24 h, the solution was cooled and 
then poured into aqueous 1 M HCl (50 mL). The layers were separated and the aqueous phase 
was extracted with diethyl ether (4 x 50 mL). The combined organics were dried over Na2SO4, 
filtered, and concentrated. The residue was dissolved in diethyl ether (11 mL) and methanol (43 
mL), and the resulting solution was treated with TMS-diazomethane (2.0 M in hexanes, 5.40 mL, 
5.40 mmol, 4.0 equiv). After stirring for 2 h at room temperature, the solution was concentrated 
and the residue was purified by flash chromatography through silica gel (5-20% ethyl acetate in 
hexanes) to give 847 mg (49%) 3.17 as a pale yellow oil. [α]23D  = +19.6º (c 1.0, CH2Cl2, l = 50 
mm); IR (thin film, neat) 2942, 2864, 1731, 1686, 1514, 1463, 1248, 1155, 1090, 1064, 1041, 
883, 801, 681 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.24 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.6 Hz, 
2H), 5.66 (d, J = 15.9 Hz, 1H), 5.62 (t, J = 7.5 Hz, 1H), 5.56 (dt, J = 15.8, 5.9 Hz, 1H), 4.38 (s, 
2H), 3.93 (dd, J = 5.9, 1.1 Hz, 2H), 3.80 (s, 3H), 3.53 (s, 3H), 3.47 (tt, J = 10.2, 3.4 Hz, 1H), 
2.82 – 2.70 (m, 2H), 2.65 (dt, J = 13.1, 4.3 Hz, 1H), 2.59 – 2.41 (m, 5H), 2.34 (d, J = 16.9 Hz, 
1H), 2.31 – 2.14 (m, 3H), 1.71 (ddd, J = 13.2, 10.2, 4.6 Hz, 1H), 1.60 – 1.49 (m, 2H), 1.39 (dt, J 
= 13.1, 3.3 Hz, 1H), 1.20 (s, 3H), 1.04 (s, 21H); 13C NMR (101 MHz, CDCl3) δ 212.6, 173.4, 
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48.6, 45.8, 45.2, 38.2, 37.3, 32.7, 31.0, 26.5, 26.1, 25.2, 18.2, 18.2, 12.4; HRMS for 
C38H58O6SiNa (ESI+): calcd 661.3900 ([M+Na]+); found: 661.3895 ([M+Na]+). 
 
Ketal 3.23: To a solution of ketone 3.17 (832 mg, 1.30 mmol) in benzene (30 mL) was added 
ethylene glycol (3.60 mL, 64.6 mmol, 50 equiv), triethyl orthoformate (4.30 mL, 25.9 mmol, 20 
equiv), and para-toluenesulfonic acid (22.6 mg, 0.119 mmol, 0.09 equiv). The solution was then 
heated to 50 ºC. After 16 h, the reaction was poured into saturated aqueous NaHCO3 (30 mL). 
The layers were partitioned and the aqueous phase extracted with diethyl ether (3 x 20 mL). The 
combined organic layers were dried over Na2SO4, filtered, and concentrated. The crude reaction 
mixture was purified by flash chromatography through silica gel (5-10% ethyl acetate in 
hexanes) to give 774 mg (87%) 3.23 as a pale yellow oil. [α]23D  = +68.4º (c 1.0, CH2Cl2, l = 50 
mm); IR (thin film, neat) 2942, 2864, 1732, 1513, 1462, 1247, 1086, 1060, 1040, 1002, 883, 680 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.24 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 5.66 (d, J 
= 15.8 Hz, 1H), 5.54 (dt, J = 15.8, 6.0 Hz, 1H), 5.45 (dd, J = 8.2, 4.8 Hz, 1H), 4.37 (s, 2H), 4.17 
(qt, J = 5.1, 2.2 Hz, 1H), 3.95 – 3.83 (m, 6H), 3.79 (s, 3H), 3.52 (s, 3H), 2.71 – 2.62 (m, 1H), 
2.58 – 2.48 (m, 2H), 2.41 (dd, J = 4.7, 1.1 Hz, 1H), 2.38 – 2.28 (m, 2H), 2.18 (dd, J = 15.9, 11.9 
Hz, 2H), 2.05 (dt, J = 11.6, 6.2 Hz, 1H), 1.80 (dt, J = 14.0, 5.8 Hz, 1H), 1.62 (dd, J = 14.0, 9.8 
Hz, 1H), 1.54 – 1.42 (m, 2H), 1.34 (dt, J = 10.5, 2.3 Hz, 1H), 1.31 – 1.23 (m, 2H), 1.21 (s, 3H), 
1.05 (d, J = 2.5 Hz, 21H); 13C NMR (101 MHz, CDCl3) δ 174.0, 159.3, 143.2, 142.7, 130.7, 






















38.3, 36.9, 35.7, 33.8, 33.0, 31.8, 29.1, 25.4, 25.4, 24.8, 18.2, 18.2, 18.2, 12.4; HRMS for 
C40H62O7SiNa (ESI+): calcd 705.4163 ([M+Na]+); found: 705.4161 ([M+Na]+). 
 
Aldehyde 3.24β: To a solution of ester 3.23 (757 mg, 1.11 mmol) in tetrahydrofuran (11 mL) 
was added LiAlH4 (215 mg, 5.67 mmol, 5.1 equiv). The reaction was heated at 50 ºC for 12 h, 
then diluted with diethyl ether (10 mL) and cooled to 0 ºC. The resulting mixture was then 
slowly quenched by the dropwise addition of water (215 µL), followed by 3 M NaOH (270 µL) 
and additional water (640 µL). The slurry was warmed to room temperature and stirred for 30 
min until a fine white precipitate formed. The mixture was dried over MgSO4, filtered and 
concentrated to give the primary alcohol as a white solid. The crude alcohol was dissolved in 
dichloromethane (15 mL) and added dropwise to a cold (-78 ºC) solution of oxalyl chloride (280 
µL, 3.31 mmol, 3.0 equiv) and DMSO (350 µL, 4.93 mmol, 4.5 equiv) in dichloromethane (11 
mL). After 1 h at -78 ºC, triethylamine (1.2 mL, 8.6 mmol, 7.5 equiv) was added and the reaction 
was warmed to room temperature. After 1 h, the mixture was poured into saturated aqueous 
NaHCO3 (20 mL). The layers were partitioned and the aqueous phase extracted with 
dichloromethane (2 x 20 mL). The combined organic layers were dried over Na2SO4, filtered, 
and concentrated. The crude aldehyde was dissolved in methanol (20 mL) and then treated with 
potassium carbonate (1.50 g, 10.9 mmol, 10.0 equiv). The resulting slurry was stirred vigorously 
for 16 h, then diluted with dichloromethane (50 mL) and poured into water (50 mL). The layers 
were separated and the aqueous phase was extracted with diethyl ether (2 x 50 mL). The 
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mixture was purified by flash chromatography through pH 7.0 buffered silica gel (10% ethyl 
acetate in hexanes) to give 512 mg (71% over 3 steps) 3.24β  : 3.24α  in a 3.8 : 1 ratio. After 
repeated treatments of the minor diastereomer to the epimerization conditions (K2CO3/MeOH), 
the ratio of aldehydes 3.24β  : 3.24α  was increased to 10 : 1 dr. [α]24D  = +91.1º (c 1.0, CH2Cl2, l 
= 50 mm); IR (thin film, neat) 2937, 2864, 1720, 1513, 1463, 1248, 1086, 1036, 1010, 883, 680 
cm-1; 1H NMR (500 MHz, CDCl3) δ 9.79 (d, J = 4.4 Hz, 0.09H for (R)-isomer), 9.54 (d, J = 5.1 
Hz, 0.90H for (S)-isomer), 7.26 (d, J = 8.2 Hz, 2H), 6.87 (d, J = 8.2 Hz, 2H), 5.65 (d, J = 15.8 
Hz, 1H), 5.51 (dt, J = 15.8, 6.0 Hz, 1H), 5.43 (dd, J = 8.2, 5.0 Hz, 1H), 4.41 (s, 2H), 4.19 (dt, J = 
7.3, 3.2 Hz, 1H), 3.96 (d, J = 6.2 Hz, 2H), 3.94 – 3.81 (m, 4H), 3.80 (s, 3H), 2.64 – 2.44 (m, 3H), 
2.40 – 2.32 (m, 1H), 2.26 (d, J = 13.5 Hz, 1H), 2.08 (dt, J = 11.5, 6.2 Hz, 1H), 1.98 (dd, J = 11.7, 
5.1 Hz, 1H), 1.89 – 1.80 (m, 2H), 1.64 – 1.41 (m, 5H), 1.37 – 1.23 (m, 4H), 1.12 (d, J = 14.4 Hz, 
1H), 1.06 (d, J = 2.6 Hz, 21H); 13C NMR for 3.24β  (126 MHz, CDCl3) δ 206.4, 159.3, 143.0, 
142.9, 130.6, 129.6, 124.0, 123.3, 113.9, 112.5, 71.5, 70.6, 65.6, 64.7, 64.2, 62.5, 55.4, 52.3, 40.1, 
39.7, 37.9, 37.0, 36.2, 33.2, 31.8, 29.1, 25.3, 18.6, 18.2, 18.2, 12.4; HRMS for C39H60O6SiNa 
(ESI+): calcd 675.4057 ([M+Na]+); found: 675.4075 ([M+Na]+). 
 
Olefin 3.25: To a cooled (-78 ºC) slurry of MePPh3Br (332 mg, 930 µmol, 1.2 equiv) in 
tetrahydrofuran (8 mL) was added n-butyllithium (2.4 M in THF, 380 µL, 912 µmol, 1.2 equiv). 
The solution was warmed to 0 ºC and stirred for 30 min, then a solution of aldehyde 3.24β  (512 
mg, 784 µmol) in tetrahydrofuran (8 mL) was added to the ylide solution. After 1 h at 0 ºC, the 





















(10 mL), then the layers were partitioned and the aqueous phase extracted with diethyl ether (2 x 
10 mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated. The 
crude reaction mixture was purified by flash chromatography through silica gel (3-10% ethyl 
acetate in hexanes) to afford 428 mg (84%) 3.25 as a single diastereomer. [α]24D  = +73.0º (c 1.0, 
CH2Cl2, l = 50 mm); IR (thin film, neat) 2929, 2863, 1513, 1464, 1248, 1085, 998, 974, 882, 680 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.25 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 5.64 (d, J 
= 15.9 Hz, 1H), 5.54 – 5.33 (m, 3H), 5.08 (dd, J = 10.3, 2.3 Hz, 1H), 4.86 (dd, J = 17.3, 2.3 Hz, 
1H), 4.42 (d, J = 11.6 Hz, 1H), 4.38 (d, J = 11.6 Hz, 1H), 4.22 – 4.16 (m, 1H), 4.00 – 3.81 (m, 
6H), 3.80 (s, 3H), 2.60 – 2.48 (m, 2H), 2.35 (dt, J = 15.8, 4.2 Hz, 1H), 2.22 (d, J = 13.2 Hz, 1H), 
2.06 (dt, J = 12.2, 6.1 Hz, 1H), 1.93 (td, J = 11.0, 8.9 Hz, 1H), 1.84 (dt, J = 14.3, 6.0 Hz, 2H), 
1.70 (dd, J = 11.1, 9.8 Hz, 1H), 1.62 (dd, J = 14.3, 1.7 Hz, 1H), 1.56 – 1.48 (m, 3H), 1.44 – 1.31 
(m, 3H), 1.07 (d, J = 2.2 Hz, 21H), 1.05 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 159.2, 146.0, 
144.2, 139.3, 130.8, 129.5, 122.3, 122.2, 117.6, 113.9, 113.1, 71.2, 71.1, 65.7, 64.5, 64.0, 56.2, 
55.4, 53.2, 39.7, 39.5, 37.0, 36.5, 34.9, 33.4, 29.4, 25.4, 18.4, 18.3, 18.2, 12.4, 12.4; HRMS for 
C40H62O5SiNa (ESI+): calcd 673.4264 ([M+Na]+); found: 673.4280 ([M+Na]+). 
 
Primary Allylic Alcohol 3.26: To a solution of PMB-protected allylic alcohol 3.25 (428 mg, 
657 µmol) in dichloromethane (30 mL) and water (1.5 mL) was added 2,3-dichloro-5,6-dicyano-
1,4-benzoquinone (299 mg, 1.32 mmol, 2.0 equiv) as a solid. The reaction was vigorously stirred 
at room temperature for 1 h and then poured into saturated aqueous NaHCO3 (20 mL). The 





















combined organic layers were dried over Na2SO4, filtered, and concentrated. The crude reaction 
mixture was purified by flash chromatography through silica gel (10-15% ethyl acetate in 
hexanes) to afford 340 mg (98%) 3.26 as a white solid. [α]25D  = +77.9º (c 1.0, CH2Cl2, l = 50 
mm); IR (thin film, neat) 3356 (br), 2925, 2863, 1669, 1463, 1085, 998, 974, 882, 679 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 5.63 (d, J = 15.7 Hz, 1H), 5.53 – 5.41 (m, 2H), 5.38 (dd, J = 8.2, 4.9 
Hz, 1H), 5.07 (dd, J = 10.3, 2.3 Hz, 1H), 4.84 (dd, J = 17.2, 2.3 Hz, 1H), 4.21 – 4.15 (m, 1H), 
4.07 (t, J = 5.5 Hz, 2H), 3.94 – 3.80 (m, 4H), 2.59 – 2.47 (m, 2H), 2.34 (dt, J = 15.8, 4.2 Hz, 
1H), 2.21 (d, J = 13.2 Hz, 1H), 2.09 – 2.01 (m, 1H), 1.92 (td, J = 11.0, 8.9 Hz, 1H), 1.83 (dt, J = 
14.2, 5.9 Hz, 2H), 1.68 (dd, J = 11.1, 9.7 Hz, 1H), 1.60 (dd, J = 14.2, 1.6 Hz, 1H), 1.56 – 1.46 
(m, 3H), 1.44 – 1.29 (m, 3H), 1.25 (t, J = 5.1 Hz, 1H), 1.05 (d, J = 2.2 Hz, 21H), 1.03 (s, 3H); 
13C NMR (101 MHz, CDCl3) δ 144.8, 144.2, 139.2, 124.9, 122.2, 117.7, 113.1, 65.7, 64.5, 64.4, 
64.0, 56.2, 53.2, 39.5, 39.3, 37.0, 36.6, 36.5, 35.0, 33.4, 29.4, 25.4, 18.4, 18.3, 18.2, 12.4; HRMS 
for C32H54O4SiNa (ESI+): calcd 553.3689 ([M+Na]+); found: 553.3696 ([M+Na]+). 
 
Secondary Allylic Alcohol 3.27α/β: To a cooled (0 ºC) solution of primary allylic alcohol 3.26 
(240 mg, 640 µmol) in tetrahydrofuran (12.5 mL) was added phenyl selenocyanate (95 µL, 772 
µmol, 1.2 equiv) then tri-n-butylphosphine (190 µL, 761 µmol, 1.2 equiv). After 1 h at 0 ºC, the 
reaction was warmed to room temperature and volatiles were removed under vacuum. The crude 
reaction mixture was purified by flash chromatography through silica gel (5% ethyl acetate in 
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dichloromethane (12.5 mL) was added pyridine (2.6 mL, 32.2 mmol, 50 equiv) followed by 
dropwise addition of 30% (w/w) H2O2 in water (3.6 mL, 31.8 mmol, 50 equiv). The reaction was 
warmed to 0 ºC and stirred for 30 min, then quenched at 0 ºC with saturated aqueous sodium 
thiosulfate (20 mL). The layers were partitioned and the aqueous phase extracted with diethyl 
ether (3 x 10 mL). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated. The crude reaction mixture was purified by flash chromatography through pH 7.0 
buffered silica gel (8% ethyl acetate in hexanes) to afford 300 mg (88% over 2 steps) 3.27β  : 
3.27α  in a 1.9 : 1 ratio as a white solid. IR (thin film, neat) 3467 (br), 2927, 2864, 1673, 1463, 
1084, 1055, 998, 917, 882, 679 cm-1; 1H NMR for 3.27β  (500 MHz, CDCl3) δ 5.92 (ddd, J = 
17.1, 10.5, 6.6 Hz, 1H), 5.54 (dt, J = 17.3, 10.2 Hz, 1H), 5.37 (dd, J = 8.2, 4.8 Hz, 1H), 5.24 – 
5.12 (m, 3H), 5.07 (dd, J = 17.3, 2.4 Hz, 1H), 4.22 – 4.14 (m, 1H), 3.94 – 3.79 (m, 5H), 2.59 – 
2.47 (m, 2H), 2.34 (dt, J = 15.8, 4.2 Hz, 1H), 2.25 (t, J = 10.6 Hz, 1H), 2.20 (d, J = 13.3 Hz, 1H), 
2.05 (dt, J = 10.2, 6.0 Hz, 1H), 1.94 – 1.76 (m, 3H), 1.65 (td, J = 12.8, 4.7 Hz, 1H), 1.60 (dd, J = 
14.3, 1.0 Hz, 1H), 1.52 (d, J = 5.2 Hz, 1H), 1.51 – 1.26 (m, 5H), 1.05 (d, J = 2.0 Hz, 21H), 0.89 
(s, 3H); 13C NMR for 3.27β  (101 MHz, CDCl3) δ 144.3, 139.9, 138.1, 122.1, 118.2, 116.4, 113.2, 
78.4, 65.7, 64.5, 64.0, 52.9, 50.8, 40.9, 37.0, 36.5, 36.5, 35.0, 33.4, 31.5, 29.0, 25.4, 18.3, 18.2, 







Cyclopentenol 3.28α/β: To a solution of allylic alcohol 3.27α/β  (300 mg, 565 µmol) in 
dichloromethane (120 mL) was added Hoveyda-Grubbs II catalyst (30 mg, 48 µmol, 0.10 equiv) 
and the mixture was heated at reflux. After 3 h, the mixture was cooled and ethyl vinyl ether (2 
mL) was added. The resulting mixture was stirred open to the air for 1 h, and then concentrated. 
The crude reaction mixture was purified by flash chromatography through pH 7.0 buffered silica 
gel (10-20% ethyl acetate in hexanes) to afford 240 mg (85%) 3.28β  : 3.28α  in 1.9 : 1 ratio as a 
white solid. IR (thin film, neat) 3395 (br), 2940, 2865, 1464, 1083, 1000, 882, 680 cm-1; 1H 
NMR for 3.28β  (500 MHz, CDCl3) δ 5.97 (d, J = 6.1 Hz, 1H), 5.68 (ddd, J = 6.0, 3.3, 1.3 Hz, 
1H), 5.39 (dd, J = 7.8, 5.3 Hz, 1H), 4.33 (s, 1H), 4.22 – 4.16 (m, 1H), 3.96 – 3.84 (m, 4H), 2.60 – 
2.49 (m, 2H), 2.34 (dt, J = 15.8, 4.1 Hz, 1H), 2.22 (d, J = 13.3 Hz, 1H), 2.15 – 2.03 (m, 2H), 1.97 
(dtd, J = 11.8, 3.1, 1.7 Hz, 1H), 1.89 – 1.77 (m, 3H), 1.66 – 1.43 (m, 5H), 1.35 – 1.24 (m, 2H), 
1.06 (d, J = 2.0 Hz, 21H), 0.92 (s, 3H); 13C NMR for 3.28β  (101 MHz, CDCl3) δ 143.4, 134.4, 
132.4, 122.9, 112.8, 86.0, 65.7, 64.6, 64.1, 56.3, 55.3, 52.6, 37.1, 36.9, 35.4, 35.0, 33.2, 33.0, 
29.7, 25.9, 18.3, 18.2, 12.8, 12.4; HRMS for C30H51O4Si (ASAP+): calcd 503.3557 ([M+H]+); 

































Cyclopentanol 3.28-1α/β: To a solution of allylic alcohol 3.28α/β  (240 mg, 477 µmol) in 
toluene (9.5 mL) was added Wilkinson’s catalyst (43.3 mg, 46.8 µmol, 0.10 equiv) and the 
mixture was stirred at room temperature under H2 (1.1 atm) for 3 h. The crude reaction mixture 
was directly purified by flash chromatography through pH 7.0 buffered silica gel (10-20% ethyl 
acetate in hexanes) to afford 196 mg (81%) 3.28-1β  : 3.28-1α  in a 1.7:1 ratio as a white solid. IR 
(thin film, neat) 3375 (br), 2931, 2865, 1464, 1084, 1056, 998, 882, 679 cm-1; 1H NMR for 3.28-
1α  (500 MHz, CDCl3) δ 5.38 (dd, J = 8.2, 5.0 Hz, 1H), 4.23 – 4.15 (m, 1H), 3.97 – 3.81 (m, 4H), 
3.76 (dd, J = 6.1, 2.0 Hz, 1H), 2.58 – 2.48 (m, 2H), 2.33 (dt, J = 15.7, 4.2 Hz, 1H), 2.22 (d, J = 
13.3 Hz, 1H), 2.15 (dddd, J = 14.4, 11.0, 5.9, 2.6 Hz, 1H), 2.11 – 2.04 (m, 1H), 1.94 – 1.73 (m, 
4H), 1.66 – 1.41 (m, 8H), 1.39 – 1.20 (m, 3H), 1.06 (d, J = 1.9 Hz, 21H), 0.75 (s, 3H); 13C NMR 
for 3.28-1α  (126 MHz, CDCl3) δ 143.9, 122.5, 113.0, 80.4, 65.7, 64.5, 64.0, 54.3, 47.2, 46.4, 
37.3, 36.9, 35.7, 35.7, 33.2, 32.1, 31.8, 29.7, 25.7, 24.8, 18.3, 18.2, 17.7, 12.4; HRMS for 
C30H53O4Si (ASAP+): calcd 505.3713 ([M+H]+); found: 505.3717 ([M+H]+). 
 
Ketone 3.29: To a solution of secondary alcohol 3.28-1α/β  (196 mg, 387 µmol) in 
dichloromethane (7.7 mL) was added 4 Å molecular sieves (600 mg) and 4-methylmorpholine-
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and then tetrapropylammonium perruthenate (6.3 mg, 18 µmol, 0.05 equiv) was added as a solid. 
After 12 h at room temperature, the crude reaction mixture was directly purified by flash 
chromatography through pH 7.0 buffered silica gel (8% ethyl acetate in hexanes) to give 169 mg 
(87%) 3.29 as a white solid. [α]23D  = +138.3º (c 1.0, CH2Cl2, l = 50 mm); IR (thin film, neat) 
2939, 2864, 1741, 1463, 1081, 1017, 997, 882, 679 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.39 
(dd, J = 8.1, 5.0 Hz, 1H), 4.23 – 4.16 (m, 1H), 3.99 – 3.84 (m, 4H), 2.59 – 2.49 (m, 2H), 2.46 
(dd, J = 19.2, 8.8 Hz, 1H), 2.33 (dt, J = 15.8, 4.2 Hz, 1H), 2.20 (d, J = 13.3 Hz, 1H), 2.14 – 2.01 
(m, 3H), 1.96 (ddd, J = 12.0, 8.8, 5.7 Hz, 1H), 1.89 – 1.72 (m, 3H), 1.65 – 1.41 (m, 6H), 1.37 – 
1.28 (m, 2H), 1.06 (d, J = 2.3 Hz, 21H), 0.95 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 220.8, 
143.1, 123.0, 112.8, 65.6, 64.6, 64.0, 54.6, 49.9, 49.0, 36.9, 35.7, 35.6, 35.6, 35.1, 33.2, 31.8, 
29.3, 25.7, 22.0, 18.3, 18.2, 14.5, 12.4; HRMS for C30H50O4SiNa (ESI+): calcd 525.3376 
([M+Na]+); found: 525.3372 ([M+Na]+). 
 
Alkenyl Iodide 3.30: A suspension of ketone 3.29 (160 mg, 318 µmol) in a mixture of 200 proof 
ethanol (3.2 mL), hydrazine hydrate (160 µL, 3.30 mmol, 10 equiv), and triethylamine (170 µL, 
1.22 mmol, 4.0 equiv) was stirred under argon at 50 ºC for 17 h. After TLC and NMR indicated 
clean conversion of the ketone to the corresponding hydrazine, the volatiles were removed in 
vacuo and the resulting white solid was dissolved in tetrahydrofuran (3.2 mL) and added 
dropwise to a cold (0 ºC) solution of iodine (167 mg, 658 µmol, 2.0 equiv) and 1,1,3,3-
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After an additional 30 min at 0 ºC, the volatiles were removed in vacuo and the crude reaction 
mixture was purified by flash chromatography through pH 7.0 buffered silica gel (10% 
dichloromethane in hexanes) to afford 169 mg of an inseparable mixture of alkenyl iodide 3.30 
(75 %) and diiodide 3.30-1 (5 %) in 14.8 : 1 ratio as a yellow oil. IR (thin film, neat) 2938, 2865, 
1462, 1107, 1083, 1002, 883, 680 cm-1; 1H NMR for 3.30 (500 MHz, CDCl3) δ 6.11 (dd, J = 3.3, 
1.7 Hz, 1H), 5.39 (dd, J = 8.1, 5.1 Hz, 1H), 4.24 – 4.16 (m, 1H), 3.98 – 3.80 (m, 4H), 2.58 – 2.49 
(m, 2H), 2.33 (dt, J = 15.7, 4.2 Hz, 1H), 2.22 (d, J = 13.3 Hz, 1H), 2.20 – 2.05 (m, 3H), 1.98 
(ddd, J = 14.8, 11.4, 1.8 Hz, 1H), 1.89 – 1.81 (m, 2H), 1.72 – 1.48 (m, 4H), 1.41 (dd, J = 13.9, 
1.7 Hz, 1H), 1.37 – 1.22 (m, 3H), 1.06 (d, J = 2.2 Hz, 21H), 0.82 (s, 3H); 13C NMR for 3.30 (101 
MHz, CDCl3) δ 143.3, 137.1, 122.9, 113.1, 112.8, 65.7, 64.6, 64.0, 54.8, 53.8, 51.0, 36.9, 36.8, 
36.5, 35.5, 34.5, 34.0, 33.2, 29.8, 25.9, 18.3, 18.2, 15.8, 12.4; HRMS for C30H50IO3Si (ASAP+): 
calcd 613.2574 ([M+H]+); found: 613.2580 ([M+H]+). 
 
Enone 3.31: A solution of alkenyl iodide 3.30 (31 mg, 50 µmol) in dry tetrahydrofuran (1.0 mL) 
was added to a cooled (-78 ºC) solution of n-butyllithium (2.3 M in hexanes, 100 µL, 230 µmol, 
4.6 equiv) in tetrahydrofuran (1.0 mL). After 30 min, N-methoxy-N-methylacetamide (25 µL, 
235 µmol, 4.7 equiv) was added dropwise to the solution of alkenyl lithium. After 1 h at -78 ºC, 
the reaction was quenched with saturated aqueous NH4Cl (2.0 mL). The layers were partitioned 
and the aqueous phase extracted with diethyl ether (2 x 1 mL). The combined organic layers 























flash chromatography through pH 7.0 buffered silica gel (5-10% ethyl acetate in hexanes) to 
afford 13.8 mg (52%) of 3.31 as a colorless oil. [α]25D  = +103.1º (c 1.0, CH2Cl2, l = 50 mm); IR 
(thin film, neat) 2938, 2864, 1668, 1463, 1366, 1106, 1083, 882, 680 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 6.67 (dd, J = 3.5, 1.9 Hz, 1H), 5.38 (dd, J = 8.0, 5.2 Hz, 1H), 4.20 (ddt, J = 10.7, 5.3, 
2.5 Hz, 1H), 3.99 – 3.82 (m, 4H), 2.58 – 2.48 (m, 2H), 2.38 – 2.28 (m, 3H), 2.26 (s, 3H), 2.24 (d, 
J = 13.1 Hz, 1H), 2.15 – 2.02 (m, 3H), 1.90 – 1.76 (m, 2H), 1.69 – 1.52 (m, 3H), 1.46 (dtd, J = 
13.7, 4.2, 2.2 Hz, 1H), 1.43 – 1.24 (m, 3H), 1.06 (d, J = 1.8 Hz, 21H), 0.97 (s, 3H); 13C NMR 
(101 MHz, CDCl3) δ 196.9, 156.0, 143.9, 143.7, 122.6, 112.9, 65.7, 64.6, 64.0, 55.3, 55.0, 47.3, 
37.4, 36.9, 35.4, 35.0, 33.8, 33.2, 32.6, 30.0, 27.3, 25.8, 18.3, 18.2, 16.5, 12.4; HRMS for 
C32H52O4SiNa (ESI+): calcd 551.3533 ([M+Na]+); found: 551.3525 ([M+Na]+). 
 
Ketone 3.33: To a solution of enone 3.31 (13 mg, 25 µmol) in benzene (1.0 mL) was added 
water (10 µL, 0.56 mmol, 22 equiv) and [CuH(PPh3)]6 (38 mg, 20 µmol, 0.8 equiv). The reaction 
was stirred under argon at room temperature for 12 h and then exposed to air for 30 min. The 
slurry was filtered through Celite to remove the copper impurities then washed with hexanes (1 
mL). The filtrate was concentrated and the crude oil was purified by flash chromatography 
through pH 7.0 buffered silica gel (40% CH2Cl2 in hexanes then 4% ethyl acetate in hexanes) to 
afford 13.6 mg (99%) of 3.33 as a colorless oil. [α]25D  = +98.0º (c 1.0, CH2Cl2, l = 50 mm); IR 
(thin film, neat) 2928, 2864, 1705, 1463, 1361, 1083, 1056, 1003, 882, 680 cm-1; 1H NMR (500 






















2.48 (m, 3H), 2.34 (dt, J = 15.6, 4.2 Hz, 1H), 2.24 – 2.12 (m, 2H), 2.11 (s, 3H), 2.07 (dd, J = 
11.3, 5.3 Hz, 1H), 1.97 (dt, J = 11.1, 1.9 Hz, 1H), 1.93 – 1.79 (m, 3H), 1.76 – 1.62 (m, 2H), 1.61 
– 1.23 (m, 8H), 1.06 (d, J = 1.9 Hz, 21H), 0.71 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 209.6, 
143.7, 122.7, 112.9, 65.7, 64.6, 64.2, 64.0, 55.2, 54.4, 45.2, 39.4, 36.9, 36.8, 35.8, 35.4, 33.2, 
31.6, 30.1, 25.7, 24.7, 22.7, 18.3, 18.2, 14.0, 12.4; HRMS for C32H54O4SiNa (ESI+): calcd 
553.3689 ([M+Na]+); found: 553.3690 ([M+Na]+). 
 
Allylic alcohol 3.35: To a cooled (-78 ºC) solution of alkenyl iodide 3.34 (35 µL, 150 µmol, 5.9 
equiv) in tetrahydrofuran (0.5 mL) was added dropwise a solution of n-butyllithium (2.3 M in 
hexanes, 60 µL, 138 µmol, 5.4 equiv). After 30 min, a solution of ketone 3.33 (13.6 mg, 25.6 
µmol) in tetrahydrofuran (0.5 mL) was added and the reaction stirred for an additional 1 h at -78 
ºC. The reaction was quenched with saturated aqueous NH4Cl (1.0 mL). The layers were 
partitioned and the aqueous phase extracted with diethyl ether (2 x 1 mL). The combined organic 
layers were dried over Na2SO4, filtered, and concentrated. The crude reaction mixture was 
purified by flash chromatography through pH 7.0 buffered silica gel (8% diethyl ether in 
hexanes) to afford 14.2 mg (77%) of 3.35 as a colorless oil. [α]24D  = +47.1º (c 1.0, CH2Cl2, l = 
50 mm); IR (thin film, neat) 3496 (br), 2927, 2864, 1462, 1364, 1253, 1083, 1057, 1002, 835, 
680 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.73 (dd, J = 15.6, 1.4 Hz, 1H), 5.56 (dd, J = 15.6, 5.2 
Hz, 1H), 5.37 (dd, J = 8.1, 5.0 Hz, 1H), 4.30 (tt, J = 7.7, 5.7 Hz, 1H), 4.21 – 4.16 (m, 1H), 3.96 – 



























– 2.00 (m, 2H), 1.91 – 1.80 (m, 2H), 1.76 (td, J = 11.5, 10.6, 3.5 Hz, 1H), 1.69 – 1.24 (m, 16H), 
1.19 (d, J = 6.3 Hz, 3H), 1.06 (d, J = 1.7 Hz, 21H), 0.89 (s, 12H), 0.05 (d, J = 4.3 Hz, 6H); 13C 
NMR (101 MHz, CDCl3) δ 144.1, 136.3, 130.7, 122.3, 113.1, 75.3, 69.0, 65.8, 64.5, 64.0, 60.5, 
54.8, 54.5, 44.3, 40.8, 36.9, 36.6, 35.8, 34.7, 33.3, 30.1, 29.9, 29.3, 26.1, 25.7, 24.8, 24.2, 23.2, 
18.5, 18.3, 18.3, 14.6, 12.5, 12.4, -4.4, -4.6; HRMS for C42H76O5Si2Na (ESI+): calcd 739.5129 
([M+Na]+); found: 739.5123 ([M+Na]+). 
 
Diol 3.14-1: To a solution of vinyl epoxide 1.364  (200 mg, 648 µmol) and TBDPS ether 3.12 
(388 mg, 778 µmol, 1.2 equiv) in chloroform (12 mL) was added Hoveyda-Grubbs II (24 mg, 38 
µmol, 0.06 equiv) catalyst. The resulting green solution was purged with nitrogen and refluxed 
for 18 h, then cooled to room temperature and concentrated. The black residue was passed 
through a silica gel plug (slurry packed with 1% triethylamine in hexane and eluted with 5-10% 
diethyl ether in hexanes) to give a crude mixture of the desired ketone (3.9:1 mixture of E/Z 
isomers) and homodimer of 3.12. The crude ketone was diluted with tetrahydrofuran (2.7 mL) 
and cooled to -78 ºC, then treated to a dropwise addition of allylmagnesium bromide (1.0 M in 
Et2O, 2.2 mL, 2.2 mmol, 3.4 equiv). After 1 h at -78 ºC, the mixture was quenched with saturated 
aqueous NH4Cl (5 mL) then stirred to room temperature. The layers were partitioned and the 
aqueous phase extracted with diethyl ether (3 x 3 mL). The combined organic layers were dried 
over Na2SO4, filtered, and concentrated. The crude reaction mixture was repeatedly purified (3 
times) by flash chromatography through pH 7.0 buffered silica gel (5-10% ethyl acetate in 












1. 6 mol% Hoveyda-Grubbs II
    CHCl3, reflux




CH2Cl2, l = 50 mm); IR (thin film, neat) 3429 (br), 2928, 2864, 1467, 1428, 1112, 1059, 1006, 
883, 703, 505 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.68 (dt, J = 8.0, 1.7 Hz, 4H), 7.47 – 7.36 (m, 
6H), 5.84 (ddt, J = 17.5, 10.2, 7.5 Hz, 1H), 5.26 – 5.20 (m, 1H), 5.20 – 5.04 (m, 3H), 4.46 (td, J 
= 8.3, 3.8 Hz, 1H), 4.06 (t, J = 5.2 Hz, 1H), 3.58 (dd, J = 10.2, 3.7 Hz, 1H), 3.51 (dd, J = 10.2, 
8.3 Hz, 1H), 2.70 (d, J = 16.8 Hz, 1H), 2.29 (ddd, J = 13.4, 5.2, 3.2 Hz, 2H), 2.21 – 2.10 (m, 
4H), 2.07 – 1.88 (m, 5H), 1.72 (dt, J = 13.7, 2.9 Hz, 1H), 1.67 (dt, J = 14.2, 2.8 Hz, 1H), 1.57 (d, 
J = 1.3 Hz, 3H), 1.08 (s, 9H), 1.02 (d, J = 1.6 Hz, 21H); 13C NMR (126 MHz, CDCl3) δ 143.0, 
141.0, 135.7, 133.9, 133.4, 133.3, 130.0, 129.9, 127.9, 122.7, 120.7, 119.6, 77.3, 69.5, 67.8, 65.6, 
48.8, 42.9, 39.9, 39.3, 37.9, 36.0, 31.4, 27.0, 26.9, 19.4, 18.3, 18.3, 16.8, 12.3; HRMS for 
C44H68O4Si2Na (ESI+): calcd 739.4554 ([M+Na]+); found: 739.4548 ([M+Na]+). 
 
Acrylate 3.15-1: To a cooled (0 ºC) solution of (E)-diol 3.14-1 (155 mg, 217 µmol) in 
dichloromethane (0.7 mL) was added triethylamine (300 µL, 2.15 mmol, 10 equiv), acrylic acid 
(45 µL, 656 µmol, 3.0 equiv) then 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (166 mg, 866 
µmol, 4.0 equiv). The resulting slurry was allowed to warm to room temperature and stirred for 
14 h, then diluted with dichloromethane (2 mL) and poured into saturated aqueous NaHCO3 (2 
mL). The layers were separated and the aqueous phase was extracted with diethyl ether (3 x 2 
mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated. The crude 
reaction mixture was purified by flash chromatography through pH 7.0 buffered silica gel (5-
30% ethyl acetate in hexanes) to give 89 mg (53%) 3.15-1 as a yellow oil and 70 mg (45%) 
















2863, 1725, 1462, 1428, 1404, 1267, 1193, 1113, 1059, 1007, 882, 703 cm-1; 1H NMR (500 
MHz, CDCl3) δ 7.67 (ddd, J = 7.9, 4.3, 1.5 Hz, 4H), 7.45 – 7.34 (m, 6H), 6.39 (dd, J = 17.3, 1.6 
Hz, 1H), 6.13 (dd, J = 17.3, 10.4 Hz, 1H), 5.88 – 5.73 (m, 3H), 5.23 (dq, J = 8.6, 4.5, 3.7 Hz, 
1H), 5.16 (dd, J = 10.2, 2.2 Hz, 1H), 5.14 – 5.09 (m, 2H), 4.06 (t, J = 5.2 Hz, 1H), 3.76 (dd, J = 
10.8, 7.3 Hz, 1H), 3.64 (dd, J = 10.8, 4.3 Hz, 1H), 2.71 (d, J = 16.5 Hz, 1H), 2.30 (dtd, J = 13.6, 
5.4, 3.3 Hz, 2H), 2.21 – 2.09 (m, 4H), 2.07 – 1.88 (m, 5H), 1.76 – 1.63 (m, 5H), 1.64 – 1.54 (m, 
1H), 1.03 (s, 9H), 1.02 (d, J = 1.4 Hz, 21H); 13C NMR (126 MHz, CDCl3) δ 165.7, 143.1, 142.8, 
135.8, 135.8, 133.8, 133.6, 130.4, 129.8, 129.8, 129.1, 127.8, 127.8, 120.5, 119.7, 119.6, 77.2, 
72.3, 65.7, 48.8, 42.9, 40.0, 39.3, 37.9, 36.0, 31.4, 26.9, 26.9, 19.3, 18.3, 18.3, 17.1, 12.3; HRMS 
for C47H70O5Si2Na (ESI+): calcd 793.4659 ([M+Na]+); found: 793.4670 ([M+Na]+). 
 
Macrolactone 3.19: To a solution of acrylate 3.15-1 (124 mg, 160 µmol) in dichloromethane (32 
mL) was added Hoveyda-Grubbs II catalyst (10 mg, 16 µmol, 0.10 equiv) and the mixture was 
heated at reflux. After 16 h, the mixture was cooled and ethyl vinyl ether (0.5 mL) was added. 
The resulting mixture was stirred open to the air for 1 h, and then concentrated. The crude 
reaction mixture was purified by flash chromatography through pH 7.0 buffered silica gel (5-
10% ethyl acetate in hexanes) to give 94 mg (79%) 3.19 as a white solid. [α]24D  = +48.7º (c 0.4, 
CH2Cl2, l = 50 mm); IR (thin film, neat) 3405 (br), 2923, 2854, 1714, 1461, 1428, 1112, 1058, 
1025, 1011, 818, 703 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.67 (dd, J = 6.5, 4.9 Hz, 4H), 7.44 – 
7.33 (m, 6H), 6.33 (ddd, J = 11.6, 9.1, 5.8 Hz, 1H), 5.87 (d, J = 11.7 Hz, 1H), 5.73 (ddd, J = 
10.5, 6.7, 4.3 Hz, 1H), 5.16 – 5.08 (m, 2H), 4.04 (t, J = 5.2 Hz, 1H), 3.79 (dd, J = 11.0, 6.7 Hz, 















1H), 3.72 (dd, J = 11.0, 4.2 Hz, 1H), 3.01 (dd, J = 15.8, 9.4 Hz, 1H), 2.64 (d, J = 16.2 Hz, 1H), 
2.48 (ddd, J = 15.8, 6.0, 1.9 Hz, 1H), 2.29 – 2.07 (m, 5H), 1.99 – 1.83 (m, 4H), 1.76 (s, 3H), 1.73 
(d, J = 12.0 Hz, 1H), 1.67 (d, J = 14.6 Hz, 1H), 1.30 (s, 1H), 1.03 (s, 9H), 1.02 (d, J = 2.4 Hz, 
21H); 13C NMR (126 MHz, CDCl3) δ 166.4, 143.8, 143.0, 141.4, 135.8, 135.8, 133.7, 133.7, 
129.8, 129.7, 127.8, 127.7, 122.8, 121.2, 120.9, 77.9, 71.0, 65.6, 65.2, 49.5, 39.7, 39.2, 39.1, 
37.9, 35.8, 31.3, 29.9, 26.9, 26.7, 19.4, 18.3, 18.3, 16.6, 12.2; HRMS for C45H66O5Si2Na (ESI+): 
calcd 765.4346 ([M+Na]+); found: 765.4354 ([M+Na]+). 
 
Ketoester 3.20: To a solution of macrolactone 3.19 (83 mg, 112 µmol) in trifluorotoluene (2.2 
mL) in a scintillation vial was added 1,8-diazabicyclo[5.4.0]undec-7-ene (170 µL, 1.14 mmol, 10 
equiv) and Me2PhSiCl (190 µL, 1.13 mmol, 10 equiv). The vessel was sealed under argon using 
a PTFE lined screw cap and heated to 140 ºC. After 24 h, the solution was cooled and then 
poured into aqueous 1 M HCl (2 mL). The layers were separated and the aqueous phase was 
extracted with diethyl ether (4 x 2 mL). The combined organics were dried over Na2SO4, filtered, 
and concentrated. The residue was dissolved in diethyl ether (0.5 mL) and methanol (1.8 mL), 
and the resulting solution was treated with TMS-diazomethane (2.0 M in hexanes, 230 µL, 460 
µmol, 4.1 equiv). After stirring for 2 h at room temperature, the solution was concentrated and 
the residue was purified by flash chromatography through silica gel (4% ethyl acetate in 
hexanes) to give 60 mg (71%) 3.20 as a pale yellow oil. [α]23D  = +10.2º (c 1.0, CH2Cl2, l = 50 
mm); IR (thin film, neat) 2939, 2862, 1733, 1687, 1462, 1429, 1372, 1154, 1109, 1064, 882, 823, 
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(dt, J = 15.8, 1.7 Hz, 1H), 5.62 (t, J = 7.3 Hz, 1H), 5.52 (dt, J = 15.7, 4.8 Hz, 1H), 4.15 (dd, J = 
4.8, 1.6 Hz, 2H), 3.51 (s, 3H), 3.47 (ddt, J = 10.3, 6.8, 3.2 Hz, 1H), 2.84 – 2.71 (m, 2H), 2.66 
(dd, J = 13.2, 4.4 Hz, 1H), 2.59 – 2.51 (m, 2H), 2.50 – 2.42 (m, 3H), 2.35 (d, J = 16.9 Hz, 1H), 
2.28 (ddt, J = 13.6, 8.4, 2.2 Hz, 1H), 2.24 – 2.13 (m, 2H), 1.72 (ddd, J = 13.0, 10.2, 4.7 Hz, 1H), 
1.60 – 1.51 (m, 2H), 1.36 (dd, J = 13.4, 3.3 Hz, 1H), 1.17 (s, 3H), 1.04 (d, J = 2.1 Hz, 31H); 13C 
NMR (126 MHz, CDCl3) δ 212.7, 173.4, 146.8, 138.4, 135.7, 135.7, 134.0, 133.9, 129.7, 127.8, 
126.6, 124.1, 66.0, 64.6, 54.8, 51.1, 49.6, 48.7, 45.8, 45.3, 38.0, 37.3, 32.8, 31.2, 27.0, 26.6, 26.2, 
25.3, 19.4, 18.2, 18.2, 12.4; HRMS for C46H68O5Si2Na (ESI+): calcd 779.4503 ([M+Na]+); 
found: 779.4520 ([M+Na]+). 
 
Ketal 3.21: To a solution of ketone 3.20 (54 mg, 71 µmol) in benzene (1.4 mL) was added 
ethylene glycol (80.0 µL, 1.43 µmol, 20 equiv), triethyl orthoformate (120 µL, 721 µmol, 10 
equiv), and para-toluenesulfonic acid (1.0 mg, 5.3 µmol, 0.07 equiv). The solution was then 
heated to 60 ºC. After 16 h, the reaction was poured into saturated aqueous NaHCO3 (1 mL). The 
layers were partitioned and the aqueous phase extracted with diethyl ether (3 x 1 mL). The 
combined organic layers were dried over Na2SO4, filtered, and concentrated. The crude reaction 
mixture was purified by flash chromatography through silica gel (3-5% ethyl acetate in hexanes) 
to give 52 mg (92%) 3.21 as a colorless oil. [α]23D  = +56.8º (c 1.0, CH2Cl2, l = 50 mm); IR (thin 
film, neat) 2940, 2863, 1734, 1462, 1430, 1365, 1149, 1109, 1086, 1059, 1002, 882, 823, 704, 
505 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.66 (dt, J = 7.8, 1.4 Hz, 4H), 7.44 – 7.35 (m, 6H), 5.69 






















4.16 (m, 1H), 4.14 (dd, J = 4.9, 1.6 Hz, 2H), 3.95 – 3.84 (m, 4H), 3.50 (s, 3H), 2.68 (td, J = 11.2, 
7.8 Hz, 1H), 2.58 – 2.48 (m, 2H), 2.41 (d, J = 4.6 Hz, 1H), 2.38 – 2.29 (m, 2H), 2.23 – 2.12 (m, 
2H), 2.06 (dt, J = 11.4, 6.2 Hz, 1H), 1.81 (dt, J = 14.0, 5.8 Hz, 1H), 1.63 (dd, J = 13.9, 9.8 Hz, 
1H), 1.52 – 1.45 (m, 2H), 1.35 – 1.24 (m, 4H), 1.18 (s, 3H), 1.05 (d, J = 8.7 Hz, 31H); 13C NMR 
(126 MHz, CDCl3) δ 174.0, 143.4, 139.2, 139.1, 135.7, 135.7, 134.0, 134.0, 129.7, 127.8, 126.0, 
122.9, 112.9, 65.7, 64.7, 64.7, 64.2, 57.0, 50.9, 44.7, 38.5, 38.1, 36.9, 35.7, 33.8, 33.1, 31.9, 29.2, 
27.0, 25.5, 24.8, 19.4, 18.3, 18.2, 12.4; HRMS for C48H72O6Si2Na (ESI+): calcd 823.4765 
([M+Na]+); found: 823.4777 ([M+Na]+). 
 
Diol 3.17-1α/β: To a solution of ester 3.17 (175 mg, 273 µmol) in tetrahydrofuran (2.7 mL) was 
added LiAlH4 (104 mg, 2.74 mmol, 10 equiv). The reaction was heated at 50 ºC for 17 h, then 
diluted with diethyl ether (1 mL) and cooled to 0 ºC. The resulting mixture was slowly quenched 
by the dropwise addition of water (138 µL), followed by 3 M NaOH (165 µL) and additional 
water (413 µL). The slurry was warmed to room temperature and stirred for 1 h until a fine white 
precipitate formed, then MgSO4 (500 mg) was added as a solid. The mixture was filtered through 
Celite and concentrated. The crude reaction mixture was purified by flash chromatography 
through silica gel (20-50% ethyl acetate in hexanes) to give 138 mg (82%) 3.17-1α  : 3.17-1β  in 
a 5 : 1 ratio as pale yellow oil. [α]23D  for 3.17-1α  = +54.0º (c 1.0, CH2Cl2, l = 50 mm); IR (thin 
film, neat) 3366 (br), 2933, 2864, 1612, 1514, 1464, 1248, 1095, 1060, 1037, 882, 825, 676 cm-1; 
1H NMR for 3.17-1α  (500 MHz, CDCl3) δ 7.26 (d, J = 8.4 Hz, 2H), 6.88 (d, J = 8.6 Hz, 2H), 





























4.45 (s, 2H), 4.26 (ddd, J = 8.0, 5.1, 3.0 Hz, 1H), 3.96 (dd, J = 6.1, 1.2 Hz, 2H), 3.80 (s, 3H), 
3.79 (br s, 1H), 3.65 (ddd, J = 11.4, 7.5, 3.9 Hz, 1H), 3.48 (ddd, J = 11.5, 8.6, 2.1 Hz, 1H), 2.60 
(dd, J = 13.6, 6.0 Hz, 1H), 2.53 (ddd, J = 15.9, 9.3, 8.1 Hz, 1H), 2.37 – 2.28 (m, 2H), 1.89 (d, J = 
13.2 Hz, 1H), 1.84 (ddd, J = 12.6, 9.2, 3.8 Hz, 1H), 1.79 – 1.64 (m, 5H), 1.51 (ddt, J = 7.4, 3.6, 
1.6 Hz, 1H), 1.48 – 1.25 (m, 6H), 1.16 (s, 3H), 1.06 (d, J = 2.2 Hz, 21H); 13C NMR for XXα  
(101 MHz, CDCl3) δ 159.4, 145.3, 143.2, 130.5, 129.5, 122.5, 122.4, 114.0, 72.2, 70.5, 65.5, 
60.9, 55.4, 55.1, 47.3, 39.1, 38.4, 37.1, 36.4, 32.5, 30.8, 29.5, 29.2, 25.6, 25.4, 18.3, 18.3, 18.3, 
12.4, 12.4; HRMS for C37H60O5SiNa (ESI+): calcd 635.4108 ([M+Na]+); found: 635.4089 
([M+Na]+). 
 
Aldehyde 3.24-1β: To a cooled (-78 ºC) solution of oxalyl chloride (205 µL, 2.42 mmol, 12 
equiv) in dichloromethane (1.5 mL) was added DMSO (260 µL, 3.66 mmol, 18 equiv). After 10 
min, a solution of diol 3.17-1α/β  (124 mg, 202 µmol) in dichloromethane (2.0 mL) was added 
by syringe. The reaction was warmed to -50 ºC and stirred for 1 h, then triethylamine (680 µL, 
4.88 mmol, 24 equiv) was added and the reaction was allowed to warmed to room temperature. 
The mixture was poured into saturated aqueous NaHCO3 (3 mL). The layers were partitioned 
and the aqueous phase extracted with dichloromethane (2 x 2 mL). The combined organic layers 
were dried over Na2SO4, filtered, and concentrated. The crude aldehyde was dissolved in 
methanol (4 mL) and then treated with potassium carbonate (290 mg, 2.10 mmol, 10 equiv). The 
resulting slurry was stirred vigorously for 22 h, then diluted with dichloromethane (2 mL) and 
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diethyl ether (2 x 2 mL). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated. The crude reaction mixture was purified by flash chromatography through pH 7.0 
buffered silica gel (10-20% ethyl acetate in hexanes) to give 106 mg (86%) 3.24-1β  : 3.24-1α  in 
a 8.5 : 1 ratio as a pale yellow oil. [α]24D  = +38.1º (c 1.0, CH2Cl2, l = 50 mm); IR (thin film, 
neat) 2939, 2864, 1719, 1686, 1513, 1464, 1248, 1091, 1064, 1040, 882, 804, 680 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 9.76 (d, J = 3.9 Hz, 0.1H for (R)-isomer), 9.60 (d, J = 2.8 Hz, 0.9H for (S)-
isomer), 7.26 (d, J = 8.6 Hz, 2H), 6.88 (d, J = 8.6 Hz, 2H), 5.77 (dt, J = 15.9, 1.3 Hz, 0.9H for 
(S)-isomer), 5.71 (dt, J = 15.9, 1.3 Hz, 0.1H for (R)-isomer), 5.63 – 5.51 (m, 2H), 4.43 (s, 1.8H 
for (S)-isomer), 4.40 (s, 0.2H for (R)-isomer), 3.98 (dd, J = 5.8, 1.3 Hz, 1.8H for (S)-isomer), 
3.95 (dd, J = 5.8, 1.3 Hz, 0.2H for (R)-isomer), 3.81 (s, 3H), 3.56 (tt, J = 10.5, 3.6 Hz, 0.9H for 
(S)-isomer), 3.50 (tt, J = 9.9, 3.5 Hz, 0.1H for (R)-isomer), 2.80 (dt, J = 8.2, 4.5 Hz, 0.9H for (S)-
isomer), 2.74 – 2.45 (m, 6H), 2.29 – 2.21 (m, 1H), 2.18 (dd, J = 11.0, 2.8 Hz, 0.9H for (S)-
isomer), 2.04 (dd, J = 17.9, 12.2 Hz, 0.9H for (S)-isomer), 1.92 (td, J = 11.2, 3.4 Hz, 1H), 1.68 
(ddd, J = 13.0, 10.2, 4.3 Hz, 1H), 1.58 (t, J = 11.1 Hz, 2H), 1.54 – 1.44 (m, 2H), 1.21 (s, 0.3H for 
(R)-isomer), 1.14 (s, 2.7H for (S)-isomer), 1.05 (d, J = 1.9 Hz, 19H for (S)-isomer), 1.04 (d, J = 
2.2 Hz, 2H for (R)-isomer); 13C NMR (126 MHz, CDCl3) for 3.24-1β  δ 211.3, 204.6, 159.4, 
146.8, 141.8, 130.4, 129.6, 125.0, 124.1, 114.0, 72.0, 70.5, 65.4, 61.6, 55.4, 52.6, 49.6, 48.5, 
44.8, 39.9, 39.3, 37.2, 31.0, 27.0, 26.9, 18.6, 18.2, 18.2, 12.4; HRMS for C37H56O5SiNa (ESI+): 






Olefin 3.56: To a cooled (0 ºC) slurry of MePPh3Br (75 mg, 210 µmol, 1.05 equiv) in 
tetrahydrofuran (1.0 mL) was added KHMDS (1.0 M in THF, 210 µL, 210 µmol, 1.05 equiv) 
and the suspension was stirred for 30 min. The ylide was then added dropwise to a cooled (-78 
ºC) solution of aldehyde 3.24-1β  (122 mg, 200 µmol) in tetrahydrofuran (1.0 mL). After 15 min, 
the reaction was warmed to room temperature and stirred for 1 h. The reaction was poured into 
saturated aqueous NH4Cl (2 mL), then the layers were partitioned and the aqueous phase 
extracted with dichloromethane (2 x 1 mL). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated. The crude reaction mixture was purified by flash 
chromatography through silica gel (5-8% ethyl acetate in hexanes) to afford 105 mg (86%) 3.56 
as a single diastereomer. [α]25D  = +19.9º (c 1.0, CH2Cl2, l = 50 mm); IR (thin film, neat) 2924, 
2863, 1685, 1513, 1464, 1247, 1093, 1064, 1042, 916, 882, 804, 681 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.24 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 5.61 (dt, J = 15.9, 1.3 Hz, 1H), 5.52 
(dd, J = 8.2, 6.5 Hz, 1H), 5.48 – 5.38 (m, 2H), 5.07 (dd, J = 10.2, 2.1 Hz, 1H), 4.87 (dd, J = 17.0, 
2.0 Hz, 1H), 4.43 – 4.35 (m, 2H), 3.99 – 3.90 (m, 2H), 3.80 (s, 3H), 3.55 (tt, J = 10.4, 3.5 Hz, 
1H), 2.74 (q, J = 5.0 Hz, 1H), 2.71 – 2.64 (m, 1H), 2.64 – 2.52 (m, 3H), 2.49 (d, J = 13.7 Hz, 
1H), 2.25 (dddd, J = 13.5, 8.3, 3.0, 1.9 Hz, 1H), 2.15 – 1.99 (m, 2H), 1.91 (td, J = 10.6, 3.5 Hz, 
1H), 1.73 – 1.52 (m, 5H), 1.49 – 1.44 (m, 1H), 1.07 – 1.02 (m, 24H); 13C NMR (126 MHz, 
CDCl3) δ 213.1, 159.3, 147.7, 145.0, 137.4, 130.7, 129.5, 123.2, 122.9, 118.6, 113.9, 71.3, 71.0, 
65.7, 55.9, 55.4, 53.7, 49.7, 49.0, 45.0, 39.3, 38.8, 37.2, 34.4, 27.2, 26.9, 18.3, 18.2, 18.2, 12.5; 



















Primary Allylic Alcohol 3.60: To a solution of PMB-protected allylic alcohol 3.56 (65 mg, 107 
µmol) in dichloromethane (5.4 mL) and water (270 µL) was added 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (48.2 mg, 212 µmol, 2.0 equiv) as a solid. The reaction was vigorously stirred at 
room temperature for 1 h and then quenched with saturated aqueous NaHCO3 (4 mL). The layers 
were partitioned and the aqueous phase extracted with diethyl ether (3 x 3 mL). The combined 
organic layers were dried over Na2SO4, filtered, and concentrated. The crude reaction mixture 
was purified by flash chromatography through silica gel (15% ethyl acetate in hexanes) to afford 
52 mg (99%) of 3.60 as a pale yellow oil. [α]25D  = +18.0º (c 1.0, CH2Cl2, l = 50 mm); IR (thin 
film, neat) 3390 (br), 2941, 2923, 2864, 1683, 1464, 1092, 1067, 997, 916, 882, 801, 681 cm-1; 
1H NMR (500 MHz, CDCl3) δ 5.61 (d, J = 15.8 Hz, 1H), 5.56 – 5.47 (m, 2H), 5.41 (dt, J = 17.0, 
10.0 Hz, 1H), 5.07 (dd, J = 10.2, 2.0 Hz, 1H), 4.85 (dd, J = 17.1, 2.0 Hz, 1H), 4.08 (d, J = 5.8 
Hz, 2H), 3.55 (tt, J = 10.5, 3.5 Hz, 1H), 2.74 (q, J = 5.1 Hz, 1H), 2.67 (dd, J = 13.0, 4.4 Hz, 1H), 
2.63 – 2.52 (m, 3H), 2.49 (d, J = 13.6 Hz, 1H), 2.25 (ddt, J = 13.4, 8.3, 2.4 Hz, 1H), 2.16 – 1.98 
(m, 2H), 1.91 (td, J = 10.8, 3.4 Hz, 1H), 1.73 – 1.51 (m, 5H), 1.50 – 1.43 (m, 1H), 1.31 (br s, 
1H), 1.08 – 1.01 (m, 24H); 13C NMR (126 MHz, CDCl3) δ 213.1, 147.6, 143.8, 137.3, 125.4, 
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Our expedition into the unchartered territory of cyclocitrinol has been chronicled in this 
thesis and in the theses of Drs. Arash Soheili and Chris Plummer. The journey toward 
accomplishing the first de novo synthesis of this unique steroid, which contains a rare 
bicyclo[4.4.1]undec-7,10-diene AB ring with a bridgehead double bond, has been fraught with 
many challenges, multiple missteps and a few sweet moments in between.  
For our proposed synthesis of cyclocitrinol there were two main challenges. The first 
challenge was the formation of a key highly strained, 10-membered macrocyclic intermediate, 
which we proposed could undergo a strain-accelerated Cope rearrangement to generate the 
bridged [4.4.1]-bicycle of the AB ring rapidly. This was eventually accomplished through a ring-
contraction strategy, which led to the development of a tandem Ireland-Claisen/Cope 
rearrangement to form the ABC tricyclic core (Chapter 1). The second challenge was converting 
the limited functionality of the resulting ABC core into the fully elaborated structure of 
cyclocitrinol. Although a Claisen/Cope/Claisen strategy to access the C17 side-chain and form 
the D ring was evaluated (Chapter 2), we ultimately attained the ABCD tetracyclic core of 
cyclocitrinol through a 1,3-allylic transposition followed by ring-closing metathesis to give a 
C17 keto D-ring, which allowed the facile installation of the C17 side-chain (Chapter 3).  
The collective efforts of multiple members of the Leighton group have laid the 













APPENDIX 1:  
















































































































































































































































































































































Spectrum 2.31. NOESY NMR (500 MHz, CDCl3) of compound 2.61. 
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APPENDIX 2:  
CHAPTER 3 SPECTRAL DATA 
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 Spectrum 3.68. Chiral GC spectra (β-Dex 325, Supelco, 90 °C for 5 min, ramp 2 °C/min to 
160 °C, 20 psi) for the ee% determination of 3.9. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
